<!DOCTYPE html>

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>WAAMS - Western Australia AntiMicrobial Stewardship</title>
    <link rel="shortcut icon" type="image/ico" href="favicon.ico" />
    <link rel="apple-touch-icon" href="apple-touch-icon-precomposed.png">
    <link rel="apple-touch-icon-precomposed" href="apple-touch-icon-precomposed.png">
    <link rel="stylesheet" href="bootstrap/css/bootstrap.min.css" />
    <link rel="stylesheet" href="bootstrap/css/bootstrap-theme.min.css" />
    <link rel="stylesheet" href="bootstrap/css/basic.css" />
    <link rel="stylesheet" href="bootstrap/css/style.css" />
    <script src="bootstrap/js/jquery-1.11.1.min.js"></script>
    <script type="text/javascript" src="bootstrap/js/codecheckWA.js"></script>
    <!-- Needed for Forms Feature Detection -->
    <script src="polyfill/better-dom.min.js"></script>
    <!-- Needed for Validation -->
    <script src="polyfill/better-dateinput-polyfill.js"></script>
    <script src="polyfill/ie-array-polyfill.js"></script>
    <!-- General helpful functions -->
    <script src="bootstrap/js/kraken.js"></script>
</head>

<body>

        <!-- loading page -->
        <div data-role="page" id="load" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
                <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                        Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Loading</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Loading</span>
                </h3>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span
                        class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /load -->


    <!-- start of DOG,CAT,HUMAN Bite treatment maze -->
    <!-- Start of penicillin allergy page: #bite -->
    <div data-role="page" id="bite" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog,Cat or Human Bite</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <br>
            <h4 class="mrgn20b biteSpecial">
                <span class="font15">For bites and clenched-fist injuries that are not infected, antibiotic therapy is
                    usually not necessary for otherwise healthy individuals if the risk of wound infection is low (eg
                    small wounds not involving deeper tissues that present within 8 hours and can be adequately debrided
                    and irrigated).</span>
            </h4>
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bite1">No penicillin allergy</a></li>
                <li><a href="#bite2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#bite3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite -->

    <!-- start of DOG,CAT,HUMAN Bite treatment maze, NO Pen Allergy, -->
    <div data-role="page" id="bite1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog,Cat or Human Bite</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the infection?</span>
                <span class="font15">Prophylactic antibiotic therapy may not be required if there is no established
                    infection. &#40;see list below for details on when antibiotic prophylaxis is required&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bite1a">No infection established &#40;prophylaxis&#41;</a></li>
                <li><a href="#bite1b">Established mild infection &#40;not involving deep tissues&#41;</a></li>
                <li><a href="#bite1c">Established moderate/severe infection</a></li>
            </ul>
            <hr>
            <span class="color-primary">Antibiotic prophylaxis is only required for bites and fist injuries with
                established infection or a high risk of infection such as:</span>
            <ul type=circle>
                <li>Wounds with delayed presentation for washout &#40;8 hours or more&#41;</li>
                <li>Puncture wounds which can not be debrided adequately</li>
                <li>Any wounds on the hands feet or face</li>
                <li>Wounds involving deeper tissues &#40;eg. bones, joints, tendons&#41;</li>
                <li>Wounds in immunocompromised patients</li>
                <li>Wounds which also involve an open fracture &#40;see open fracture section&#41;</li>
                <li>Any cat bite</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite1 -->

    <!-- start of DOG,CAT,HUMAN Bite treatment maze, MILD Pen Allergy, -->
    <div data-role="page" id="bite2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog,Cat or Human Bite</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the infection?</span>
                <span class="font15">Prophylactic antibiotic therapy may not be required if there is no established
                    infection. &#40;see list below for details on when antibiotic prophylaxis is required&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bite2a">No infection established &#40;prophylaxis&#41;</a></li>
                <li><a href="#bite2b">Established mild infection &#40;not involving deep tissues&#41;</a></li>
                <li><a href="#bite2c">Established moderate/severe infection</a></li>
            </ul>
            <hr>
            <span class="color-primary">Antibiotic prophylaxis is only required for bites and fist injuries with
                established infection or a high risk of infection such as:</span>
            <ul type=circle>
                <li>Wounds with delayed presentation for washout &#40;8 hours or more&#41;</li>
                <li>Puncture wounds which can not be debrided adequately</li>
                <li>Any wounds on the hands feet or face</li>
                <li>Wounds involving deeper tissues &#40;eg. bones, joints, tendons&#41;</li>
                <li>Wounds in immunocompromised patients</li>
                <li>Wounds which also involve an open fracture &#40;see open fracture section&#41;</li>
                <li>Any cat bite</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite1 -->


    <!-- start of DOG,CAT,HUMAN Bite treatment maze, BAD Pen Allergy, -->
    <div data-role="page" id="bite3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog,Cat or Human Bite</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the infection?</span>
                <span class="font15">Prophylactic antibiotic therapy may not be required if there is no established
                    infection. &#40;see list below for details on when antibiotic prophylaxis is required&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#bite2a">No infection established &#40;prophylaxis&#41;</a></li>
                <li><a href="#bite2b">Established mild infection &#40;not involving deep tissues&#41;</a></li>
                <li><a href="#bite2c">Established moderate/severe infection</a></li>
            </ul>
            <hr>
            <span class="color-primary">Antibiotic prophylaxis is only required for bites and fist injuries with
                established infection or a high risk of infection such as:</span>
            <ul type=circle>
                <li>Wounds with delayed presentation for washout &#40;8 hours or more&#41;</li>
                <li>Puncture wounds which can not be debrided adequately</li>
                <li>Any wounds on the hands feet or face</li>
                <li>Wounds involving deeper tissues &#40;eg. bones, joints, tendons&#41;</li>
                <li>Wounds in immunocompromised patients</li>
                <li>Wounds which also involve an open fracture &#40;see open fracture section&#41;</li>
                <li>Any cat bite</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite2 -->


    <!-- start of DOG,CAT,HUMAN Bite treatment maze, NO Pen Allergy, Prophylaxis -->
    <div data-role="page" id="bite1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog, cat or human bite prophylaxis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If patient has no penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple">Amoxicillin+clavulanate 875+125 mg
                        &#40;child: 22.5+3.2 mg/kg up to 875+125 mg&#41; orally, 12-hourly for 3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if oral absorption is likely to be impared &#40;i.e. following trauma&#41;
                </p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Amoxicillin + clavulanate
                        intravenously for 3 days</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
            </div>
            <p class="mrgn20b"><b>OR</b> if at increased risk of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA)
                infection, in place of the regimen above, use:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly for
                        3 days</span>
                </h4>
                <p class="mrgn60b"><b>AND EITHER</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple">Doxycycline orally, 12-hourly for 3
                        days</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">100 mg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 8 years or older and less than 26 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 50 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 8 years or older and 26 to 35 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 75 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 8 years or older and more than 35 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 100 mg</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn60b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 160+800
                        mg &#40;child 1 month or older: 4+20 mg/kg &#40;up to 160+800 mg&#41; orally, 12-hourly for 3
                        days</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Amoxicillin iv & clavulanate is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>bit</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>For patients hypersensitive to penicillins who require intravenous or intramuscular therapy, seek
                    expert advice</li>
                <li>Switch to oral amoxicillin+clavulanate &#40;see dosage above&#41; as soon as oral absorption is
                    adequate and oral therapy is tolerated</li>
                <li>The recommended management of clenched fist injuries, and human and animal bites, is thorough
                    cleaning, debridement, irrigation, elevation and immobilisation</li>
                <li>For bites and clenched-fist injuries that are not infected, antibiotic therapy is usually not
                    necessary for otherwise healthy individuals if the risk of wound infection is low &#40;e.g. small
                    wounds not involving deeper tissues that present within 8 hours and can be adequately debrided and
                    irrigated&#41;. Give presumptive therapy if the risk of wound infection is high</li>
                <li><b>In all cases, the patient's tetanus immunisation status must be ascertained and must be up to
                        date and must be up to date</b></li>
                <li>The organisms associated with human bites and clenched fist injuries are <i>Staphylococcus
                        aureus</i>, <i>Eikenella corrodens</i>, <i>Streptococcus</i> species and
                    beta-lactamase–producing anaerobic bacteria</li>
                <li>The organisms associated with animal bites are <i>Pasteurella</i> species, <i>S. aureus</i>,
                    <i>Capnocytophaga canimorsus</i>, <i>Streptococcus</i> species and anaerobic bacteria</li>
                <li>Cat bites have a higher incidence of deep infection than dog bites</li>
                <li>For wounds on the hands, feet or face, or if infection progresses despite antibiotic therapy,
                    consider surgical consultation. Surgical advice may also be sought on the appropriateness of primary
                    versus delayed wound closure</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bites wounds and clenched fist injuries</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite1a -->

    <!-- start of DOG,CAT,HUMAN Bite treatment maze, MILD or BAD Pen Allergy, Prophylaxis -->
    <div data-role="page" id="bite2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog, cat or human bite prophylaxis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If patient has a penicillin allergy use:</h3>

            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly for
                        3 days</span>
                </h4>
                <p class="mrgn60b"><b>AND EITHER</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline orally, 12-hourly for 3
                        days</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">100 mg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 8 years or older and less than 26 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 50 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 8 years or older and 26 to 35 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 75 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 8 years or older and more than 35 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 100 mg</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn60b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 160+800
                        mg &#40;child 1 month or older: 4+20 mg/kg &#41;up to 160+800 mg&#41; orally&#42; 12-hourly for
                        3 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>The recommended management of clenched fist injuries, and human and animal bites, is thorough
                    cleaning, debridement, irrigation, elevation and immobilisation</li>
                <li>For bites and clenched-fist injuries that are not infected, antibiotic therapy is usually not
                    necessary for otherwise healthy individuals if the risk of wound infection is low &#40;e.g. small
                    wounds not involving deeper tissues that present within 8 hours and can be adequately debrided and
                    irrigated&#41;. Give presumptive therapy if the risk of wound infection is high</li>
                <li><b>In all cases, the patient's tetanus immunisation status must be ascertained and must be up to
                        date and must be up to date</b></li>
                <li>The organisms associated with human bites and clenched fist injuries are <i>Staphylococcus
                        aureus</i>, <i>Eikenella corrodens</i>, <i>Streptococcus</i> species and
                    beta-lactamase–producing anaerobic bacteria</li>
                <li>The organisms associated with animal bites are <i>Pasteurella</i> species, <i>S. aureus</i>,
                    <i>Capnocytophaga canimorsus</i>, <i>Streptococcus</i> species and anaerobic bacteria</li>
                <li>Cat bites have a higher incidence of deep infection than dog bites</li>
                <li>For wounds on the hands, feet or face, or if infection progresses despite antibiotic therapy,
                    consider surgical consultation. Surgical advice may also be sought on the appropriateness of primary
                    versus delayed wound closure</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bites wounds and clenched fist injuries</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite2a -->


    <!-- start of DOG,CAT,HUMAN Bite treatment maze, NO Pen Allergy, MEDIUM infection -->
    <div data-role="page" id="bite1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog, cat or human bite treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If patient has no penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if oral absorption is likely to be impared &#40;i.e. following trauma&#41;
                </p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin + clavulanate intravenously for 3 days</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn60b"><b>AND</b> if the patient is at increased risk of methicillin-resistant
                    <i>Staphylococcus aureus</i> &#40;MRSA&#41; infection <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Amoxicillin iv & Clavulanate is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>bit</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past five days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>bit</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>A longer antibiotic course may be required according to clinical response</li>
                <li>Depending on microbiological findings from wound swab, the usual oral step down for animal or human
                    bites is Amoxicillin/clavulanic acid 875/125mg twice daily</li>
                <li>Modify therapy based on the results of Gram stain, cultures and susceptibility testing. Switch to
                    oral therapy once the patient is stable.</li>
                <li>For severe and penetrating wounds, total treatment duration is usually 14 days &#40;IV + oral&#41;.
                    A longer duration of directed therapy is needed for injuries involving bones, joints and/or tendons
                </li>
                <li>The recommended management of clenched fist injuries, and human and animal bites, is thorough
                    cleaning, debridement, irrigation, elevation and immobilisation</li>
                <li><b>In all cases, the patient's tetanus immunisation status must be ascertained and must be up to
                        date and must be up to date</b></li>
                <li>The organisms associated with human bites and clenched fist injuries are <i>Staphylococcus
                        aureus</i>, <i>Eikenella corrodens</i>, <i>Streptococcus</i> species and
                    beta-lactamase–producing anaerobic bacteria</li>
                <li>The organisms associated with animal bites are <i>Pasteurella</i> species, <i>S. aureus</i>,
                    <i>Capnocytophaga canimorsus</i>, <i>Streptococcus</i> species and anaerobic bacteria</li>
                <li>Cat bites have a higher incidence of deep infection than dog bites</li>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul type=circle class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bites wounds and clenched fist injuries</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite1b -->

    <!-- start of DOG,CAT,HUMAN Bite treatment maze, MILD or BAD Pen Allergy, Prophylaxis -->
    <div data-role="page" id="bite2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog, cat or human bite prophylaxis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If patient has a penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly for
                        5 days</span>
                </h4>
                <p class="mrgn60b"><b>AND EITHER</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline orally, 12-hourly for 5
                        days</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">100 mg </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 8 years or older and less than 26 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 50 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 8 years or older and 26 to 35 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 75 mg</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child 8 years or older and more than 35 kg: &nbsp;</span></td>
                                <td><span class="color-purple"> 100 mg</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn60b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 160+800
                        mg &#40;child 1 month or older: 4+20 mg/kg &#41;up to 160+800 mg&#41; orally&#42; 12-hourly for
                        5 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>A longer antibiotic course may be required according to clinical response</li>
                <li>The recommended management of clenched fist injuries, and human and animal bites, is thorough
                    cleaning, debridement, irrigation, elevation and immobilisation</li>
                <li>For bites and clenched-fist injuries that are not infected, antibiotic therapy is usually not
                    necessary for otherwise healthy individuals if the risk of wound infection is low &#40;e.g. small
                    wounds not involving deeper tissues that present within 8 hours and can be adequately debrided and
                    irrigated&#41;. Give presumptive therapy if the risk of wound infection is high</li>
                <li>In all cases, the patient's tetanus immunisation status must be ascertained and must be up to date
                </li>
                <li>The organisms associated with human bites and clenched fist injuries are <i>Staphylococcus
                        aureus</i>, <i>Eikenella corrodens</i>, <i>Streptococcus</i> species and
                    beta-lactamase–producing anaerobic bacteria</li>
                <li>The organisms associated with animal bites are <i>Pasteurella</i> species, <i>S. aureus</i>,
                    <i>Capnocytophaga canimorsus</i>, <i>Streptococcus</i> species and anaerobic bacteria</li>
                <li>Cat bites have a higher incidence of deep infection than dog bites</li>
                <li>For wounds on the hands, feet or face, or if infection progresses despite antibiotic therapy,
                    consider surgical consultation. Surgical advice may also be sought on the appropriateness of primary
                    versus delayed wound closure</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bites wounds and clenched fist injuries</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite2b -->


    <!-- start of DOG,CAT,HUMAN Bite treatment maze, MILD OR BAD Pen Allergy, BAD infection -->
    <div data-role="page" id="bite2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog, cat or human bite treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If patient has a penicillin allergy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; IV,
                        12-hourly</span>
                </h4>
                <p class="mrgn60b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV,
                        8-hourly</span>
                </h4>
            </div>
            <p class="mrgn60b"><b>OR</b> if the patient is at an increased risk of <b>MRSA</b> infection, in place of
                the regimen above give:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; IV,
                        12-hourly</span>
                </h4>
                <p class="mrgn60b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        8-hourly</span>
                </h4>
                <p class="mrgn60b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin iv and clindamycin iv is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>bit</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>bit</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Modify therapy based on the results of Gram stain, cultures and susceptibility testing. Switch to
                    oral therapy once the patient is stable.</li>
                <li>For severe and penetrating wounds, total treatment duration is usually 14 days &#40;IV + oral&#41;.
                    A longer duration of directed therapy is needed for injuries involving bones, joints and/or tendons
                </li>
                <li>The recommended management of clenched fist injuries, and human and animal bites, is thorough
                    cleaning, debridement, irrigation, elevation and immobilisation</li>
                <li>In all cases, the patient's tetanus immunisation status must be ascertained and must be up to date
                </li>
                <li>The organisms associated with human bites and clenched fist injuries are <i>Staphylococcus
                        aureus</i>, <i>Eikenella corrodens</i>, <i>Streptococcus</i> species and
                    beta-lactamase–producing anaerobic bacteria</li>
                <li>The organisms associated with animal bites are <i>Pasteurella</i> species, <i>S. aureus</i>,
                    <i>Capnocytophaga canimorsus</i>, <i>Streptococcus</i> species and anaerobic bacteria</li>
                <li>Cat bites have a higher incidence of deep infection than dog bites</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul type=circle class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bites wounds and clenched fist injuries</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite2c -->

    <!-- start of DOG,CAT,HUMAN Bite treatment maze, NO Pen Allergy, BAD infection -->
    <div data-role="page" id="bite1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Dog, cat or human bite treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If patient has no penicillin allergy use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin + clavulanate intravenously</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 6-hourly, </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn60b"><b>AND</b> if the patient is at increased risk of methicillin-resistant
                    <i>Staphylococcus aureus</i> &#40;MRSA&#41; infection <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a
                            href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Amoxicillin iv & Clavulanate is:</span>
                <span class="font15 bold"> 5<script>document.write(getCode())</script>bit</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past five days. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>bit</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>A longer antibiotic course may be required according to clinical response</li>
                <li>Depending on microbiological findings from wound swab, the usual oral step down for animal or human
                    bites is Amoxicillin/clavulanic acid 875/125mg twice daily</li>
                <li>Modify therapy based on the results of Gram stain, cultures and susceptibility testing. Switch to
                    oral therapy once the patient is stable.</li>
                <li>For severe and penetrating wounds, total treatment duration is usually 14 days &#40;IV + oral&#41;.
                    A longer duration of directed therapy is needed for injuries involving bones, joints and/or tendons
                </li>
                <li>The recommended management of clenched fist injuries, and human and animal bites, is thorough
                    cleaning, debridement, irrigation, elevation and immobilisation</li>
                <li>In all cases, the patient's tetanus immunisation status must be ascertained and must be up to date
                </li>
                <li>The organisms associated with human bites and clenched fist injuries are <i>Staphylococcus
                        aureus</i>, <i>Eikenella corrodens</i>, <i>Streptococcus</i> species and
                    beta-lactamase–producing anaerobic bacteria</li>
                <li>The organisms associated with animal bites are <i>Pasteurella</i> species, <i>S. aureus</i>,
                    <i>Capnocytophaga canimorsus</i>, <i>Streptococcus</i> species and anaerobic bacteria</li>
                <li>Cat bites have a higher incidence of deep infection than dog bites</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                            &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                        period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                        however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br />48 hly</td>
                        <td>750 mg<br />24 hly</td>
                        <td>750 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />15 min</td>
                    </tr>
                    <tr>
                        <td>50-64</td>
                        <td>1000 mg<br />48 hly</td>
                        <td>1000 mg<br />24 hly</td>
                        <td>1000 mg<br />12 hly</td>
                        <td class="bg-success">1 hr<br />40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br />48 hly</td>
                        <td>1250 mg<br />24 hly</td>
                        <td>1250 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />5 min</td>
                    </tr>
                    <tr>
                        <td>80-94</td>
                        <td>1500 mg<br />48 hly</td>
                        <td>1500 mg<br />24 hly</td>
                        <td>1500 mg<br />12 hly</td>
                        <td class="bg-success">2 hrs<br />30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br />48 hly</td>
                        <td>1750 mg<br />24 hly</td>
                        <td>1750 mg<br />12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                        class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                    considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                    the next dose is given before the trough concentration is available or withheld until the result is
                    known</li>
            </ol>
            <hr />
            <ul type=circle class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                    baseline creatinine will almost always result in an increase in vancomycin concentration as
                    vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                    an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                    available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                    interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on bites wounds and clenched fist injuries</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /bite1c -->
    <!--Dog Cat and HUMAN BITES MAZE ENDS-->

        
    <!-- Carbuncle Maze Begins -->
    <!-- Start of carbuncle page: #carble -->
    <div data-role="page" id="carble" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Carbuncle</h1>
        </div>
        <!-- /header -->
        <br>
        <div data-role="content" class="container-fluid">	
            <h4 class="mrgn20b biteSpecial">
                <span class="font15">Incision and drainage is the key therapeutic intervention for boils and carbuncles</span>
            </h4>
            <h3 class="color-primary mrgn15b">Are antibiotics indicated (> 5 cm abscess or surrounding cellulitis)?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec">Yes, antibiotics are indicated</a></li>
                <li><a href="#carble2">No, antibiotics not required</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carble -->

    <!-- Start of carbuncle page: #carble2 -->
    <div data-role="page" id="carble2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- /header -->
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For treatment in a patient where antibiotics are not normally indicated (5 cm or less abscess or surrounding cellulitis):</h3>
                <div id = "backcolour">
                        <span class="color-danger bold">Antibiotics may be considered. Educate patient regarding general signs of worsening and when to represent. Incision and drainage is recommended. Antibiotics do reduce the rate of recurrence however this must be weighed against the potential harms including diarrhoea, rash or more serious adverse reactions</span>
                </div>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on bronchiectasis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carble2 -->

    <!-- Carbuncle Sourced Cellulitis Maze Begins -->
    <!-- Start of carbuncle sourced cellulitis page: #carblec -->
    <div data-role="page" id="carblec" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec3">No penicillin allergy</a></li>
                <li><a href="#carblec1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#carblec2">Severe immediate or delayed penicillin hypersensitivity</a></li>    
            </ul>
            <hr/>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class ="bold">No penicillin allergy</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                    <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
                </ul>
            <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>        
            <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                </ul>
                <hr>
            <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec -->

    <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy: #carblec1 -->
    <div data-role="page" id="carblec1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b color-primary">Would you class the cellulitis as mild/moderate or severe?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec1a">Mild/Moderate</a></li>
                <li><a href="#carblec1b">Severe</a></li>      
            </ul>
            <hr/>
            <ul class="line30">
                <li>Choose severe if there are significant systemic features or no improvement in &gt; 48hours</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec1 -->

    <!-- Start of carbuncle sourced cellulitis with anaphylactic Penicillin Allergy: #carblec2 -->
    <div data-role="page" id="carblec2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Would you class the cellulitis/abscess as mild/moderate or severe?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec2c">Mild/Moderate</a></li>
                <li><a href="#carblec2b">Severe</a></li>     
            </ul>
            <hr/>
            <ul class="line30">
                <li>Choose severe if there are significant systemic features or no improvement in &gt; 48hours</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec2 -->

    <!-- Start of carbuncle sourced cellulitis with anaphylactic Penicillin Allergy, mild, ?child: #carblec2c -->
    <div data-role="page" id="carblec2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">Is the patient an adult or a child?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec2a2">Adult</a></li>     
                <li><a href="#carblec2c1">Child (&lt; 12 years)</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec2c -->

    <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy: #carblec3 -->
    <div data-role="page" id="carblec3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Would you class the cellulitis/abscess as mild/moderate or severe?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec3a">Mild/Moderate</a></li>
                <li><a href="#carblec3b">Severe</a></li>           
            </ul>
            <hr/>
            <ul class="line30">
                <li>Choose severe if there are significant systemic features or no improvement in &gt; 48hours</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec3 -->

    <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy MILD: #carblec1a -->
    <div data-role="page" id="carblec1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Does the patient have a history of previous nmMRSA colonisation?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec1a3">Yes</a></li>
                <li><a href="#carblec1a2">No</a></li>
            </ul>
            <hr/>
            <ul class="line30">
                <li>Please check the patient's previous admission details. Areas with a high level of nmMRSA prevalence include detention centres, army barracks, remote communities and gaols</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec1a -->

    <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy MILD, ?Child: #carblec1a3 -->
    <div data-role="page" id="carblec1a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">Is the patient an adult or a child?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec1a3a">Adult</a></li>
                <li><a href="#carblec1a3b">Child &#40;&lt; 12 yrs&#41;</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec1a -->

    <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy SEVERE: #carblec1b -->
    <div data-role="page" id="carblec1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have a history of previous nmMRSA colonisation?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec1b3">Yes</a></li>
                <li><a href="#carblec1b2">No</a></li>
            </ul>
            <hr/>
            <ul class="line30">
                <li>Please check the patient's previous admission details. Areas with a high level of nmMRSA prevalence include detention centres, army barracks, remote communities and gaols</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec1b -->

    <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy mild: #carblec3a -->
    <div data-role="page" id="carblec3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have a history of previous nmMRSA colonisation?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec1a3">Yes</a></li>
                <li><a href="#carblec3a2">No</a></li>
            </ul>
            <hr/>
            <ul class="line30">
                <li>Please check the patient's previous admission details. Areas with a high level of nmMRSA prevalence include detention centres, army barracks, remote communities and gaols</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec3a -->

    <!-- Start of carbuncle sourced cellulitis with anaphylactic Penicillin Allergy Severe: #carblec3b -->
    <div data-role="page" id="carblec3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitic Carbuncle/Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Does the patient have a history of previous nmMRSA colonisation?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec3b3">Yes</a></li>            
                <li><a href="#carblec3b2">No</a></li>
            </ul>
            <hr/>
            <ul class="line30">
                <li>Please check the patient's previous admission details. Areas with a high level of nmMRSA prevalence include detention centres, army barracks, remote communities and gaols</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec3b -->

    <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy MILD: #carblec1a2 -->
    <div data-role="page" id="carblec1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Mild/moderate cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Mild/moderate cellulitis from carbuncle with non-life threatening penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefalexin 500 mg &#40;child 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 5 days</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Treatment for 5 days is generally sufficient, but a longer duration of therapy may be required for patients who are slow to respond or have a more severe infection</li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on boils and carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec1a2 -->

    <!-- Start of carbuncle sourced cellulitis with Anaphylactic Penicillin Allergy MILD: #carblec2a2 -->
    <div data-role="page" id="carblec2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Mild/moderate cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Mild/moderate cellulitis from carbuncle with life threatening penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</h3>
            <div id = "backcolour">
            <h4 class="medicine mrgn20b">
                <span class="font17">&#9312;</span><span class="color-purple"> Clindamycin 450 mg orally, 8-hourly for 5 days</span>
            </h4>
            <p class="mrgn20b"><strong>OR,</strong></p>
            <h4 class="medicine mrgn20b">
                <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 160+800 mg orally, 12-hourly for 5 days</span>
            </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin orally is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>cac</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past five days. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Treatment for 5 days is generally sufficient, but a longer duration of therapy may be required for patients who are slow to respond or have a more severe infection</li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on boils and carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>   
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec2a2 -->

    <!-- Start of carbuncle sourced cellulitis with Anaphylactic Penicillin Allergy MILD, Child: #carblec2c1 -->
    <div data-role="page" id="carblec2c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Mild/moderate cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">Mild/moderate cellulitis from carbuncle with life threatening penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</h3>
            <div id = "backcolour">
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Trimethoprim+sulfamethoxazole 4+20 mg/kg &#40;up to 160+800 mg&#41; orally, 12-hourly for 5 days</span>
            </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Treatment for 5 days is generally sufficient, but a longer duration of therapy may be required for patients who are slow to respond or have a more severe infection</li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://pch.health.wa.gov.au/For-health-professionals/Childrens-Antimicrobial-Management-Program/Guidelines">See the CHAMP guidelines </a> on the intranet for further information on antibiotic treatment in a child </span>
            </h4>   
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec2c1 -->


    <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy MILD: #carblec3a2 -->
    <div data-role="page" id="carblec3a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Mild/Moderate cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Mild/Moderate cellulitis from carbuncle with no penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</h3>
            <div id = "backcolour">
            <h4 class="medicine mrgn20b">
                <span class="font17">&#9312;</span><span class="color-purple"> Flucloxacillin 500 mg &#40;child flucloxacillin 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 5 to 10 days.</span>
            </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on boils and carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec3a2 -->

    <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy SEVERE: #carblec1b2 -->
    <div data-role="page" id="carblec1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe abscess/cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">For empirical therapy in a patient with mild penicillin allergy; while awaiting the results of cultures and susceptibility testing, use:</h3>
            <div id = "backcolour">
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Cefazolin 2 g &#40;child 50 mg/kg up to 2 g&#41; IV, 8-hourly until systemic features improve then switch to oral</span>
            </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Switch to oral therapy when systemic features have improved &#40;see Therapeutic Guidelines for details&#41;</li>
                <li>For oral regimens see the <a href="#carblec1a2">mild/moderate infection section</a></li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on boils and carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>     
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec1b2 -->

    <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy SEVERE, adult: #carblec3b2 -->
    <div data-role="page" id="carblec3b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe abscess/cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">For empirical therapy in a patient with no penicillin allergy, while awaiting the results of cultures and susceptibility use:</h3>
            <div id = "backcolour">
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Flucloxacillin 2 g &#40;child 50 mg/kg up to 2 g&#41; IV, 6-hourly until systemic features improve then switch to oral</span>
            </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Switch to oral therapy when systemic features have improved &#40;see Therapeutic Guidelines for details&#41;</li>
                <li>For oral regimens see the <a href="#carblec3a2">mild/moderate infection section</a></li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>      
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec3b2 -->

    <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy MILD, nmMRSA, ADULT: #carblec1a3a -->
    <div data-role="page" id="carblec1a3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Mild cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Mild cellulitis from a carbuncle in an adult at risk of nmMRSA or with non-life threatening penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg orally, 8-hourly for 5 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim/sulfamethoxazole 160/800 mg orally, 12-hourly for 5 days</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin orally is: </span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>cac</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past five days. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Treatment for 5 days is generally sufficient, but a longer duration of therapy may be required for patients who are slow to respond or have a more severe infection</li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>     
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec1a3a -->

    <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy MILD, nmMRSA, CHILD: #carblec1a3b -->
    <div data-role="page" id="carblec1a3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Mild/moderate cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">Mild/moderate cellulitis from a carbuncle in a child at risk of nmMRSA or with non-life threatening penicillin allergy is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim/sulfamethoxazole 4+20 mg/kg &#40;up to 160+800 mg&#41; orally, 12-hourly for 5 to 10 days</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>     
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec1a3b -->

    <!-- Start of carbuncle sourced cellulitis with mild Penicillin Allergy SEVERE, nmMRSA: #carblec1b3 -->
    <div data-role="page" id="carblec1b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe abscess/cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Severe cellulitis/abscess in a patient at risk of nmMRSA can be treated with vancomycin and Cefazolin:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g &#40;child 50 mg/kg up to 2 g&#41; IV, 8-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cac</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Switch to oral therapy when systemic features have improved &#40;see Therapeutic Guidelines for details&#41;</li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                <br>
            </h4> 	
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec1b3 -->

    <!-- Start of carbuncle sourced cellulitis with anaphylactic Penicillin Allergy SEVERE, nmMRSA or no nmMRSA: #carblec2b -->
    <div data-role="page" id="carblec2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Severe cellulitis/abscess in patients at risk of nmMRSA with penicillin hypersensitivity can be treated with vancomycin:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">As a single agent use vancomycin as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cac</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Switch to oral therapy when systemic features have improved &#40;see Therapeutic Guidelines for details&#41;</li>
                <li>For oral regimens see the <a href="#carblec2c">mild/moderate infection section</a></li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Actual body<br> weight &#40;kg&#41;</th>
                        <th>CrClr <br>&lt; 20 mL/min</th>
                        <th>CrClr <br>20-60 mL/min</th>
                        <th>CrClr <br>&gt; 60 mL/min</th>
                        <th class="bg-success">Administer over<sup>(1)</sup></th>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /carblec2b -->

    <!-- Start of carbuncle sourced cellulitis with no Penicillin Allergy SEVERE, adult nmMRSA: #carblec3b3 -->
    <div data-role="page" id="carblec3b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe cellulitis treatment in a patient from an nmMRSA environment with no penicillin allergy</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">Severe cellulitis/abscess in adult patients at risk of nmMRSA should be treated with vancomycin and flucloxacillin:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g &#40;child 50 mg/kg up to 2 g&#41; IV, 6-hourly.</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin, as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cac</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Switch to oral therapy when systemic features have improved &#40;see Therapeutic Guidelines for details&#41;</li>
                <li>See the <a href="carblec1a3">mild/moderate treatment</a> section for nmMRSA for oral step down options</li>
                <li>The mainstay of treatment for carbuncles is incision and drainage. Antibiotic therapy will not be effective unless the collection is drained</li>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Actual body<br> weight &#40;kg&#41;</th>
                        <th>CrClr <br>&lt; 20 mL/min</th>
                        <th>CrClr <br>20-60 mL/min</th>
                        <th>CrClr <br>&gt; 60 mL/min</th>
                        <th class="bg-success">Administer over<sup>(1)</sup></th>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 	
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /-->
    <!-- END of Carbuncle Sourced CELLULITIS treatment maze -->

    <!-- Cellulitis Maze Begins -->
    <!-- Start of cellulitis page: #cell -->
    <div data-role="page" id="cell" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Is there a purulent focus for infection such as an abscess or carbuncle or history of penentrating trauma?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#carblec">Yes</a></li>
                <li><a href="#cellu">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cell -->

    <!-- Start of cellulitis page: #cellu -->
    <div data-role="page" id="cellu" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#cellu3">No penicillin allergy</a></li>
                <li><a href="#cellu1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#cellu2">Severe immediate or delayed penicillin hypersensitivity</a></li>   
            </ul>
            <hr/>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class ="bold">No penicillin allergy</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                    <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
                </ul>
            <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>        
            <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                </ul>
                <hr>
            <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>        
            <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                </ul>
            <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu -->

    <!-- Start of cellulitis Tx with mild Penicillin Allergy ?severity : #cellu1 -->
    <div data-role="page" id="cellu1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Would you class the cellulitis as mild/moderate or severe?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#cellu1a1">Mild/Moderate</a></li>
                <li><a href="#cellu1b">Severe</a></li>      
            </ul>
            <hr/>
            <ul type="circle" class="line30"><li>Choose severe if there are significant systemic features or no improvement in &gt; 48hours</li></ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu1 -->

    <!-- Start of cellulitis Tx with BAD Penicillin Allergy ?severity : #cellu2 -->
    <div data-role="page" id="cellu2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Would you class the cellulitis as mild/moderate or severe?</h3>
        <div data-role="content" class="container-fluid">	
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#cellu2a">Mild/Moderate</a></li>
                <li><a href="#cellu2b">Severe</a></li>      
            </ul>
        </div>
        <hr/>
        <ul type="circle" class="line30"><li>Choose severe if there are significant systemic features or no improvement in &gt; 48hours</li></ul>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu2 -->

    <!-- Start of cellulitis Tx with BAD Penicillin Allergy MILD, ?CHILD : #cellu2a -->
    <div data-role="page" id="cellu2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Is the patient an adult or a child?</h3>
        <div data-role="content" class="container-fluid">   
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#cellu2a1">Adult</a></li>
                <li><a href="#cellu2a2">Child &#40;&lt; 12 years&#41;</a></li>      
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu2 -->


    <!-- Start of cellulitis Tx with NO Penicillin Allergy ?severity : #cellu3 -->
    <div data-role="page" id="cellu3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Would you class the cellulitis/abscess as mild/moderate or severe?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#cellu3a">Mild/Moderate</a></li>
                <li><a href="#cellu3b">Severe</a></li>      
            </ul>
            <hr/>
            <ul type="circle" class="line30"><li>Choose severe if there are significant systemic features or no improvement in &gt; 48hours</li></ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu3 -->

    <!-- Start of cellulitis Tx with NO Penicillin Allergy MILD ?strep : #cellu3a -->
    <div data-role="page" id="cellu3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="mrgn20b">
                <span class="color-primary">Are there suggestive signs of <i>S.pyogenes</i>? (eg, erysipelas or rapid progression with no associated wound or ulcer)</span>
                <span class="font15"> &#40;i.e. erysipelas? or rapid progression&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#cellu3a1">Yes</a></li>
                <li><a href="#cellu3a2">No</a></li>      
            </ul>
            <hr>
            <ul class="line30">
                <li>Erysipelas typically presents as a rapidly progressing erythematous skin lesion that has a sharply demarcated, raised edge</li>
                <li>Erysipelas is most common in infants, indigenous patients, young children and older adults.</li>
                <li>Classically, erysipelas involves either facial skin in a butterfly pattern, or the lower legs</li>
                <li>Spontaneous rapid spreading cellulitis is most commonly due to <i>S.pyogenes</i> or another streptococci</li>
            </ul>	
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu3a -->

    <!-- Start of cellulitis, Pen MILD, Cellu MILD, Strep YES or NO: #cellu1a1 -->
    <div data-role="page" id="cellu1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn20">For mild/moderate cellulitis in a patient with penicillin hypersensitivity &#40;non-life threatening&#41; use as a single agent:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefalexin 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 5 to 10 days</span>
                </h4>
            </div>
            <hr/>
            <ul type="circle" class="line30"><li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li></ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu1a1 -->

    <!-- Start of cellulitis, Pen BAD, Cellu MILD, Strep NO, ADULT: #cellu2a1 -->
    <div data-role="page" id="cellu2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">For mild/moderate cellulitis in an adult with immediate (life threatening) penicillin hypersensitivity use as a single agent:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg orally, 8-hourly for 5 to 10 days</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin orally is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>cel</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past five days. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr/>
            <ul type=circle class="line30"><li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li></ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu2a1 -->

    <!-- Start of cellulitis with mild Penicillin Allergy MILD, no strep, CHILD: #cellu2a2 -->
    <div data-role="page" id="cellu2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Mild cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">Mild cellulitis in a child with immediate &#40;life threatening&#41; penicillin hypersensitivity is treated with oral antibiotics. For empirical therapy while awaiting the results of cultures and susceptibility testing, use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim/sulfamethoxazole 4+20 mg/kg &#40;up to 160+800 mg&#41; orally, 12-hourly for 5 to 10 days</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See the CHAMP guidelines</a> on the intranet for more information on antibiotic treatment in a child</span>
            </h4>     
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu2a2 -->

    <!-- Start of cellulitis, Pen OK, Cellu MILD, Strep YES : #cellu3a1 -->
    <div data-role="page" id="cellu3a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">For mild/moderate cellulitis in a patient with signs of <i>S.pyogenes</i> use as a single agent:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Phenoxymethylpenicillin 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 5 to 10 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Procaine penicillin 1.5 g &#40;child: 50 mg/kg up to 1.5 g) IM, daily for at least 3 days</span>
                </h4>
            </div>
            <hr/>
            <ul type=circle class="line30"><li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li></ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu3a1 -->

    <!-- Start of cellulitis, Pen OK, Cellu MILD, Strep NO : #cellu3a2 -->
    <div data-role="page" id="cellu3a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">For mild/moderate cellulitis in a patient without signs of <i>S.pyogenes</i> use as a single agent:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 500 mg &#40;child: Flucloxacillin 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 5 to 10 days</span>
                </h4>
            </div>
            <hr/>
            <ul type=circle class="line30"><li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li></ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu3a2 -->

    <!-- Start of cellulitis Tx with mild Penicillin Allergy SEVERE: #cellu1b -->
    <div data-role="page" id="cellu1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">For empirical therapy of severe cellulitis in an adult with mild penicillin allergy; while awaiting the results of cultures and susceptibility testing, use: </h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b">Switch to oral therapy when systemic features have improved &#40;see Therapeutic Guidelines for details&#41;</p>
            </div>
            <hr/>
            <ul class="line30" type="circle">
                <li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li>
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>For patients with significant systemic symptoms, assess for necrotising fasciitis or underlying myonecrosis, see the Therapeutic Guidelines section on <a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">necrotising skin and soft tissue infections</a></li>
                <li>For patients with associated bacteraemia see the severe sepsis section or the severe sepsis: directed therapy section of the Therapeutic Guidelines</li>
                <li>Vancomycin may also be needed in patients with severe sepsis or septic shock. &#40;see the <a href="#cellu2b">severe cellulitis treatment in a patient with severe penicillin allergy</a> for the dosing nomogram and approval code if needed&#41;</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu1b -->

    <!-- Start of cellulitis Tx with anaphylactic Penicillin Allergy SEVERE,: #cellu2b -->
    <div data-role="page" id="cellu2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For empirical treatment of severe cellulitis in a patient with life threatening penicillin hypersensitivity use either vancomycin or clindamycin.</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Vancomycin as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin or vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>cel</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr/>
            <ul class="line30" type="circle">
                <li>Consider an early switch to oral clindamycin &#40;within 48 hours&#41;, clindamycin has excellent oral bioavailability &#40;90% orally bioavailable&#41;</li>
                <li>In addition to treating cellulitis, examine patient for tinea of the feet and treat if necessary</li>
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                <li>For patients with significant systemic symptoms, assess for necrotising fasciitis or underlying myonecrosis, see the Therapeutic Guidelines section on <a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">necrotising skin and soft tissue infections</a></li>
                <li>For patients with associated bacteraemia see the <a href="sepsisNsimilar.html#sepsis">severe sepsis</a> section or the severe sepsis: directed therapy section of the Therapeutic Guidelines</li>
            </ul>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Actual body<br> weight &#40;kg&#41;</th>
                        <th>CrClr <br>&lt; 20 mL/min</th>
                        <th>CrClr <br>20-60 mL/min</th>
                        <th>CrClr <br>&gt; 60 mL/min</th>
                        <th class="bg-success">Administer over<sup>(1)</sup></th>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu2b -->

    <!-- Start of cellulitis Tx with no Penicillin Allergy SEVERE, #cellu3b -->
    <div data-role="page" id="cellu3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">For empirical therapy in a patient with no penicillin allergy, while awaiting the results of cultures and susceptibility use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b">Switch to oral therapy when systemic features have improved &#40;see Therapeutic Guidelines for details&#41;</p>
            </div>
            <hr/>
            <ul type="circle" class="line30">
                <li>In addition to treating cellulitis examine patient for tinea of the feet and treat if necessary</li>
                <li>This is a guide for empirical treatment only. It is imperative that cultures are taken prior to administration of antibiotics (where possible) for targeted therapy</li>
                <li>For patients with significant systemic symptoms, assess for necrotising fasciitis or underlying myonecrosis, see the Therapeutic Guidelines section on <a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">necrotising skin and soft tissue infections</a></li>
                <li>For patients with associated bacteraemia see the <a href="sepsisNsimilar.html#sepsis">severe sepsis</a> section or the severe sepsis: directed therapy section of the Therapeutic Guidelines</li>
                <li>Vancomycin may also be needed in patients with severe sepsis or septic shock. &#40;see the <a href="#cellu2b">severe cellulitis treatment in a patient with severe penicillin allergy</a> for the dosing nomogram and approval code if needed&#41;</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis and erysipelas</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /cellu3b -->
    <!-- END of CELLULITIS treatment maze -->

    <!-- start of EYE CELLULITIS treatment maze -->
    <!-- Start of EYE CELLULITIS LANDING page : #celli -->
    <div data-role="page" id="celli" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">What type of cellulitis does the patient have?</span>
                <span class="font15"> &#40;see table below&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1">Periorbital &#40;preseptal&#41;</a></li>
                <li><a href="#celli2">Orbital &#40;postseptal&#41;</a></li>  
            </ul>
            <h4 class="color-primary mrgn20b">Classification of eye cellulitis</h4>
            <hr/>
            <ul class="line30">
                <li><b>Periorbital &#40;preseptal&#41; cellulitis -</b> is a soft tissue infection of the eyelids, originating anterior to the orbital septum &#40;the anatomical barrier separating the eyelids from the orbit&#41;. It is usually caused by local introduction of organisms from trauma or infection of the surrounding skin</li>
                <li><b>Orbital &#40;postseptal&#41; cellulitis -</b> usually arises from infection &#40;especially untreated&#41; of paranasal sinuses or orbital trauma. It is less common but much more serious than periorbital &#40;preseptal&#41; cellulitis. Clinical symptoms are more pronounced; patients are generally unwell and may have reduced vision, limited or painful extra-ocular movement, or proptosis.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli -->

    <!-- Start of EYE CELLULITIS, Periorbital ?Severe page : #celli1 -->
    <div data-role="page" id="celli1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">Is the patient severely ill?</span>
                <span class="font15"> &#40;i.e. periorbital cellulitis is the primary reason for hospitalisation&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1a">Yes</a></li>
                <li><a href="#celli1b">No</a></li>  
            </ul>
            <hr>
            <ul class="line30">
                <li>In severe cases of periorbital cellulitis a CT scan should be performed to exclude sinusitis associated infection and treatment should continue as per orbital cellulitis</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1 -->

    <!-- Start of Non-severe periorbital cellulitis allergy page: #celli1b -->
    <div data-role="page" id="celli1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1b1">No penicillin allergy</a></li> 
                <li><a href="#celli1b2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#celli1b3">Severe immediate or delayed penicillin hypersensitivity</a></li>   
            </ul>
            <hr/>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class ="bold">No penicillin allergy</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                    <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
                </ul>
            <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>        
            <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                </ul>
                <hr>
            <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b -->


    <!-- Start of EYE CELLULITIS, Periorbital ?Severe page : #celli1 -->
    <div data-role="page" id="celli1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1b1a">Yes</a></li>
                <li><a href="#celli1b1b">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b1 -->


    <!-- Start of EYE CELLULITIS, Periorbital ?MRSA page-->
    <div data-role="page" id="celli1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1b2a">Yes</a></li>
                <li><a href="#celli1b2b">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b2 -->

    <!-- Start of EYE CELLULITIS, Periorbital ?H.flu risks page-->
    <div data-role="page" id="celli1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have risk factors for <i>Haemophilus influenzae</i> or active sinusitis? &#40;see below&#41;</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1b1a1">Yes</a></li>
                <li><a href="#celli1b1a2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Patients at risk for <i>Haemophilus influenzae</i> include children under 5 years of age who are not fully vaccinated, especially those attending a daycare</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b1a -->

    <!-- Start of EYE CELLULITIS, Periorbital ?H.flu risks page-->
    <div data-role="page" id="celli1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have risk factors for <i>Haemophilus influenzae</i> or active sinusitis? &#40;see below&#41;</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1b1b1">Yes</a></li>
                <li><a href="#celli1b1b2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Patients at risk for <i>Haemophilus influenzae</i> include children under 5 years of age who are not fully vaccinated, especially those attending a daycare</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b1b -->

    <div data-role="page" id="celli1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have risk factors for <i>Haemophilus influenzae</i> or active sinusitis? &#40;see below&#41;</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1b2a1">Yes</a></li>
                <li><a href="#celli1b2a2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Patients at risk for <i>Haemophilus influenzae</i> include children under 5 years of age who are not fully vaccinated, especially those attending a daycare</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b2a -->

    <div data-role="page" id="celli1b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have risk factors for <i>Haemophilus influenzae</i> or active sinusitis? &#40;see below&#41;</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1b2b1">Yes</a></li>
                <li><a href="#celli1b2b2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Patients at risk for <i>Haemophilus influenzae</i> include children under 5 years of age who are not fully vaccinated, especially those attending a daycare</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b2b -->


    <!-- start of Periorbital cellulitis treatment, non severe, no penicillin allergy #celli1b1-->
    <div data-role="page" id="celli1b1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has no penicillin allergy or other risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 500 mg &#40;child: Flucloxacillin 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 7 days.</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to intravenous therapy</li>
                <li>If oral flucloxacillin is not tolerated then cefalexin can be used to replace oral flucloxacillin</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b1 -->

    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1b1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has no penicillin allergy but MRSA and <i>Haemophilus influenzae</i> risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin + clavulanate orally</span>
                    <br><br>
                        <div class="table-responsive">
                            <table class="table-blank">
                                <tr>
                                    <td><span class="font17">Adult and child 2 months or older:  &nbsp;</span></td>
                                    <td><span class="color-purple"> 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally, 12-hourly for 7 days</span></td>
                                </tr>
                                <tr>
                                    <td><span class="font17">Infant 1 month to younger than 2 months:  &nbsp;</span></td>
                                    <td><span class="color-purple"> 15+3.75 mg/kg orally, 8-hourly for 7 days</span></td>
                                </tr>
                            </table>
                        </div>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg &#40;child 1 month or older: 4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly for 7 days</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b1a1 -->

    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1b1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has no penicillin allergy or <i>Haemophilus influenzae</i> risk factors but is at risk of MRSA use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 500 mg &#40;child: Flucloxacillin 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 7 days.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg &#40;child 1 month or older: 4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly for 7 days</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b1a2 -->

    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1b1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has no penicillin allergy or MRSA risk factors, but is at risk of <i>Haemophilus influenzae</i> infection use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin + clavulanate orally</span>
                    <br><br>
                        <div class="table-responsive">
                            <table class="table-blank">
                                <tr>
                                    <td><span class="font17">Adult and child 2 months or older:  &nbsp;</span></td>
                                    <td><span class="color-purple"> 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally, 12-hourly for 7 days</span></td>
                                </tr>
                                <tr>
                                    <td><span class="font17">Infant 1 month to younger than 2 months:  &nbsp;</span></td>
                                    <td><span class="color-purple"> 15+3.75 mg/kg orally, 8-hourly for 7 days</span></td>
                                </tr>
                            </table>
                        </div>
                    </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b1b1 -->

    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1b2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity and MRSA and <i>Haemophilus influenzae</i> risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefuroxime 500 mg &#40;child 3 months or older: 15 mg/kg up to 500 mg&#41; orally, 12-hourly for 7 days.</span>
                </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg &#40;child 1 month or older: 4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly for 7 days</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b2a1 -->


    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1b2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity and MRSA risk factors but no <i>Haemophilus influenzae</i> risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefalexin 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 7 days.</span>
                </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg &#40;child 1 month or older: 4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly for 7 days</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b2a2 -->

    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1b2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity with no MRSA risk factors but with <i>Haemophilus influenzae</i> risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefuroxime 500 mg &#40;child 3 months or older: 15 mg/kg up to 500 mg&#41; orally, 12-hourly for 7 days.</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b2b1 -->


    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1b2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity with no MRSA or <i>Haemophilus influenzae</i> risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefalexin 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 7 days.</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b2b2 -->


    <!-- start of Periorbital cellulitis treatment, non severe, BAD penicillin allergy #celli1b3 -->
    <div data-role="page" id="celli1b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has a mild penicillin allergy use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg &#40;child: 15 mg/kg up to 450 mg&#41; orally, 8-hourly for 7 days.</span>
                </h4>
                <p class="mrgn60b"><b>AND</b> if the patient has sinusitis or other risk factors for <i>Haemophilus influenzae</i> type B <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 500 mg &#40;child: 10 mg/kg up to 500 mg&#41; PO, 12-hourly</span>
                </h4>
                
            </div>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for clindamycin orally is:</span>
                    <span class="font15 bold"> 7<script> document.write(getCode())</script>per</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past one week. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
            <ul class="line30">
                <li>Patients at risk for <i>Haemophilus influenzae</i> include children under 5 years of age who are not fully vaccinated, especially those attending a daycare</li>
                <li>If methicillin-resistant S. aureus &#40;MRSA&#41; is suspected &#40;eg if patient from a jail, detention centre or community with high MRSA prevalence&#41;, seek expert advice.</li>
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1b3 -->

    <!-- Start of Non-severe periorbital cellulitis allergy page: #celli1a -->
    <div data-role="page" id="celli1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1a1">No penicillin allergy</a></li> 
                <li><a href="#celli1a2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#celli1a3">Severe immediate or delayed penicillin hypersensitivity</a></li>   
            </ul>
            <hr/>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class ="bold">No penicillin allergy</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                    <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
                </ul>
            <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>        
            <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                </ul>
                <hr>
            <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a -->


    <!-- Start of EYE CELLULITIS, Periorbital ?Severe page : #celli1 -->
    <div data-role="page" id="celli1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1a1a">Yes</a></li>
                <li><a href="#celli1a1b">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a1 -->


    <!-- Start of EYE CELLULITIS, Periorbital ?MRSA page-->
    <div data-role="page" id="celli1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1a2a">Yes</a></li>
                <li><a href="#celli1a2b">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a2 -->

    <!-- Start of EYE CELLULITIS, Periorbital ?H.flu risks page-->
    <div data-role="page" id="celli1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have risk factors for <i>Haemophilus influenzae</i> or active sinusitis? &#40;see below&#41;</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1a1a1">Yes</a></li>
                <li><a href="#celli1a1a2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Patients at risk for <i>Haemophilus influenzae</i> include children under 5 years of age who are not fully vaccinated, especially those attending a daycare</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a1a -->

    <!-- Start of EYE CELLULITIS, Periorbital ?H.flu risks page-->
    <div data-role="page" id="celli1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have risk factors for <i>Haemophilus influenzae</i> or active sinusitis? &#40;see below&#41;</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1a1b1">Yes</a></li>
                <li><a href="#celli1a1b2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Patients at risk for <i>Haemophilus influenzae</i> include children under 5 years of age who are not fully vaccinated, especially those attending a daycare</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a1b -->

    <div data-role="page" id="celli1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have risk factors for <i>Haemophilus influenzae</i> or active sinusitis? &#40;see below&#41;</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1a1a1">Yes</a></li>
                <li><a href="#celli1a2a2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Patients at risk for <i>Haemophilus influenzae</i> include children under 5 years of age who are not fully vaccinated, especially those attending a daycare</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a2a -->

    <div data-role="page" id="celli1a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have risk factors for <i>Haemophilus influenzae</i> or active sinusitis? &#40;see below&#41;</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli1a1b1">Yes</a></li>
                <li><a href="#celli1a2b2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Patients at risk for <i>Haemophilus influenzae</i> include children under 5 years of age who are not fully vaccinated, especially those attending a daycare</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a2b -->

    <!-- start of Periorbital cellulitis treatment, non severe, no penicillin allergy #celli1a1-->
    <div data-role="page" id="celli1a1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity and no other risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly for 7 days.</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to broad spectrum intravenous therapy</li>
                <li>If oral flucloxacillin is not tolerated then cefalexin can be used to replace oral flucloxacillin</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a1 -->

    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1a1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity with MRSA and <i>Haemophilus influenzae</i> risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 1 g &#40;child 1 month or older: 50 mg/kg up to 1 g&#41; intravenously, daily for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if the patient is less than 2 months old replace ceftriaxone with:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefotaxime 1 g &#40;child: 50 mg/kg up to 1 G&#41; IV, 8-hourly daily</span>
                </h4>
                    <p class="mrgn20b"><b>AND</b> with either ceftriaxone or cefotaxime <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>per</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for cefotaxime or ceftriaxone is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>per</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
            <ul class="line30">
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to broad spectrum intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a1a1 -->

    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1a1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity with no <i>Haemophilus influenzae</i> risk factors but is at risk of MRSA use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly for 7 days.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>per</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
            <ul class="line30">
                <li>In patients with severe disease consider contacting infectious diseases for addition of vancomycin for MRSA cover.</li>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                <li>Modify therapy based on the results of Gram stain, cultures and susceptibility testing. Switch to oral therapy once the patient is stable.</li>
                <li>If methicillin-resistant S. aureus &#40;MRSA&#41; is suspected &#40;eg if patient from a jail, detention centre or community with high MRSA prevalence&#41;, seek expert advice.</li>
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
            </ul>
            <hr/>
            <ul class="line30">
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to broad spectrum intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a1a2 -->

    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1a1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity with no MRSA risk factors, but is at risk of <i>Haemophilus influenzae</i> infection use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 1 g &#40;child 1 month or older: 50 mg/kg up to 1 g&#41; intravenously, daily for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if the patient is less than 2 months old replace ceftriaxone with:</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefotaxime 1 g &#40;child: 50 mg/kg up to 1 G&#41; IV, 8-hourly daily</span>
                </h4>
            </div>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for cefotaxime or ceftriaxone is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>per</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
            <ul class="line30">
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to broad spectrum intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a1b1 -->


    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1a2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity and MRSA risk factors but no <i>Haemophilus influenzae</i> risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g &#40;child: 50 mg/kg up to 2 g&#41; intravenously, 8-hourly for 7 days.</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>per</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to broad spectrum intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a2a2 -->


    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1a2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has delayed penicillin hypersensitivity with no MRSA or <i>Haemophilus influenzae</i> risk factors use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g &#40;child: 50 mg/kg up to 2 g&#41; intravenously, 8-hourly for 7 days.</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to broad spectrum intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a2b2 -->

    <!-- start of Periorbital cellulitis treatment-->
    <div data-role="page" id="celli1a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has immediate severe penicillin hypersensitivity use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; IV, 12-hourly</span>
                </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>per</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>per</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
            <ul class="line30">
                <li>Ciprofloxacin is not licensed for use in children on the basis of animal studies that showed an adverse effect on cartilage development with quinolone use; however, there are few data from human trials to support this finding. Ciprofloxacin can be used in children when it is the drug of choice.</li>
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
                <li>For periorbital cellulitis without systemic features, 7 days of antibiotic treatment is usually sufficient. Extend therapy if the infection has not resolved completely by the end of the treatment course.</li>
                <li>Review within 48 hours is essential to ensure the patient’s condition is improving. If symptoms and signs have not improved after 48 hours, consider switching to broad spectrum intravenous therapy</li>
                <li>Common pathogens causing periorbital cellulitis are <i>Staphylococcus aureus</i> and Streptococcus species, or, in patients who are not fully vaccinated, Haemophilus influenzae type b (Hib). Staphylococcal infection is more likely in patients with a local lesion such as a hordeolum, dacryocystitis or a wound. Herpes simplex virus and herpes zoster virus are other causes.</li>
            </ul>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on periorbital cellulitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli1a3 -->


    <!-- Start of severe periorbital or postseptal cellulitis allergy page: #celli2 -->
    <div data-role="page" id="celli2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Periorbital cellulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#celli2a">No penicillin allergy</a></li> 
                <li><a href="#celli2b">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#celli2c">Severe immediate or delayed penicillin hypersensitivity</a></li>   
            </ul>
            <hr/>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class ="bold">No penicillin allergy</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                    <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
                </ul>
            <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>        
            <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                </ul>
                <hr>
            <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli2 -->

    <!-- start of Periorbital cellulitis treatment severe or orbital, NO penicillin allergy #celli2a -->
    <div data-role="page" id="celli2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Orbital or severe periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has no penicillin allergy use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                        <span class="color-purple">Flucloxacillin 2 g &#40;child: 50 mg/kg up to 2 G&#41; IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b> AND If the patient has concurrent sinusitis or risk factors for <i>H. influenzae</i> type b infection (eg children younger than 5 years who are not fully vaccinated), use:</b></p>
                <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 G&#41; IV, daily</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>per</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>If there is concern about possible MRSA infection please replace flucloxacillin with vancomycin &#40;see <a href="#dose">dosing nomograms and calculators</a> for dosing&#41;
                    <ul>
                        <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                        <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                    </ul>
                </li>
                <li>Modify therapy based on the results of Gram stain, cultures and susceptibility testing. Switch to oral therapy once the patient is stable.</li>
                <li>In most cases oral step down therapy should be Augmentin Duo Forte &#40;875+125 mg 12-hourly&#41; for a further 10 days</li>
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
                <li>If orbital cellulitis is suspected, collect blood samples for culture. A CT scan of the orbits and sinuses should be performed in all cases of suspected orbital cellulitis, because a delay in diagnosis can result in visual compromise or spread to the cranial fossa. If there is intracranial extension, consider brain abscess, which requires empirical antibiotic therapy with activity against anaerobes</li>
                <li>The total duration of therapy (intravenous + oral) is usually 10 to 14 days.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis of the eye</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli2a -->

    <!-- start of severe periorbital cellulitis treatment, or orbital MILD penicillin allergy #celli2b -->
    <div data-role="page" id="celli2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Orbital or severe periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has non-severe immediate or delayed penicillin hypersensitivity use:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone  2 g &#40;child: 50 mg/kg up to 2 G&#41; IV, daily for seven days</span>
                </h4>
                <p class="mrgn60b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for ceftriaxone is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>cli</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>cli</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
            <ul class="line30">
                <li>Modify therapy based on the results of Gram stain, cultures and susceptibility testing. Switch to oral therapy once the patient is stable.</li>
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
                <li>If orbital cellulitis is suspected, collect blood samples for culture. A CT scan of the orbits and sinuses should be performed in all cases of suspected orbital cellulitis, because a delay in diagnosis can result in visual compromise or spread to the cranial fossa. If there is intracranial extension, consider brain abscess, which requires empirical antibiotic therapy with activity against anaerobes</li>
                <li>The total duration of therapy (intravenous + oral) is usually 10 to 14 days.</li>
            </ul>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis of the eye</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli2b -->

    <!-- start of severe periorbital cellulitis treatment, or orbital BAD penicillin allergy #celli2c -->
    <div data-role="page" id="celli2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Orbital or severe periorbital cellulitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">  
            <h3 class="color-primary mrgn15b">If patient has a severe penicillin allergy:</h3>
            <hr>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; IV, 12-hourly</span>
                </h4>
                <p class="mrgn60b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin as per nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>cli</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 72 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>cli</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
            <ul class="line30">
                <li>Ciprofloxacin is not licensed for use in children on the basis of animal studies that showed an adverse effect on cartilage development with quinolone use; however, there are few data from human trials to support this finding. Ciprofloxacin can be used in children when it is the drug of choice.</li>
                <li>If the patient has concurrent sinusitis or risk factors for H. influenzae type b infection (eg children younger than 5 years who are not fully vaccinated), then seek specialist advice.</li>
                <li>In patients with severe disease consider contacting infectious diseases for addition of vancomycin for MRSA cover.</li>
                <li>Modify therapy based on the results of Gram stain, cultures and susceptibility testing. Switch to oral therapy once the patient is stable.</li>
                <li>Four-hourly eye observations are advised. If signs worsen, surgical drainage is required, with postoperative antibiotic therapy guided by the results of susceptibility testing.</li>
                <li>If orbital cellulitis is suspected, collect blood samples for culture. A CT scan of the orbits and sinuses should be performed in all cases of suspected orbital cellulitis, because a delay in diagnosis can result in visual compromise or spread to the cranial fossa. If there is intracranial extension, consider brain abscess, which requires empirical antibiotic therapy with activity against anaerobes</li>
                <li>The total duration of therapy (intravenous + oral) is usually 10 to 14 days.</li>
            </ul>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on cellulitis of the eye</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /celli2c -->






    <!-- END of EYE CELLULITIS treatment maze -->

    <!-- start of DIABETIC FOOT treatment maze -->
    <!-- Start of Diabet foot page: #diabf -->
    <div data-role="page" id="diabf" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diabetic foot infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#diabf3">No penicillin allergy</a></li> 
                <li><a href="#diabf1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#diabf2">Severe immediate or delayed penicillin hypersensitivity</a></li>   
            </ul>
            <hr/>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class ="bold">No penicillin allergy</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                    <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
                </ul>
            <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>        
            <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                </ul>
                <hr>
            <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /diabf -->

    <!-- Start of Diabet foot page Penicillin MILD: #diabf1 -->
    <div data-role="page" id="diabf1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diabetic foot infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the infection?</span>
                <span class="font15"> (see table below)</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#diabf1a">Mild</a></li>
                <li><a href="#diabf1b2">Moderate</a></li>
                <li><a href="#diabf1c1">Severe</a></li>    
            </ul>
            <h4 class="color-primary mrgn20b">Classification of diabetic foot infection</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                        <tr>
                            <th>Severity</th>
                            <th>Features</th>
                        </tr>
                        <tr>
                            <td><b>Uninfected</b></td>
                            <td><ul><li>Wound lacking purulence or any manifestation of inflammation</li></ul></td>
                        </tr>
                        <tr>
                            <td><b>Mild</b></td>
                            <td>
                                <ul>
                                    <li>Presence of 2 or more manifestations of inflammation (purulence, or erythema, pain, tenderness,warmth, or induration) </li>
                                    <li>Extent of cellulitis/erythema: 0.5 - 2cm around ulcer, and infection is limited to the skin or superficial subcutaneous tissues </li>
                                    <li>No other local complications or systemic illness.</li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                        <td><b>Moderate</b></td>
                            <td>
                                <ul>
                                    <li>Infection (as above) in a patient who is systemically well and metabolically stable, but which has
                                        greater than 1 of the following characteristics:
                                            <ul>
                                                <li>cellulitis > 2 cm, lymphangitic streaking, spread beneath the superficial fascia, deeptissue
                                                abscess, gangrene and involvement of muscle, tendon, joint or bone.</li>
                                            </ul>
                                    </li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                            <td><b>Severe</b></td>
                            <td>
                                <ul>
                                    <li>Infection in a patient with systemic toxicity or metabolic instability</li>
                                        <ul type=circle>
                                        <li>eg. Fever, chills, tachycardia, hypotension, confusion, vomiting, leukocytosis,
                                            acidosis, severe hyperglycaemia, renal impairment</li>
                                        </ul>
                                        <li>Any osteomyelitis, systemic toxicity, bacteraemia, gangrene, ulceration to deep tissues, severe cellulitis
                                        </li>
                                </ul>
                            </td>
                        </tr>
                </table>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /diabf1 -->

            <!-- Start of Diabet foot page penicillin BAD: #diabf2 -->
            <div data-role="page" id="diabf2" data-theme="a">
                <div data-role="header" class="frontpage">
                    <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
                </div>
                <!-- /header -->
                <div data-role="header" class="secondpage">
                    <h1>Diabetic foot infection</h1>
                </div>
                <!-- /header -->
                <div data-role="content" class="container-fluid">
                    <h3 class="mrgn20b">
                        <span class="color-primary">How severe is the infection?</span>
                        <span class="font15"> (see table below)</span>
                    </h3>
                    <ul data-role="listview"  data-inset="true" class="listview">
                        <li><a href="#diabf2a">Mild</a></li>
                        <li><a href="#diabf2b2">Moderate</a></li>
                        <li><a href="#diabf1c1">Severe</a></li>    
                    </ul>
                    <h4 class="color-primary mrgn20b">Classification of diabetic foot infection</h4>
                    <div class="table-responsive">
                        <table class="table table-bordered table-striped">
                            <tr>
                                <th>Severity</th>
                                <th>Features</th>
                            </tr>
                            <tr>
                                <td><b>Uninfected</b></td>
                                <td><ul><li>Wound lacking purulence or any manifestation of inflammation</li></ul></td>
                            </tr>
                                    <tr>
                                        <td><b>Mild</b></td>
                                        <td>
                                            <ul>
                                                <li> Presence of 2 or more manifestations of inflammation (purulence, or erythema, pain, tenderness,
                                                    warmth, or induration) </li>
                                                <li> Extent of cellulitis/erythema: 0.5 - 2cm around ulcer, and infection is limited to the skin or
                                                    superficial subcutaneous tissues </li>
                                                <li> No other local complications or systemic illness. </li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td><b>Moderate</b></td>
                                        <td>
                                            <ul>
                                                <li>Infection (as above) in a patient who is systemically well and metabolically stable, but which has
                                                    greater than 1 of the following characteristics:
                                                    <ul>
                                                        <li>
                                                            cellulitis > 2 cm, lymphangitic streaking, spread beneath the superficial fascia, deeptissue
                                                            abscess, gangrene and involvement of muscle, tendon, joint or bone.
                                                        </li>
                                                    </ul>
                                                </li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td><b>Severe</b></td>
                                        <td>
                                            <ul>
                                                <li>Infection in a patient with systemic toxicity or metabolic instability</li>
                                                    <ul type=circle>
                                                    <li>eg. Fever, chills, tachycardia, hypotension, confusion, vomiting, leukocytosis,
                                                        acidosis, severe hyperglycaemia, renal impairment</li>
                                                    </ul>
                                                    <li>Any osteomyelitis, systemic toxicity, bacteraemia, gangrene, ulceration to deep tissues, severe cellulitis
                                                    </li>
                                            </ul>
                                        </td>
                                    </tr>
                        </table>
                    </div>
                </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf2 -->

        <!-- Start of Diabet foot page Penicillin MILD: #diabf3 -->
        <div data-role="page" id="diabf3" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot infection</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="mrgn20b">
                    <span class="color-primary">How severe is the infection?</span>
                    <span class="font15"> (see table below)</span>
                </h3>
                <ul data-role="listview"  data-inset="true" class="listview"> 
                    <li><a href="#diabf3a">Mild</a></li>
                    <li><a href="#diabf3b2">Moderate</a></li>
                    <li><a href="#diabf3c1">Severe</a></li>    
                </ul>
                <h4 class="color-primary mrgn20b">Classification of diabetic foot infection</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <th>Severity</th>
                            <th>Features</th>
                        </tr>
                        <tr>
                            <td><b>Uninfected</b></td>
                            <td><ul><li>Wound lacking purulence or any manifestation of inflammation</li></ul></td>
                        </tr>
                        <tr>
                            <td><b>Mild</b></td>
                            <td>
                                <ul>
                                    <li> Presence of 2 or more manifestations of inflammation (purulence, or erythema, pain, tenderness,
                                        warmth, or induration) </li>
                                        <li> Extent of cellulitis/erythema: 0.5 - 2cm around ulcer, and infection is limited to the skin or
                                            superficial subcutaneous tissues </li>
                                            <li> No other local complications or systemic illness. </li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                            <td><b>Moderate</b></td>
                            <td>
                                <ul>
                                    <li>Infection (as above) in a patient who is systemically well and metabolically stable, but which has
                                        greater than 1 of the following characteristics:
                                        <ul type=circle>
                                            <li>
                                                cellulitis > 2 cm, lymphangitic streaking, spread beneath the superficial fascia, deeptissue
                                                abscess, gangrene and involvement of muscle, tendon, joint or bone.
                                            </li>
                                        </ul>
                                    </li>
                                </ul>
                            </td>
                        </tr>
                        <tr>
                            <td><b>Severe</b></td>
                            <td>
                                <ul>
                                    <li>Infection in a patient with systemic toxicity or metabolic instability</li>
                                        <ul type=circle>
                                        <li>eg. Fever, chills, tachycardia, hypotension, confusion, vomiting, leukocytosis,
                                            acidosis, severe hyperglycaemia, renal impairment</li>
                                        </ul>
                                        <li>Any osteomyelitis, systemic toxicity, bacteraemia, gangrene, ulceration to deep tissues, severe cellulitis
                                        </li>
                                </ul>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3 -->

        <!-- Start of diab foot pen MILD, Diab MILD: #diabf1a -->
        <div data-role="page" id="diabf1a" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">For mild diabetic foot in a patient with non-life-threatening penicillin allergy:</h3>
                <div id = "backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefalexin 500 mg PO, 6-hourly for 1-2 weeks</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 400 mg PO, 12-hourly for 1-2 weeks</span>
                    </h4>
                </div>
                <hr/>
                <ul type=circle>
                    <li>Treatment may extend up to 4 weeks if slow to resolve</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> ciprofloxacin or piperacillin with tazobactam may be required</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                </h4> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1a -->

        <!-- Start of diab foot pen BAD, Diab MILD: #diabf2a -->
        <div data-role="page" id="diabf2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">For mild diabetic foot in a patient with life-threatening penicillin allergy:</h3>
                <div id = "backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg PO, 12-hourly for 1-2 weeks</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 400 mg PO, 12-hourly for 1-2 weeks</span>
                    </h4>
                </div>
                </h4>
                <hr>
                <ul class="line30">
                    <li>Treatment may extend up to 4 weeks if slow to resolve</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> the empirical dosage of ciprofloxacin may need to be modified</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf2a -->

        <!-- Start of diab foot pen OK, Diab MILD: #diabf3a -->
        <div data-role="page" id="diabf3a" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn15b">For mild diabetic foot in a patient with no penicillin allergy:</h3>
                <div id = "backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Amoxicillin 875 mg/Clavulanic acid 125 mg PO, 12-hourly for 1-2 weeks</span>
                    </h4>
                </div>
                <hr/>
                <ul class="line30">
                    <li>Treatment may extend up to 4 weeks if slow to resolve</li>
                    <li>In patients with severe renal failure Amoxicillin dose may need to be reduced</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> ciprofloxacin or piperacillin with tazobactam may be required</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3a -->

        <!-- Start of Diabet foot page: #diabf2b2 ? MRSA-->
        <div data-role="page" id="diabf2b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot infection</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
                <ul data-role="listview"  data-inset="true" class="listview"> 
                    <li><a href="#diabf2b2a">Yes</a></li>
                    <li><a href="#diabf2b2b">No</a></li>
                </ul> 
                <hr>
                <ul type=circle>
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf2b2 -->

        <!-- Start of Diabet foot page: #diabf1b2 ? MRSA-->
        <div data-role="page" id="diabf1b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot infection</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
                <ul data-role="listview"  data-inset="true" class="listview"> 
                    <li><a href="#diabf1b2a">Yes</a></li>
                    <li><a href="#diabf1b2b">No</a></li>
                </ul> 
                <hr>
                <ul type=circle>
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1b2 -->

        <!-- Start of Diabet foot page: #diabf3b -->
        <div data-role="page" id="diabf3b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot infection</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
                <ul data-role="listview"  data-inset="true" class="listview">
                    <li><a href="#diabf3b2a">Yes</a></li>
                    <li><a href="#diabf3b2b">No</a></li>
                </ul>
                <hr>
                <ul type=circle>
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3b -->

        <!-- Start of diab foot pen BAD, Diab BAD, MRSA YES: #diabf2b2a -->
        <div data-role="page" id="diabf2b2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn15b">For moderate diabetic foot in patient with penicillin hypersensitivity with MRSA risk factors treatment will depend on whether patient can tolerate oral therapy. Give either:</h3>
                <hr>
                <h4 class="color-primary mrgn15b"><b>If patient cannot tolerate oral therapy give:</b></h4>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg IV, 12-hourly until stable then step down to oral &#40;below&#41;</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Clindamycin 900 mg IV, 8-hourly until stable then step down to oral &#40;below&#41;</span>
                    </h4>
                </div>
                <h4 class="color-primary mrgn15b"><b>If patient tolerates oral therapy give:</b></h4>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim + sulfamethoxazole 160+800 mg PO, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 400 mg PO, 12-hourly</span>
                    </h4>
                </div>
                <p class="mrgn20b"><b>AND</b> with either of the above regimens, if MRSA cover is required <b>ADD:</b></p>
                <div id="backcolour">
                    <br>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin IV, as per nomograms below &#40;until culture results return&#41; or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin, IV ciprofloxacin and IV clindamycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr/>
                <ul type=circle class="line30">
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>Please note trimethoprim and metronidazole both have excellent oral bioavailability (98% and 99% orally bioavailable), consider an early switch to oral therapy if is to be used</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> contact infectious diseases for advice</li>
                </ul>
                <hr>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                    <br>
                    
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf2b2a -->



        <!-- Start of diab foot pen BAD, Diab BAD, MRSA NO: #diabf1b2a -->
        <div data-role="page" id="diabf1b2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">For moderate diabetic foot in patient intolerant of penicillin with no MRSA risk factors use:</h3>
                <div id = "backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefazolin 2 g IV, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg IV, 12-hourly</span>
                    </h4>
                </div>
                <p class="mrgn20b"><b>AND</b> if MRSA cover is required <b>ADD:</b></p>
                <div id="backcolour">
                    <br>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin IV, as per nomograms below &#40;until culture results return&#41; or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr/>
                <ul type=circle class="line30">
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> contact infectious diseases for advice</li>
                </ul>
                <hr>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1b2a -->

        <!-- Start of diab foot pen BAD, Diab BAD, MRSA YES: #diabf2b2b -->
        <div data-role="page" id="diabf2b2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For moderate diabetic foot in patient with immediate severe penicillin hypersensitivity with MRSA risk factors treatment will depend on whether patient can tolerate oral therapy. Give either:</h3>
                <hr>
                <h4 class="color-primary mrgn15b"><b>If patient cannot tolerate oral therapy give:</b></h4>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg IV, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Clindamycin 900 mg IV, 8-hourly until stable then step down to oral clindamycin 450 mg 8-hourly</span>
                    </h4>
                </div>
                <h4 class="color-primary mrgn15b"><b>If patient tolerates oral therapy give:</b></h4>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim + sulfamethoxazole 160+800 mg PO, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 400 mg PO, 12-hourly</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV ciprofloxacin and IV clindamycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr/>
                <ul type=circle class="line30">
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>Please note trimethoprim and metronidazole both have excellent oral bioavailability (98% and 99% orally bioavailable), consider an early switch to oral therapy if is to be used</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> contact infectious diseases for advice</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                    <br>
                    
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf2b2b -->


        <!-- Start of diab foot pen BAD, Diab BAD, MRSA YES: #diabf1c1 -->
        <div data-role="page" id="diabf1c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For severe diabetic foot or moderate diabetic foot with sepsis in any patient intolerant of penicillin use:</h3>
                <hr>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 400 mg IV, 12-hourly until patient can switch to oral</span>
                    </h4>
                    <p class="mrgn20b"><b>OR</b> if oral therapy is possible use:</p>
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9312;</span><span class="color-purple"> Ciprofloxacin 750 mg PO, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Clindamycin 900 mg IV, 8-hourly until stable then step down to oral clindamycin 450 mg 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b> &#40;if at risk of MRSA&#41; <b>ADD</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin IV, with a loading dose of 25-30 mg/kg then as per nomogram below &#40;until culture results return&#41; or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV ciprofloxacin, IV clindamycin and vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for oral ciprofloxacin and oral clindamycin is:</span>
                    <span class="font15 bold"> 7<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue past one week. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr/>
                <ul type=circle class="line30">
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>Please note clindamycin has excellent oral bioavailability (90% orally bioavailable), consider an early switch to oral if clindamycin is to be used</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> the empirical dosage of ciprofloxacin may need to be modified</li>
                    <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to allow directed therapy</li>
                    <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                    <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                    <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment . Please see the severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                    <li>Please contact infectious diseases within 24 hours to rationalise antibiotics once blood culture results return.</li>
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                    <li>If cultures return sensitive to clindamycin this is often a good alternative to vancomycin with excellent tissue penetration</li>
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
                <hr>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr/>
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                    
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1c1 -->

        <!-- Start of diab foot pen BAD, Diab BAD, MRSA NO: #diabf1b2b -->
        <div data-role="page" id="diabf1b2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">For moderate diabetic foot in patient intolerant of penicillin with no MRSA risk factors use:</h3>
                <div id = "backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefazolin 2 g IV, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg IV, 12-hourly</span>
                    </h4>
                </div>
                <hr/>
                <hr>
                <ul type=circle class="line30">
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>Please note metronidazole has excellent oral bioavailability (98% orally bioavailable), consider an early switch to oral if tolerated</li>
                    <li>Depending on the organisms that are isolated from cultures of deep tissue specimens, other antibiotic combinations may be required. For infection with <i>Pseudomonas aeruginosa</i> the regimen may need to be modified</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf1b2b -->

        <!-- Start of diab foot pen OK, Diab MODERATE, MRSA YES: #diabf3b2a -->
        <div data-role="page" id="diabf3b2a" data-theme="a">
            <div data-role="header" class="secondpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="frontpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">For moderate diabetic foot in patient at risk of MRSA use:</h3>
                <div id = "backcolour">
                    <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin + clavulanate intravenously:</span>
                    <br><br>
                        <div class="table-responsive">
                            <table class="table-blank">
                                <tr>
                                    <td><span class="font17">Adult:&nbsp;&nbsp;</span></td>
                                    <td><span class="color-purple">1 + 0.2 g, 8-hourly, </span></td>
                                </tr>
                                <tr>
                                    <td><span class="font17"><b>OR</b> if the <u>bone is infected</u>:  &nbsp;</span></td>
                                    <td><span class="color-purple">1 + 0.2 g, 6-hourly,,</span></td>
                                </tr>
                            </table>
                        </div>
                    </h4>
                    <p class="mrgn20b"><b>AND</b> if MRSA cover is required <b>ADD</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin IV, as per nomogram below &#40;until culture results return&#41; or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for Amoxicillin iv & Clavulanate is:</span>
                    <span class="font15 bold"> 7<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 2 weeks. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                    <li>If cultures return sensitive to clindamycin this is often a good alternative to vancomycin with excellent tissue penetration</li>
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>If <i>Pseudomonas aeruginosa</i> is isolated from cultures of deep tissue specimens then the regimen may need to be changed to piperacillin and tazobactam with 6-hourly dosing.</li>
                    <li>Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
                </ul>
                <hr>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3b2a -->

        <!-- Start of diab foot pen OK, Diab BAD, MRSA NO: #diabf3b2 -->
        <div data-role="page" id="diabf3b2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">	
                <h3 class="color-primary mrgn15b">For moderate diabetic foot in a patient with no penicillin allergy and no signs of MRSA or sepsis use:</h3>
                <div id = "backcolour">
                    <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin + clavulanate intravenously:</span>
                    <br><br>
                        <div class="table-responsive">
                            <table class="table-blank">
                                <tr>
                                    <td><span class="font17">Adult:&nbsp;&nbsp;</span></td>
                                    <td><span class="color-purple">1 + 0.2 g, 8-hourly, </span></td>
                                </tr>
                                <tr>
                                    <td><span class="font17"><b>OR</b> if the <u>bone is infected</u>:  &nbsp;</span></td>
                                    <td><span class="color-purple">1 + 0.2 g, 6-hourly,,</span></td>
                                </tr>
                            </table>
                        </div>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for Amoxicillin iv & Clavulanate is:</span>
                    <span class="font15 bold"> 7<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 1 week. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr/>
                <ul type=circle class="line30">
                    <li>Treatment may extend up to 4 weeks if slow to resolve</li>
                    <li>If <i>Pseudomonas aeruginosa</i> is isolated from cultures of deep tissue specimens then the regimen may need to be changed to piperacillin and tazobactam with 6-hourly dosing.</li>
                    <li>Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                </h4>
            </div>
            <!-- /content -->

            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3b2 -->


    <!-- Start of diab foot pen OK, Diab BAD, MRSA YES: #diabf3c1 -->
        <div data-role="page" id="diabf3c1" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">For severe diabetic foot or moderate diabetic foot in a patient with sepsis use:</h3>
                <div id = "backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Piperacillin 4 g and tazobactam 0.5 g IV, 6-hourly until patient meets switch to oral criteria</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b> for MRSA cover <b>ADD</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin IV, with a loading dose of 25-30 mg/kg then as per nomogram below &#40;until culture results return&#41; or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for piperacillin+tazobactam is:</span>
                    <span class="font15 bold"> 7<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 2 weeks. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 2<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                    <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to allow directed therapy</li>
                    <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                    <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                    <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment . Please see the severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                    <li>Please contact infectious diseases within 24 hours to rationalise antibiotics once blood culture results return.</li>
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
                    <li>If cultures return sensitive to clindamycin this is often a good alternative to vancomycin with excellent tissue penetration</li>
                    <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities are available </li>
                    <li>If <i>Pseudomonas aeruginosa</i> is isolated from cultures of deep tissue specimens then the empirical dose of piperacillin and tazobactam may need to be maintained at 6-hourly dosing for longer.</li>
                    <li>Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
                </ul>
                <hr>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br/>48 hly</td>
                            <td>750 mg<br/>24 hly</td>
                            <td>750 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>15 min</td>
                        </tr>
                        <tr><td>50-64</td>
                            <td>1000 mg<br/>48 hly</td>
                            <td>1000 mg<br/>24 hly</td>
                            <td>1000 mg<br/>12 hly</td>
                            <td class="bg-success">1 hr<br/>40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br/>48 hly</td>
                            <td>1250 mg<br/>24 hly</td>
                            <td>1250 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>5 min</td>
                        </tr>
                        <tr><td>80-94</td>
                            <td>1500 mg<br/>48 hly</td>
                            <td>1500 mg<br/>24 hly</td>
                            <td>1500 mg<br/>12 hly</td>
                            <td class="bg-success">2 hrs<br/>30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br/>48 hly</td>
                            <td>1750 mg<br/>24 hly</td>
                            <td>1750 mg<br/>12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
                </ol>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                    <br>
                    
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3c1 -->

        <!-- Start of diab foot pen OK, Diab BAD, MRSA NO: #diabf3c2 -->
        <div data-role="page" id="diabf3c2" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Diabetic foot treatment</h1>
            </div>
            <!-- /header -->

            <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For mild to moderate diabetic foot in a patient with non-life-threatening penicillin allergy:</h3>
                <div id = "backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Piperacillin 4 g and tazobactam 500 mg IV, 8-hourly until patient meets switch to oral criteria</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for piperacillin+tazobactam is:</span>
                    <span class="font15 bold"> 7<script> document.write(getCode())</script>dfi</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 1 week. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr/>
                <ul type=circle class="line30">
                    <li>Treatment may extend up to 4 weeks if slow to resolve</li>
                    <li>If <i>Pseudomonas aeruginosa</i> is isolated from cultures of deep tissue specimens then the empirical dose of piperacillin and tazobactam may need to be increased to 6-hourly dosing.</li>
                    <li>Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on diabetic foot infection management</a> - Therapeutic Guidelines Group Melbourne</span>
                </h4>
            </div>
            <!-- /content -->

            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /diabf3c2 -->
        <!-- END of DIABETIC FOOT treatment maze -->


<!-- start of LACTATIONAL MASTITIS treatment maze -->
    <!-- Start of penicillin allergy page: #lacto -->
    <div data-role="page" id="lacto" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lactational Mastitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <br>
            <h4 class="mrgn20b biteSpecial">
                <span class="font15">In patients without systemic symptoms, increased breastfeeding and gently expressing milk from the affected breast may prevent progression and resolve infection without antibiotics.
                    In patients with systemic symptoms, or symptoms or signs that have not resolved after 24 to 48 hours of increased breastfeeding and expressing of milk, early antibiotic therapy is important to prevent abscess formation. Combine antibiotic therapy with increased breastfeeding and expressing of milk.
                </span>
            </h4>
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#lacto1">No penicillin allergy</a></li>
                <li><a href="#lacto2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#lacto3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /lacto -->

    <!-- Start Lactational Mastitis - No penicillin allergy -->
    <div data-role="page" id="lacto1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lactational mastitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">If the patient has no penicillin allergy treat with:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 500 mg orally, 6-hourly. If symptoms and signs resolve rapidly, 5 days of therapy may be sufficient; otherwise continue treatment for 10 days</span>
                </h4>
            </div>
            <hr/>
            <ul type=circle class="line30">
                <li>If mastitis is not associated with breastfeeding, seek expert advice for management</li>
                <li>If infection does not resolve with antibiotic therapy, evaluate the patient for an abscess and consider whether infection is caused by another pathogen</li>
                <li>If the patient has severe cellulitis, treat as <a href="#cellu">Cellulitis</a> associated with systemic features for initial treatment. Switch to oral therapy (as above) when symptoms are resolving</li>
                <li>Acute mastitis is usually associated with breastfeeding and is often caused by Staphylococcus aureus. Poor infant positioning, milk stasis and nipple damage are contributing factors. Breastfeeding or expressing milk (manually or via a pump) from the infected breast is safe and should be continued</li>
                <li>In patients without systemic symptoms, increased breastfeeding and gently expressing milk from the affected breast may prevent progression and resolve infection without antibiotics</li>
                <li>In patients with systemic symptoms, or symptoms or signs that have not resolved after 24 to 48 hours of increased breastfeeding and expressing of milk, early antibiotic therapy is important to prevent abscess formation. Combine antibiotic therapy with increased breastfeeding and expressing of milk</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on lactational mastitis</a> - Therapeutic Guidelines Group Melbourne</span>
            </h4>
        </div>
        <!-- /content -->

        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /lacto1 -->

    <!-- Start Lactational Mastitis - MILD penicillin allergy -->
    <div data-role="page" id="lacto2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lactational mastitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">If the patient has non-severe penicillin allergy treat with:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefalexin 500 mg orally, 6-hourly. If symptoms and signs resolve rapidly, 5 days of therapy may be sufficient; otherwise continue treatment for 10 days</span>
                </h4>
            </div>
            <hr/>
            <ul type=circle class="line30">
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                <li>If mastitis is not associated with breastfeeding, seek expert advice for management</li>
                <li>If infection does not resolve with antibiotic therapy, evaluate the patient for an abscess and consider whether infection is caused by another pathogen</li>
                <li>If the patient has severe cellulitis, treat as <a href="#cellu">Cellulitis</a> associated with systemic features for initial treatment. Switch to oral therapy (as above) when symptoms are resolving</li>
                <li>Acute mastitis is usually associated with breastfeeding and is often caused by Staphylococcus aureus. Poor infant positioning, milk stasis and nipple damage are contributing factors. Breastfeeding or expressing milk (manually or via a pump) from the infected breast is safe and should be continued</li>
                <li>In patients without systemic symptoms, increased breastfeeding and gently expressing milk from the affected breast may prevent progression and resolve infection without antibiotics</li>
                <li>In patients with systemic symptoms, or symptoms or signs that have not resolved after 24 to 48 hours of increased breastfeeding and expressing of milk, early antibiotic therapy is important to prevent abscess formation. Combine antibiotic therapy with increased breastfeeding and expressing of milk</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on lactational mastitis</a> - Therapeutic Guidelines Group Melbourne</span>
            </h4>
        </div>
        <!-- /content -->

        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /lacto2 -->

    <!-- Start Lactational Mastitis - No penicillin allergy -->
    <div data-role="page" id="lacto3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Lactational mastitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">If the patient has severe penicillin allergy treat with:</h3>
            <div id = "backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg orally, 8-hourly. If symptoms and signs resolve rapidly, 5 days of therapy may be sufficient; otherwise continue treatment for 10 days</span>
                </h4>
            </div>
            <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for clindamycin oral is:</span>
                    <span class="font15 bold"> 10<script> document.write(getCode())</script>lac</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>TEN</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 10 days. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
                </h4>
            <hr/>
            <ul type=circle class="line30">
                <li>If mastitis is not associated with breastfeeding, seek expert advice for management</li>
                <li>If infection does not resolve with antibiotic therapy, evaluate the patient for an abscess and consider whether infection is caused by another pathogen</li>
                <li>If the patient has severe cellulitis, treat as <a href="#cellu">Cellulitis</a> associated with systemic features for initial treatment. Switch to oral therapy (as above) when symptoms are resolving</li>
                <li>Acute mastitis is usually associated with breastfeeding and is often caused by Staphylococcus aureus. Poor infant positioning, milk stasis and nipple damage are contributing factors. Breastfeeding or expressing milk (manually or via a pump) from the infected breast is safe and should be continued</li>
                <li>In patients without systemic symptoms, increased breastfeeding and gently expressing milk from the affected breast may prevent progression and resolve infection without antibiotics</li>
                <li>In patients with systemic symptoms, or symptoms or signs that have not resolved after 24 to 48 hours of increased breastfeeding and expressing of milk, early antibiotic therapy is important to prevent abscess formation. Combine antibiotic therapy with increased breastfeeding and expressing of milk</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on lactational mastitis</a> - Therapeutic Guidelines Group Melbourne</span>
            </h4>
        </div>
        <!-- /content -->

        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /lacto3 -->

    <!-- END OF LACTATIONAL MASTITIS MAZE-->


    <!-- LET THE NECROTISING FASCIITIS MAZE BEGIN!! -->
        <!-- Start of necrotising fasciitis page: #necro -->
        <div data-role="page" id="necro" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Necrotising Fasciitis</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
                </h3>
                <ul data-role="listview"  data-inset="true" class="listview"> 
                    <li><a href="#necro1">No penicillin allergy</a></li>
                    <li><a href="#necro2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                    <li><a href="#necro3">Severe immediate or delayed penicillin hypersensitivity</a></li>    
                </ul>
                <hr/>
                <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
                <p class ="bold">No penicillin allergy</p>
                    <ul class="line30">
                        <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                        <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
                    </ul>
                <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                    <ul class="line30">
                        <li>This includes non-severe reactions such as isolated rash.</li>
                        <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                    </ul>        
                <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                    <ul class="line30">
                        <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                    </ul>
                    <hr>
                <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
                <div id="allergycolour">
                    <div class="row">
                        <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                        <div class="col-sm-9">
                            <ul class="line30">
                                <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                                <b>OR</b>
                                <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                            </ul>
                        </div>
                    </div>
                </div>
                <p class ="bold">OR </p>
                <div id="allergycolour">
                    <div class="row">
                        <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                        <div class="col-sm-9">
                            <ul class="line30">
                                <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                                <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                                <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                                <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                            </ul>
                        </div>
                    </div>
                </div>
                <p class ="bold">OR </p>
                <div id="allergycolour">
                    <div class="row">
                        <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                        </div>
                        <div class="col-sm-9">
                            <ul class="line30">
                                <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                                <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                                <ul class="circle">
                                    <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                    <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                    <li>Less than 90 mmHg from 11 to 17 years</li>
                                </ul>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /necro -->

    <!-- Start of mnec fasc, pen OK, page: #necro1 -->
    <div data-role="page" id="necro1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Necrotising Fasciitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">For necrotising fasciitis or cellulitis sourced sepsis, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <p style="text-decoration: underline"><b>IF WOUND HAS NOT BEEN EXPOSED TO WATER</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child 100 + 12.5 mg/kg up to 4+0.5 g&#41; IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>PLUS</b></p>
                <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin IV, with a 25-30mg loading dose then dosed as per the nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>PLUS</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600mg &#40;child 15mg/kg up to 600mg&#41; IV, 8-hourly</span>
                </h4>
                <p style="text-decoration: underline"><b>IF WOUND HAS BEEN EXPOSED TO WATER</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Meropenem 1g &#40;child 20 mg/kg up to 1g&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>PLUS</b></p>
                <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin IV, with a 25-30mg loading dose then dosed as per the nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>PLUS</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400mg &#40;child 10mg/kg up to 400mg&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>PLUS</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600mg &#40;child 15mg/kg up to 600mg&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam, meropenem, ciprofloxacin iv, vancomycin and clindamycin iv is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>nec</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>If the patient only has a single IV line it is important to give the other antibiotics before vancomycin as it has the longest infusion time</li>
                <li>Infectious diseases should be involved as soon as possible with all hospital acquired sepsis or necrotising fasciitis, cases as a wide range of organisms could be causing the infection which may not be covered by the above regimen</li>
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to allow directed therapy</li>
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment . Please see the severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                <li>Please contact infectious diseases within 24 hours to rationalise antibiotics once blood culture results return.</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on necrotising fasciitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /necro1 -->


    <!-- Start of nec fasc, pen MILD, page: #necro2 -->
    <div data-role="page" id="necro2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Necrotising Fasciitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">For necrotising fasciitis or cellulitis sourced sepsis, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Meropenem 1g &#40;child 25 mg/kg up to 1g&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600mg &#40;child 15mg/kg up to 600mg&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, with a 25-30mg loading dose then dosed as per the nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if the infection is from a wound that has been immersed in water, for <i>Aeromonus</i> cover <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400mg &#40;child 10mg/kg up to 400mg&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for meropenem, ciprofloxacin iv, vancomycin and clindamycin iv is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>nec</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>If the patient only has a single IV line it is important to give the other antibiotics before vancomycin as it has the longest infusion time</li>
                <li>Infectious diseases should be involved as soon as possible with all hospital acquired sepsis or necrotising fasciitis, cases as a wide range of organisms could be causing the infection which may not be covered by the above regimen</li>
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to allow directed therapy</li>
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment . Please see the severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                <li>Please contact infectious diseases within 24 hours to rationalise antibiotics once blood culture results return.</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on necrotising fasciitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /necro2 -->



    <!-- Start of Nec Fasc, pen BAD, page: #necro3 -->
    <div data-role="page" id="necro3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Necrotising Fasciitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with immediate penicillin hypersensitivity treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Meropenem 1g &#40;child 25 mg/kg up to 1g&#41; IV, 8-hourly</span><span class="color-danger">contact infectious diseases and give cautiously in a critical care area and monitor for signs of reaction</span>
                </h4>
                
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600mg &#40;child 15mg/kg up to 600mg&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND THEN</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, with a 25-30mg loading dose then dosed as per the nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if the infection is from a wound that has been immersed in water, for <i>Aeromonus</i> cover <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400mg &#40;child 10mg/kg up to 400mg&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for meropenem, vancomycin, ciprofloxacin iv and clindamycin iv is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>nec</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>If the patient only has a single IV line it is important to give the other antibiotics before vancomycin as it has the longest infusion time</li>
                <li>Infectious diseases should be involved as soon as possible with all hospital acquired sepsis or necrotising fasciitis, cases as a wide range of organisms could be causing the infection which may not be covered by the above regimen</li>
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to allow directed therapy</li>
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment . Please see the severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                <li>Please contact infectious diseases within 24 hours to rationalise antibiotics once blood culture results return.</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on necrotising fasciitis</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /necro3 -->

    <!-- NECROTISING FASCIITIS MAZE ENDS!! -->

    <!-- SURGICAL SITE INFECTIONS Maze Begins -->

    <!-- Start of SURGICAL SITE INFECTION PAGE ?PENICILLIN -->
    <div data-role="page" id="surginf" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Surgical site infection</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">   
        <h3 class="mrgn20b">
            <span class="color-primary">Does the patient have a penicillin allergy?</span>
            <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
        </h3>
        <ul data-role="listview"  data-inset="true" class="listview"> 
            <li><a href="#surginf1">No penicillin allergy</a></li>
            <li><a href="#surginf2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
            <li><a href="#surginf3">Severe immediate or delayed penicillin hypersensitivity</a></li>    
        </ul>
        <hr/>
        <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
        <p class ="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
            </ul>
        <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
            </ul>        
        <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
        <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
        <div id="allergycolour">
            <div class="row">
                <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                <div class="col-sm-9">
                    <ul class="line30">
                        <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                        <b>OR</b>
                        <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                    </ul>
                </div>
            </div>
        </div>
        <p class ="bold">OR </p>
        <div id="allergycolour">
            <div class="row">
                <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                <div class="col-sm-9">
                    <ul class="line30">
                        <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                        <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                        <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                        <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                    </ul>
                </div>
            </div>
        </div>
        <p class ="bold">OR </p>
        <div id="allergycolour">
            <div class="row">
                <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                </div>
                <div class="col-sm-9">
                    <ul class="line30">
                        <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                        <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                        <ul class="circle">
                            <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                            <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                            <li>Less than 90 mmHg from 11 to 17 years</li>
                        </ul>
                    </ul>
                </div>
            </div>
        </div>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
    </div>
    <!-- /surginf -->

    <!-- Start of SURGICAL SITE INFECTION NO PEN, ?DEEP/SEPSIS -->
    <div data-role="page" id="surginf1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection a superficial site infection or deep incisional site infection? &#40;see below&#41;</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Deep incisional surgical site infections are any surgical sites involving the fascia or muscle</li>
                <li>If the patient is displaying any systemic features treat as if a deep incisional infection regardless of the surgery type</li>
            </ul> 
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#surginf1a">Wound infection is from a <u>superficial surgical site</u></a></li>
                <li><a href="#surginf1b">Wound infection is a <u>deep incisional surgical site or patient has systemic features</u></a></li>         
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1 -->

    <!-- Start of SURGICAL SITE INFECTION MILD PEN, ?DEEP/SEPSIS -->
    <div data-role="page" id="surginf2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection a superficial site infection or deep incisional site infection? &#40;see below&#41;</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Deep incisional surgical site infections are any surgical sites involving the fascia or muscle</li>
                <li>If the patient is displaying any systemic features treat as if a deep incisional infection regardless of the surgery type</li>
            </ul> 
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#surginf2a">Wound infection is from a <u>superficial surgical site</u></a></li>
                <li><a href="#surginf2b">Wound infection is a <u>deep incisional surgical site or patient has systemic features</u></a></li>         
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2 -->

    <!-- Start of SURGICAL SITE INFECTION BAD PEN, ?DEEP/SEPSIS -->
    <div data-role="page" id="surginf3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the infection a superficial site infection or deep incisional site infection? &#40;see below&#41;</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Deep incisional surgical site infections are any surgical sites involving the fascia or muscle</li>
                <li>If the patient is displaying any systemic features treat as if a deep incisional infection regardless of the surgery type</li>
            </ul> 
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#surginf3a">Wound infection is from a <u>superficial surgical site</u></a></li>
                <li><a href="#surginfx">Wound infection is a <u>deep incisional surgical site or patient has systemic features</u></a></li>         
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf3 -->

    <!-- Start of SURGICAL SITE INFECTION NO PEN, NOT DEEP/SEPSIS ?GRAM NEG -->
    <div data-role="page" id="surginf1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Did the procedure enter the gastrointestinal, respiratory or genitourinary tracts? Or is there any other reason to suspect gram negative or anaerobic bacteria?</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#surginf1a1">Yes, <u>Gram negative or anaerobic bacteria</u> suspected</a></li>
                <li><a href="#surginf1a2">No, surgery did not involve any mucosal membranes</a></li>         
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1a -->

    <!-- Start of SURGICAL SITE INFECTION NO PEN, YES DEEP/SEPSIS ?GRAM NEG -->
    <div data-role="page" id="surginf1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Did the procedure enter the gastrointestinal, respiratory or genitourinary tracts? Or is there any other reason to suspect gram negative or anaerobic bacteria?</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#surginf1b1">Yes, <u>Gram negative or anaerobic bacteria</u> suspected</a></li>
                <li><a href="#surginf1b2">No, surgery did not involve any mucosal membranes</a></li>         
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1b -->

    <!-- Start of SURGICAL SITE INFECTION MILD PEN, NOT DEEP/SEPSIS ?GRAM NEG -->
    <div data-role="page" id="surginf2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Did the procedure enter the gastrointestinal, respiratory or genitourinary tracts? Or is there any other reason to suspect gram negative or anaerobic bacteria?</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#surginf2a1">Yes, <u>Gram negative or anaerobic bacteria</u> suspected</a></li>
                <li><a href="#surginf2a2">No, surgery did not involve any mucosal membranes</a></li>         
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2a -->

    <!-- Start of SURGICAL SITE INFECTION MILD PEN, YES DEEP/SEPSIS ?GRAM NEG -->
    <div data-role="page" id="surginf2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Did the procedure enter the gastrointestinal, respiratory or genitourinary tracts? Or is there any other reason to suspect gram negative or anaerobic bacteria?</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#surginfx">Yes, <u>Gram negative or anaerobic bacteria</u> suspected</a></li>
                <li><a href="#surginf2b2">No, surgery did not involve any mucosal membranes</a></li>         
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2b -->

    <!-- Start of SURGICAL SITE INFECTION BAD PEN, NO DEEP/SEPSIS ?GRAM NEG -->
    <div data-role="page" id="surginf3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Did the procedure enter the gastrointestinal, respiratory or genitourinary tracts? Or is there any other reason to suspect gram negative or anaerobic bacteria?</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#surginf1a1a">Yes, <u>Gram negative or anaerobic bacteria</u> suspected</a></li>
                <li><a href="#surginf3a2">No, surgery did not involve any mucosal membranes</a></li>         
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf3a -->

    <!-- Start of SURGICAL SITE INFECTION NO PEN, NOT DEEP/SEPSIS, YES GRAM NEG, ?MRSA -->
    <div data-role="page" id="surginf1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#surginf1a1a">Yes</a></li>
                <li><a href="#surginf1a1b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1a1 -->

    <!-- Start of SURGICAL SITE INFECTION NO PEN, NOT DEEP/SEPSIS, NO GRAM NEG, ?MRSA -->
    <div data-role="page" id="surginf1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#surginf1a2a">Yes</a></li>
                <li><a href="#surginf1a2b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1a2 -->

    <!-- Start of SURGICAL SITE INFECTION NO PEN, YES DEEP/SEPSIS, YES GRAM NEG, ?MRSA -->
    <div data-role="page" id="surginf1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#surginf1b1a">Yes</a></li>
                <li><a href="#surginf1b1b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1b1 -->

    <!-- Start of SURGICAL SITE INFECTION NO PEN, YES DEEP/SEPSIS, NO GRAM NEG, ?MRSA -->
    <div data-role="page" id="surginf1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#surginf1b2a">Yes</a></li>
                <li><a href="#surginf1b2b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1b2 -->

    <!-- Start of SURGICAL SITE INFECTION MILD PEN, NOT DEEP/SEPSIS, YES GRAM NEG, ?MRSA -->
    <div data-role="page" id="surginf2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#surginf1a1a">Yes</a></li>
                <li><a href="#surginf2a1b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2a1 -->

    <!-- Start of SURGICAL SITE INFECTION MILD PEN, NOT DEEP/SEPSIS, NO GRAM NEG, ?MRSA -->
    <div data-role="page" id="surginf2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#surginf1a2a">Yes</a></li>
                <li><a href="#surginf2a2b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2a2 -->

    <!-- Start of SURGICAL SITE INFECTION MILDO PEN, YES DEEP/SEPSIS, NO GRAM NEG, ?MRSA -->
    <div data-role="page" id="surginf2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#surginf2b2a">Yes</a></li>
                <li><a href="#surginf2b2b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2b2 -->

    <!-- Start of SURGICAL SITE INFECTION BAD PEN, NOT DEEP/SEPSIS, NO GRAM NEG, ?MRSA -->
    <div data-role="page" id="surginf3a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is MRSA infection suspected?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#surginf1a2a">Yes</a></li>
                <li><a href="#surginf3a2b">No</a></li>
            </ul>
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous
                    heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf3a2 -->

    <!-- SURGICAL SITE INFECTION ANY PEN, NOT DEEP/SEPSIS, YES GRAM NEG, YES MRSA -->
    <div data-role="page" id="surginf1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with known risk factors for MRSA and risk factors for Gram negative or anaerobic infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>Continue antibiotic therapy for 5 days; a longer duration may be required depending on clinical response. If there is a poor response to empirical therapy, review whether the pathogen is adequately treated and re-evaluate the wound for evidence of deeper tissue involvement</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1a1a -->

    <!-- SURGICAL SITE INFECTION NO PEN, NOT DEEP/SEPSIS, YES GRAM NEG, NO MRSA -->
    <div data-role="page" id="surginf1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with no known risk factors for MRSA but with risk factors for Gram negative or anaerobic infection, and no penicillin allergy, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg (child 2 months or older: 22.5+3.2 mg/kg up to 875+125 mg) orally, 12-hourly</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>Amoxicillin+clavulanate may be suitable for children aged 1 month to younger than 2 months, but a different dosage is required</li>
                <li>Continue antibiotic therapy for 5 days; a longer duration may be required depending on clinical response. If there is a poor response to empirical therapy, review whether the pathogen is adequately treated and re-evaluate the wound for evidence of deeper tissue involvement</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1a1b -->

    <!-- SURGICAL SITE INFECTION ANY PEN, NOT DEEP/SEPSIS, NO GRAM NEG, YES MRSA -->
    <div data-role="page" id="surginf1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with known risk factors for MRSA infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, 12-hourly</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>Continue antibiotic therapy for 5 days; a longer duration may be required depending on clinical response. If there is a poor response to empirical therapy, review whether the pathogen is adequately treated and re-evaluate the wound for evidence of deeper tissue involvement</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1a2a -->

    <!-- SURGICAL SITE INFECTION NO PEN, NOT DEEP/SEPSIS, NO GRAM NEG, YES MRSA -->
    <div data-role="page" id="surginf1a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with no penicillin allergy and no risk factors for MRSA infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly. See below for duration of therapy</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>Continue antibiotic therapy for 5 days; a longer duration may be required depending on clinical response. If there is a poor response to empirical therapy, review whether the pathogen is adequately treated and re-evaluate the wound for evidence of deeper tissue involvement</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1a2b --> 

    <!-- SURGICAL SITE INFECTION NO PEN, YES DEEP/SEPSIS, YES GRAM NEG, YES MRSA -->
    <div data-role="page" id="surginf1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with no penicillin allergy, deep site infection and risk factors for MRSA infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple"> Amoxicillin + clavulanate
                            intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, dosed as per the nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <br>
            <div id = "backcolour"> 
                <p class="mrgn20b">Or, if <i>Pseudomonas aeruginosa</i> is suspected (e.g. based on previous culture results or local epidemiology) <b>replace</b> Amoxicillin + clavulanate with:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) intravenously, 6-hourly</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin, iv amoxicillin+clavulanate or piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>sfi</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>If patient is displaying any signs of sepsis please treat as per <a href="sepsisNsimilar.html#sepsis">severe sepsis from a surgical site infection</a></li>
                <li>Modify therapy based on the results of culture and susceptibility testing. If susceptibility results are not available by 72 hours and empirical intravenous therapy is still required, continue amoxicillin+clavulanate or piperacillin+tazobactam as monotherapy. Switch to oral antibiotic therapy when systemic features have resolved and source control has been achieved</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1b1a -->

    <!-- SURGICAL SITE INFECTION NO PEN, YES DEEP/SEPSIS, YES GRAM NEG, NO MRSA -->
    <div data-role="page" id="surginf1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with no penicillin allergy, mucosal involvement, deep site infection or systemic features and no risk factors for MRSA infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple"> Amoxicillin + clavulanate
                            intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
            </div>
            <br>
            <div id = "backcolour"> 
                <p class="mrgn20b">OR, if <i>Pseudomonas aeruginosa</i> is suspected (e.g. based on previous culture results or local epidemiology) <b>replace</b> Amoxicillin + clavulanate with:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) intravenously, 6-hourly</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for iv amoxicillin+clavulanate or piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>sfi</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>If patient is displaying any signs of sepsis please treat as per <a href="sepsisNsimilar.html#sepsis">severe sepsis from a surgical site infection</a></li>
                <li>Modify therapy based on the results of culture and susceptibility testing. If susceptibility results are not available by 72 hours and empirical intravenous therapy is still required, continue the amoxicillin+clavulanate or piperacillin+tazobactam as monotherapy. Switch to oral antibiotic therapy when systemic features have resolved and source control has been achieved</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1b1b -->

    <!-- SURGICAL SITE INFECTION NO PEN, YES DEEP/SEPSIS, NO GRAM NEG, YES MRSA -->
    <div data-role="page" id="surginf1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with no penicillin allergy, no mucosal involvement, deep site infection or systemic features and risk factors for MRSA infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, dosed as per the nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>sfi</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>If patient is displaying any signs of sepsis please treat as per <a href="sepsisNsimilar.html#sepsis">severe sepsis from a surgical site infection</a></li>
                <li>Modify therapy based on the results of culture and susceptibility testing. If susceptibility results are not available by 72 hours and empirical intravenous therapy is still required, continue flucloxacillin as monotherapy. Switch to oral antibiotic therapy when systemic features have resolved and source control has been achieved</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1b2a -->

    <!-- SURGICAL SITE INFECTION NO PEN, YES DEEP/SEPSIS, NO GRAM NEG, NO MRSA -->
    <div data-role="page" id="surginf1b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with no penicillin allergy, no mucosal involvement, deep site infection or systemic features and risk factors for MRSA infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>If patient is displaying any signs of sepsis please treat as per <a href="sepsisNsimilar.html#sepsis">severe sepsis from a surgical site infection</a></li>
                <li>Modify therapy based on the results of culture and susceptibility testing. If susceptibility results are not available by 72 hours and empirical intravenous therapy is still required, continue flucloxacillin as monotherapy. Switch to oral antibiotic therapy when systemic features have resolved and source control has been achieved</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf1b2b -->

    <!-- SURGICAL SITE INFECTION MILD PEN, NOT DEEP/SEPSIS, YES GRAM NEG, NO MRSA -->
    <div data-role="page" id="surginf2a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with non-severe penicillin allergy, with no known risk factors for MRSA and risk factors for Gram negative or anaerobic infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drugs recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                <li>Continue antibiotic therapy for 5 days; a longer duration may be required depending on clinical response. If there is a poor response to empirical therapy, review whether the pathogen is adequately treated and re-evaluate the wound for evidence of deeper tissue involvement</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2a1b -->

    <!-- SURGICAL SITE INFECTION MILD PEN, NOT DEEP/SEPSIS, NO GRAM NEG, NO MRSA -->
    <div data-role="page" id="surginf2a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with non-severe penicillin allergy, with no known risk factors for MRSA or risk factors for Gram negative or anaerobic infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drugs recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                <li>Continue antibiotic therapy for 5 days; a longer duration may be required depending on clinical response. If there is a poor response to empirical therapy, review whether the pathogen is adequately treated and re-evaluate the wound for evidence of deeper tissue involvement</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2a2b -->

    <!-- SURGICAL SITE INFECTION BAIL OUT PAGE -->
    <div data-role="page" id="surginfx" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has a penicillin allergy</h3>
            <hr>
            <div id="backcolour">
                <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice, a decision needs to be made on the best treatment based on patient specific circumstances</h4>
            </div>
            <hr>
            <ul class="line30">
                <li>If patient is displaying any signs of sepsis please treat as per <a href="sepsisNsimilar.html#sepsis">severe sepsis from a surgical site infection</a></li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on gastroenteritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginfx -->

    <!-- SURGICAL SITE INFECTION MILD PEN, YES DEEP/SEPSIS, NO GRAM NEG, YES MRSA -->
    <div data-role="page" id="surginf2b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with non-severe penicillin allergy, no mucosal involvement, deep site infection or systemic features and risk factors for MRSA infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin IV, dosed as per the nomograms below or use the <a href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>sfi</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>If patient is displaying any signs of sepsis please treat as per <a href="sepsisNsimilar.html#sepsis">severe sepsis from a surgical site infection</a></li>
                <li>Modify therapy based on the results of culture and susceptibility testing. If susceptibility results are not available by 72 hours and empirical intravenous therapy is still required, continue cefazolin as monotherapy. Switch to oral antibiotic therapy when systemic features have resolved and source control has been achieved</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
                <li>For oral step down therapy, it is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drugs recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
            <div class="table-responsive">
                <table class="table table-bordered">
                    <tr>
                        <th class="darkbackcolour" colspan ="2">Age</th>
                        <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                        <th class="darkbackcolour">Dosing <br>frequency</th>
                        <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 14 days</td>
                        <td>15 mg/kg</td>
                        <td>18-hourly</td>
                        <td>Before the second dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>14 days or older</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" rowspan ="2">Neonates 30 to 36 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">12-hourly</td>
                        <td class="bluebackcolour">Before the third dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                        <td class="bluebackcolour">15 mg/kg</td>
                        <td class="bluebackcolour">8-hourly</td>
                        <td class="bluebackcolour">Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td rowspan ="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>15 mg/kg</td>
                        <td>12-hourly</td>
                        <td>Before the third dose</td>
                    </tr>
                    <tr>
                        <td>postnatal age <br>7 days or older</td>
                        <td>15 mg/kg</td>
                        <td>8-hourly</td>
                        <td>Before the fourth dose</td>
                    </tr>
                    <tr>
                        <td class="bluebackcolour" colspan = "2">Infants and children &#40;NB2&#41;</td>
                        <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                        <td class="bluebackcolour">6-hourly</td>
                        <td class="bluebackcolour">Before the fifth dose</td>
                    </tr>
                </table>
                <ul class="line30">
                    <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                    <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group; however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                </ul>
            </div>
            <hr/>
            <h4 class="color-primary mrgn20">Vancomycin Dosing in Adults</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <td>Actual body<br> weight &#40;kg&#41;</td>
                        <td>CrClr <br>&lt; 20 mL/min</td>
                        <td>CrClr <br>20-60 mL/min</td>
                        <td>CrClr <br>&gt; 60 mL/min</td>
                        <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                    </tr>
                    <tr>
                        <td>&lt; 40</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td>40-49</td>
                        <td>750 mg<br/>48 hly</td>
                        <td>750 mg<br/>24 hly</td>
                        <td>750 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>15 min</td>
                    </tr>
                    <tr><td>50-64</td>
                        <td>1000 mg<br/>48 hly</td>
                        <td>1000 mg<br/>24 hly</td>
                        <td>1000 mg<br/>12 hly</td>
                        <td class="bg-success">1 hr<br/>40 min</td>
                    </tr>
                    <tr>
                        <td>65-79</td>
                        <td>1250 mg<br/>48 hly</td>
                        <td>1250 mg<br/>24 hly</td>
                        <td>1250 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>5 min</td>
                    </tr>
                    <tr><td>80-94</td>
                        <td>1500 mg<br/>48 hly</td>
                        <td>1500 mg<br/>24 hly</td>
                        <td>1500 mg<br/>12 hly</td>
                        <td class="bg-success">2 hrs<br/>30 min</td>
                    </tr>
                    <tr>
                        <td>95-110</td>
                        <td>1750 mg<br/>48 hly</td>
                        <td>1750 mg<br/>24 hly</td>
                        <td>1750 mg<br/>12 hly</td>
                        <td class="bg-success">3 hrs</td>
                    </tr>
                    <tr>
                        <td>&gt; 110</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td>Call infectious diseases</td>
                        <td class="bg-success">---</td>
                    </tr>
                    <tr>
                        <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                        <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                        <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                        <td class="bg-success">Before the <br/>4<sup>th</sup> dose</td>
                        <td class="bg-success">---</td>
                    </tr>
                </table>
            </div>
            <ol type="1" class="line30">
                <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span class="bold color-danger">Red Man</span> Syndrome</li>
                <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is considered the first dose</li>
                <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether the next dose is given before the trough concentration is available or withheld until the result is known</li>
            </ol>
            <hr/>
            <ul class="line30" type="circle">
                <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from baseline creatinine will almost always result in an increase in vancomycin concentration as vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt an immediate vancomycin level prior to the next dose, witholding the next dose until the level is available.</li>
                <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for interpretation of trough levels as vancomycin will not have reached steady state</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2b2a -->

    <!-- SURGICAL SITE INFECTION MILD PEN, YES DEEP/SEPSIS, NO GRAM NEG, NO MRSA -->
    <div data-role="page" id="surginf2b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with non-severe penicillin allergy, no mucosal involvement, deep site infection or systemic features and risk factors for MRSA infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr/>
            <ul class="line30">
                <li>If patient is displaying any signs of sepsis please treat as per <a href="sepsisNsimilar.html#sepsis">severe sepsis from a surgical site infection</a></li>
                <li>Modify therapy based on the results of culture and susceptibility testing. If susceptibility results are not available by 72 hours and empirical intravenous therapy is still required, continue cefazolin as monotherapy. Switch to oral antibiotic therapy when systemic features have resolved and source control has been achieved</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
                <li>For oral step down therapy, it is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drugs recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf2b2b -->

    <!-- SURGICAL SITE INFECTION MILD PEN, NOT DEEP/SEPSIS, NO GRAM NEG, NO MRSA -->
    <div data-role="page" id="surginf3a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Surgical site infection treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">  
            <h3 class="mrgn20b">
                <span class="color-primary">In a patient with non-severe penicillin allergy, with no known risk factors for MRSA or risk factors for Gram negative or anaerobic infection, treat with:</span>
            </h3>
            <div id = "backcolour"> 
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally, 8-hourly</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>sfi</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>FIVE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past five days. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr/>
            <ul class="line30">
                <li>Continue antibiotic therapy for 5 days; a longer duration may be required depending on clinical response. If there is a poor response to empirical therapy, review whether the pathogen is adequately treated and re-evaluate the wound for evidence of deeper tissue involvement</li>
                <li>Collect samples for Gram stain and culture before starting antibiotic therapy. More severe surgical site infections (including those involving the deep soft tissues) may require surgical exploration, drainage, irrigation and debridement; delayed wound closure is often necessary</li>
                <li>See the Therapeutic Guidelines Antibiotic for advice on managing postoperative organ/space infection (involving structures deeper than the fascia or muscle)</li>
                <li>Do not use topical antibiotics for surgical site infections, because they are associated with the emergence of resistant organisms and can cause hypersensitivity reactions. Topical antiseptics do not offer an advantage over drainage and debridement, and cytotoxic antiseptics (eg sodium hypochlorite, hydrogen peroxide) can impede wound healing</li>
                <li>Most surgical site infections are caused by organisms already colonising the patient at the time of surgery. Infection is most commonly caused by skin flora, including Staphylococcus aureus, and, in clean–contaminated procedures (where the gastrointestinal, respiratory or genitourinary tracts are entered), Gram-negative bacilli and anaerobes</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on surgical site infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /surginf3a2b -->

    <!-- SURGICAL SITE INFECTIONS MAZE ENDS!! -->

    <!-- THIRD/FOURTH DEGREE TEAR MAZE BEGINS -->

    <!-- Start of THIRD/FOURTH DEGREE TEAR ?PENICILLIN -->
    <div data-role="page" id="oasis" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Prophylaxis for repair of obstetric anal sphincter injuries</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#oasis1">No penicillin allergy</a></li>
                <li><a href="#oasis2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#oasis3">Severe immediate or delayed penicillin hypersensitivity</a></li>    
            </ul>
            <hr/>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class ="bold">No penicillin allergy</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                    <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
                </ul>
            <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
                </ul>        
            <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
                </ul>
                <hr>
            <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class ="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
        </div>
        <!-- /oasis -->

        <!-- THIRD/FOURTH DEGREE TEAR, NO PEN ALL -->
        <div data-role="page" id="oasis1" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical site infection treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">In a patient with no penicillin allergy give:</span>
                </h3>
                <div id = "backcolour"> 
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefazolin 2 g intravenously, as early as possible; redosing may be required. Do not give additional intravenous doses once the procedure is completed</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg intravenously, as early as possible; redosing may be required. Do not give additional intravenous doses once the procedure is completed</span>
                    </h4>
                    <p class="mrgn20b"><b>THEN,</b> once procedure is completed continue postoperative therapy with:</p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Amoxicillin+clavulanate 875+125 mg orally, 12-hourly for 5 days</span>
                    </h4>
                </div>
                <hr/>
                <ul class="line30">
                    <li>There is no evidence to recommend maternal antibiotic prophylaxis for other indications following vaginal delivery</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on prophylaxis for repair of obstetric anal sphincter injuries</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /oasis1 -->

        <!-- THIRD/FOURTH DEGREE TEAR, MILD PEN ALL -->
        <div data-role="page" id="oasis2" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical site infection treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">In a patient with non-severe penicillin allergy give:</span>
                </h3>
                <div id = "backcolour"> 
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefazolin 2 g intravenously, as early as possible; redosing may be required. Do not give additional intravenous doses once the procedure is completed</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg intravenously, as early as possible; redosing may be required. Do not give additional intravenous doses once the procedure is completed</span>
                    </h4>
                    <p class="mrgn20b"><b>THEN,</b> once procedure is completed continue postoperative therapy with:</p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefalexin 500 mg orally, 6-hourly for 5 days</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 400 mg orally, 12-hourly for 5 days</span>
                    </h4>
                </div>
                <hr/>
                <ul class="line30">
                    <li>There is no evidence to recommend maternal antibiotic prophylaxis for other indications following vaginal delivery</li>
                    <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drugs recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on prophylaxis for repair of obstetric anal sphincter injuries</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /oasis2 -->

        <!-- THIRD/FOURTH DEGREE TEAR, BAD PEN ALL -->
        <div data-role="page" id="oasis3" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Surgical site infection treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">  
                <h3 class="mrgn20b">
                    <span class="color-primary">In a patient with severe penicillin allergy give:</span>
                </h3>
                <div id = "backcolour"> 
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Clindamycin 600 mg intravenously, as early as possible; redosing may be required. Do not give additional intravenous doses once the procedure is completed</span>
                    </h4>
                    <p class="mrgn20b"><b>THEN,</b> once procedure is completed continue postoperative therapy with:</p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg orally, 12-hourly for 5 days</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 400 mg orally, 12-hourly for 5 days</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for clindamycin IV is:</span>
                    <span class="font15 bold"> 1<script> document.write(getCode())</script>oas</span>
                    <div class="font15 mrgn20b text-left">
                        This code is valid for <b>ONE</b> day only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 24 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.
                    </div>
                </h4>
                <hr/>
                <ul class="line30">
                    <li>There is no evidence to recommend maternal antibiotic prophylaxis for other indications following vaginal delivery</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on prophylaxis for repair of obstetric anal sphincter injuries</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /oasis3 -->

    <!-- THIRD/FOURTH DEGREE TEAR MAZE ENDS!!!! -->

    <!-- POST TRAUMATIC WOUND INFECTION Maze Begins -->

    <!-- Start of post traumatic wound infection starter page -->
    <div data-role="page" id="trauma" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">See below before beginning antibiotic management for a post traumatic wound</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Antibiotics are not routinely required for traumatic wounds. They are used as:</li>
                <ul>
                    <li>Prophylaxis for wounds requiring surgical management or that are significantly contaminated (eg penetrating injuries through footwear, stab wounds)</li>
                    <li>Presumptive therapy for bites and clenched-fist injuries at high risk of infection</li>
                    <li>Prophylaxis for open fractures</li>
                    <li>treatment of established infection (see localised infection, infection associated with systemic features or deeper tissues or sepsis or septic shock associated with a traumatic wound)</li>
                </ul>
                <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                <li>Collect samples for Gram stain and culture before antibiotic therapy is started</li>
                <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg Clostridium perfringens infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries)</li>
                <li>See the Therapeutic Guidelines antibiotic or the Australian Immunisation Handbook for details on whether tetanus prophylaxis is required</li>
            </ul> 
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#traumapen">Continue to treatment/prophylaxis</a></li>    
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma -->


    <!-- Start of post traumatic wound infection page ?PENICILLIN -->
    <div data-role="page" id="traumapen" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Post traumatic wound infection</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">   
        <h3 class="mrgn20b">
            <span class="color-primary">Does the patient have a penicillin allergy?</span>
            <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
        </h3>
        <ul data-role="listview"  data-inset="true" class="listview"> 
            <li><a href="#trauma1">No penicillin allergy</a></li>
            <li><a href="#trauma2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
            <li><a href="#trauma3">Severe immediate or delayed penicillin hypersensitivity</a></li>    
        </ul>
        <hr/>
        <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
        <p class ="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
            </ul>
        <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
            </ul>        
        <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
        <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
        <div id="allergycolour">
            <div class="row">
                <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                <div class="col-sm-9">
                    <ul class="line30">
                        <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                        <b>OR</b>
                        <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                    </ul>
                </div>
            </div>
        </div>
        <p class ="bold">OR </p>
        <div id="allergycolour">
            <div class="row">
                <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                <div class="col-sm-9">
                    <ul class="line30">
                        <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                        <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                        <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                        <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                    </ul>
                </div>
            </div>
        </div>
        <p class ="bold">OR </p>
        <div id="allergycolour">
            <div class="row">
                <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                </div>
                <div class="col-sm-9">
                    <ul class="line30">
                        <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                        <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                        <ul class="circle">
                            <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                            <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                            <li>Less than 90 mmHg from 11 to 17 years</li>
                        </ul>
                    </ul>
                </div>
            </div>
        </div>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
    </div>
    <!-- /traumapen -->

    <!-- Start of post traumatic wound infection page NO PEN, ?INFECTED -->
    <div data-role="page" id="trauma1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the wound involve any deep tissues, or is already showing signs of localised or systemic infection? &#40;see below&#41;</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Any wound involving bones, joints or tendons should be treated as a deep tissue wound</li>
                <li>Any wound which has been heavily contaminated should be treated as a deep tissue wound. See <a href="#watwo">water exposed wounds</a> if wound has been exposed to water</li>
            </ul> 
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1a">Wound is <u>not</u> displaying signs of infection and does not involve any deep tissues</a></li>
                <li><a href="#trauma1b">Wound is displaying signs of <u>localised infection</u> but does not involve deep tissues</a></li>
                <li><a href="#trauma1c">Wound involves <u>deep tissues</u> or there are signs of systemic infection</a></li>            
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1 -->

    <!-- Start of post traumatic wound infection page MILD PEN, ?INFECTED -->
    <div data-role="page" id="trauma2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the wound involve any deep tissues, or is already showing signs of localised or systemic infection? &#40;see below&#41;</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Click yes for any wound penetrating through footware or any wound involving bones, joints or tendons</li>
                <li>Click yes for any wound which has been heavily contaminated. See <a href="#watwo">water exposed wounds</a> if wound has been exposed to water</li>
            </ul> 
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma2a">Wound is <u>not</u> displaying signs of infection and does not involve any deep tissues</a></li>
                <li><a href="#trauma2b">Wound is displaying signs of <u>localised infection</u> but does not involve deep tissues</a></li>
                <li><a href="#trauma2c">Wound involves <u>deep tissues</u> or there are signs of systemic infection</a></li>           
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2 -->

    <!-- Start of post traumatic wound infection page BAD PEN, ?INFECTED -->
    <div data-role="page" id="trauma3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the wound involve any deep tissues, or is already showing signs of localised or systemic infection? &#40;see below&#41;</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Click yes for any wound penetrating through footware or any wound involving bones, joints or tendons</li>
                <li>Click yes for any wound which has been heavily contaminated. See <a href="#watwo">water exposed wounds</a> if wound has been exposed to water</li>
            </ul> 
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma3a">Wound is <u>not</u> displaying signs of infection and does not involve any deep tissues</a></li>
                <li><a href="#trauma1b1">Wound is displaying signs of <u>localised infection</u> but does not involve deep tissues</a></li>
                <li><a href="#trauma3c">Wound involves <u>deep tissues</u> or there are signs of systemic infection</a></li>            
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma3 -->

    <!-- Start of post traumatic wound infection page OK PEN, NOT INFECTED, ?SURGERY  -->
    <div data-role="page" id="trauma1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the wound require surgical management?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1a1">Yes</a></li>
                <li><a href="#trauma1a2">No</a></li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1a -->

    <!-- Start of post traumatic wound infection page MILD PEN, NOT INFECTED, ?SURGERY  -->
    <div data-role="page" id="trauma2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the wound require surgical management?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1a1">Yes</a></li>
                <li><a href="#trauma2a2">No</a></li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2a -->

    <!-- Start of post traumatic wound infection page BAD PEN, NOT INFECTED, ?SURGERY  -->
    <div data-role="page" id="trauma3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the wound require surgical management?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma3a1">Yes</a></li>
                <li><a href="#trauma3a2">No</a></li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma3a -->

    <!-- Start of post traumatic wound infection page NO PEN, LOCAL INFECTED, ?MRSA  -->
    <div data-role="page" id="trauma1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1b1">Yes</a></li>
                <li><a href="#trauma1b2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1b -->

    <!-- Start of post traumatic wound infection page NO PEN, BAD INFECTED/DEEP, ?MRSA  -->
    <div data-role="page" id="trauma1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1c1">Yes</a></li>
                <li><a href="#trauma1c2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c -->

    <!-- Start of post traumatic wound infection page BAD PEN, NOT INFECTED, ?SURGERY  -->
    <div data-role="page" id="trauma3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the wound require surgical management?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma3a1">Yes</a></li>
                <li><a href="#trauma3a2">No</a></li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma3a -->

    <!-- Start of post traumatic wound infection page NO PEN, LOCAL INFECTED, ?MRSA  -->
    <div data-role="page" id="trauma1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1b1">Yes</a></li>
                <li><a href="#trauma1b2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1b -->

    <!-- Start of post traumatic wound infection page NO PEN, BAD INFECTED/DEEP, ?MRSA  -->
    <div data-role="page" id="trauma1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1c1">Yes</a></li>
                <li><a href="#trauma1c2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c -->

    <!-- Start of post traumatic wound infection page MILD PEN, LOCAL INFECTED, ?MRSA  -->
    <div data-role="page" id="trauma2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1b1">Yes</a></li>
                <li><a href="#trauma2b2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2b -->

    <!-- Start of post traumatic wound infection page MILD PEN, BAD INFECTED/DEEP, ?MRSA  -->
    <div data-role="page" id="trauma2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma2c1">Yes</a></li>
                <li><a href="#trauma2c2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2c -->

    <!-- Start of post traumatic wound infection page BAD PEN, BAD INFECTED/DEEP, ?MRSA  -->
    <div data-role="page" id="trauma3c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma3c1">Yes</a></li>
                <li><a href="#trauma3c2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma3c -->

    <!-- Start of post traumatic wound infection page OK PEN, BAD INFECTED/DEEP, YES MRSA, ?FOOTWEAR/MACERATED  -->
    <div data-role="page" id="trauma1c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the wound deeply macerated, heavily contaminated, or penetrating through footwear?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1c1a">Patient displaying systemic features only, or wound involving deeper tissues only, without significant maceration or footwear involvement</a></li>
                <li><a href="#trauma1c1b">Wound is severely contaminated or there is significant tissue maceration</a></li>
                <li><a href="#trauma1c1c">Wound involves penetrating injury through footwear</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>If the wound is a combination of penetrating footwear injury with heavy contamination or significant tissue maceration contact infectious diseases for advice</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c1 -->

    <!-- Start of post traumatic wound infection page OK PEN, BAD INFECTED/DEEP, NO MRSA, ?FOOTWEAR/MACERATED  -->
    <div data-role="page" id="trauma1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the wound deeply macerated, heavily contaminated, or penetrating through footwear?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1c2a">Patient displaying systemic features only, or wound involving deeper tissues only, without significant maceration or footwear involvement</a></li>
                <li><a href="#trauma1c2b">Wound is severely contaminated or there is significant tissue maceration</a></li>
                <li><a href="#trauma1c2c">Wound involves penetrating injury through footwear</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>If the wound is a combination of penetrating footwear injury with heavy contamination or significant tissue maceration contact infectious diseases for advice</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c2 -->

    <!-- Start of post traumatic wound infection page MILD PEN, BAD INFECTED/DEEP, YES MRSA, ?FOOTWEAR/MACERATED  -->
    <div data-role="page" id="trauma2c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the wound deeply macerated, heavily contaminated, or penetrating through footwear?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1c1a">Patient displaying systemic features only, or wound involving deeper tissues only, without significant maceration or footwear involvement</a></li>
                <li><a href="#trauma1c1b">Wound is severely contaminated or there is significant tissue maceration</a></li>
                <li><a href="#trauma1c1c">Wound involves penetrating injury through footwear</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>If the wound is a combination of penetrating footwear injury with heavy contamination or significant tissue maceration contact infectious diseases for advice</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2c1 -->

    <!-- Start of post traumatic wound infection page MILD PEN, BAD INFECTED/DEEP, NO MRSA, ?FOOTWEAR/MACERATED  -->
    <div data-role="page" id="trauma2c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the wound deeply macerated, heavily contaminated, or penetrating through footwear?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1c2a">Patient displaying systemic features only, or wound involving deeper tissues only, without significant maceration or footwear involvement</a></li>
                <li><a href="#trauma2c2b">Wound is severely contaminated or there is significant tissue maceration</a></li>
                <li><a href="#trauma2c2c">Wound involves penetrating injury through footwear</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>If the wound is a combination of penetrating footwear injury with heavy contamination or significant tissue maceration contact infectious diseases for advice</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2c2 -->

    <!-- Start of post traumatic wound infection page BAD PEN, BAD INFECTED/DEEP, YES MRSA, ?FOOTWEAR/MACERATED  -->
    <div data-role="page" id="trauma3c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the wound deeply macerated, heavily contaminated, or penetrating through footwear?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma1c1a">Patient displaying systemic features only, or wound involving deeper tissues only, without significant maceration or footwear involvement</a></li>
                <li><a href="#trauma1c1b">Wound is severely contaminated or there is significant tissue maceration</a></li>
                <li><a href="#trauma1c1c">Wound involves penetrating injury through footwear</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>If the wound is a combination of penetrating footwear injury with heavy contamination or significant tissue maceration contact infectious diseases for advice</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma3c1 -->

    <!-- Start of post traumatic wound infection page BAD PEN, BAD INFECTED/DEEP, NO MRSA, ?FOOTWEAR/MACERATED  -->
    <div data-role="page" id="trauma3c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the wound deeply macerated, heavily contaminated, or penetrating through footwear?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#trauma3c2a">Patient displaying systemic features only, or wound involving deeper tissues only, without significant maceration or footwear involvement</a></li>
                <li><a href="#trauma3c2a">Wound is severely contaminated or there is significant tissue maceration</a></li>
                <li><a href="#trauma2c2c">Wound involves penetrating injury through footwear</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>If the wound is a combination of penetrating footwear injury with heavy contamination or significant tissue maceration contact infectious diseases for advice</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma3c2 -->

    <!-- Start of post traumatic wound infection page OK PEN OR MILD, LOCALISED NO INFEC, SURGICAL  -->
    <div data-role="page" id="trauma1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient with non-severe, or no penicillin allergy and no signs of active infection but requiring surgical wound debridement give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefazolin 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly (see below for duration of prophylaxis)</span>
                    </h4>
                </div>
                <hr>
                <ul type=circle>
                    <li>For wounds that require prophylaxis, combining careful cleaning and debridement with antibiotics reduces the incidence of early infections. Administer antibiotic prophylaxis as soon as possible, ideally within 3 hours of injury.</li>
                    <li>Prophylaxis for nonsevere injuries can be discontinued at definitive wound closure. Do not continue prophylaxis for severe injuries for more than 24 hours after definitive wound closure. Regardless of injury severity, the total duration of prophylaxis should be no more than 72 hours, even if soft tissue coverage is not achievable.</li>
                    <li>The duration of prophylaxis depends on injury severity (muscular, skeletal and soft tissue trauma, crush injuries, penetrating injuries, and stab wounds are usually severe), adequacy of debridement and whether soft tissue coverage is achievable.</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>Additional anaerobic activity is recommended for heavily contaminated severe injuries, such as agricultural injuries. If heavily contaminated add metronidazole to cefazolin</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Antibiotic prophylaxis is not routinely required for traumatic wounds that do not require surgical management and are not significantly contaminated. Careful cleaning and debridement is the mainstay of therapy for these wounds.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1a1 -->

    <!-- Start of post traumatic wound infection page OK PEN, LOCALISED NO INFEC, NOT SURGICAL  -->
    <div data-role="page" id="trauma1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient with no penicillin allergy and no signs of active infection, not requiring surgical wound debridement give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Flucloxacillin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly. (see below for duration of prophylaxis)</span>
                    </h4>
                </div>
                <hr>
                <ul type=circle>
                    <li>For wounds that require prophylaxis, combining careful cleaning and debridement with antibiotics reduces the incidence of early infections. Administer antibiotic prophylaxis as soon as possible, ideally within 3 hours of injury.</li>
                    <li>Prophylaxis for nonsevere injuries can be discontinued at definitive wound closure. Do not continue prophylaxis for severe injuries for more than 24 hours after definitive wound closure. Regardless of injury severity, the total duration of prophylaxis should be no more than 72 hours, even if soft tissue coverage is not achievable.</li>
                    <li>The duration of prophylaxis depends on injury severity (muscular, skeletal and soft tissue trauma, crush injuries, penetrating injuries, and stab wounds are usually severe), adequacy of debridement and whether soft tissue coverage is achievable.</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Antibiotic prophylaxis is not routinely required for traumatic wounds that do not require surgical management and are not significantly contaminated. Careful cleaning and debridement is the mainstay of therapy for these wounds.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1a2 -->


    <!-- Start of post traumatic wound infection page MILD PEN, LOCALISED NO INFEC, NOT SURGICAL  -->
    <div data-role="page" id="trauma2a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient with non-severe penicillin allergy and no signs of active infection, not requiring surgical wound debridement give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly. (see below for duration of prophylaxis)</span>
                    </h4>
                </div>
                <hr>
                <ul type=circle>
                    <li>For wounds that require prophylaxis, combining careful cleaning and debridement with antibiotics reduces the incidence of early infections. Administer antibiotic prophylaxis as soon as possible, ideally within 3 hours of injury.</li>
                    <li>Prophylaxis for nonsevere injuries can be discontinued at definitive wound closure. Do not continue prophylaxis for severe injuries for more than 24 hours after definitive wound closure. Regardless of injury severity, the total duration of prophylaxis should be no more than 72 hours, even if soft tissue coverage is not achievable.</li>
                    <li>The duration of prophylaxis depends on injury severity (muscular, skeletal and soft tissue trauma, crush injuries, penetrating injuries, and stab wounds are usually severe), adequacy of debridement and whether soft tissue coverage is achievable.</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Antibiotic prophylaxis is not routinely required for traumatic wounds that do not require surgical management and are not significantly contaminated. Careful cleaning and debridement is the mainstay of therapy for these wounds.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2a2 -->


    <!-- Start of post traumatic wound infection page BAD PEN, LOCALISED NO INFEC, SURGICAL  -->
    <div data-role="page" id="trauma3a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient with severe penicillin allergy and no signs of active infection but requiring surgical wound debridement give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously, 8-hourly. (see below for duration of prophylaxis)</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV Clindamycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>tra</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>For wounds that require prophylaxis, combining careful cleaning and debridement with antibiotics reduces the incidence of early infections. Administer antibiotic prophylaxis as soon as possible, ideally within 3 hours of injury.</li>
                    <li>Prophylaxis for nonsevere injuries can be discontinued at definitive wound closure. Do not continue prophylaxis for severe injuries for more than 24 hours after definitive wound closure. Regardless of injury severity, the total duration of prophylaxis should be no more than 72 hours, even if soft tissue coverage is not achievable.</li>
                    <li>The duration of prophylaxis depends on injury severity (muscular, skeletal and soft tissue trauma, crush injuries, penetrating injuries, and stab wounds are usually severe), adequacy of debridement and whether soft tissue coverage is achievable.</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Antibiotic prophylaxis is not routinely required for traumatic wounds that do not require surgical management and are not significantly contaminated. Careful cleaning and debridement is the mainstay of therapy for these wounds.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma3a1 -->

    <!-- Start of post traumatic wound infection page BAD PEN, LOCALISED NO INFEC, NOT SURGICAL  -->
    <div data-role="page" id="trauma3a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient with severe penicillin allergy and no signs of active infection, not requiring surgical wound debridement give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally, 8-hourly. (see below for duration of prophylaxis)</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for PO Clindamycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>tra</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>For wounds that require prophylaxis, combining careful cleaning and debridement with antibiotics reduces the incidence of early infections. Administer antibiotic prophylaxis as soon as possible, ideally within 3 hours of injury.</li>
                    <li>Prophylaxis for nonsevere injuries can be discontinued at definitive wound closure. Do not continue prophylaxis for severe injuries for more than 24 hours after definitive wound closure. Regardless of injury severity, the total duration of prophylaxis should be no more than 72 hours, even if soft tissue coverage is not achievable.</li>
                    <li>The duration of prophylaxis depends on injury severity (muscular, skeletal and soft tissue trauma, crush injuries, penetrating injuries, and stab wounds are usually severe), adequacy of debridement and whether soft tissue coverage is achievable.</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Antibiotic prophylaxis is not routinely required for traumatic wounds that do not require surgical management and are not significantly contaminated. Careful cleaning and debridement is the mainstay of therapy for these wounds.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma3a2 -->

    <!-- Start of post traumatic wound infection page: OK, MILD OR BAD PEN, LOCALISED INFEC, BAD PEN OR MRSA POSITIVE  -->
    <div data-role="page" id="trauma1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient who is either at risk of MRSA infection or has severe penicillin allergy give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, 12-hourly for 5 days.</span>
                    </h4>
                    <p class="mrgn20b"><b>OR</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9313;</span><span class="color-purple"> Clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally, 8-hourly for 5 days.</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for PO Clindamycin is:</span>
                    <span class="font15 bold"> 5<script> document.write(getCode())</script>tra</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 5 days. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>Collect samples for Gram stain and culture before antibiotic therapy is started.</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Antibiotic prophylaxis is not routinely required for traumatic wounds that do not require surgical management and are not significantly contaminated. Careful cleaning and debridement is the mainstay of therapy for these wounds.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1b1 -->

    <!-- Start of post traumatic wound infection page: OK PEN, LOCALISED INFEC, NO MRSA  -->
    <div data-role="page" id="trauma1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient with non-severe penicillin allergy and not at risk of MRSA infection give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple"> Flucloxacillin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly for 5 days.</span>
                    </h4>
                </div>
                <hr>
                <ul type=circle>
                    <li>Collect samples for Gram stain and culture before antibiotic therapy is started.</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Antibiotic prophylaxis is not routinely required for traumatic wounds that do not require surgical management and are not significantly contaminated. Careful cleaning and debridement is the mainstay of therapy for these wounds.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1b2 -->

    <!-- Start of post traumatic wound infection page: MILD PEN, LOCALISED INFEC, NO MRSA  -->
    <div data-role="page" id="trauma2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient with no penicillin allergy and not at risk of MRSA infection give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly for 5 days.</span>
                    </h4>
                </div>
                <hr>
                <ul type=circle>
                    <li>Collect samples for Gram stain and culture before antibiotic therapy is started.</li>
                    <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Antibiotic prophylaxis is not routinely required for traumatic wounds that do not require surgical management and are not significantly contaminated. Careful cleaning and debridement is the mainstay of therapy for these wounds.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2b2 -->

    <!-- Start of post traumatic wound infection page: OK PEN, DEEP/SYSTEMIC, YES MRSA, NO FOOTWEAR NO CONTAMINATION  -->
    <div data-role="page" id="trauma1c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient without significant wound contamination, maceration or footware involvement at risk of MRSA infection or with severe penicillin allergy give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin as per nomograms below or use the <a
                                href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>tra</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>Collect samples for Gram stain and culture before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>Switch to oral therapy as soon as possible (eg 48 hours after surgery); if P. aeruginosa infection is confirmed, seek expert advice for oral continuation therapy.</li>
                    <li>Total duration of treatment (intravenous + oral) is 5 to 7 days, depending on clinical response; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons). For the suggested duration of intravenous and oral therapy, contact infectious diseases and see the Therapeutic Guidelines for infection involving bone, and for infection involving a joint.</li>
                    <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered">
                        <tr>
                            <th class="darkbackcolour" colspan="2">Age</th>
                            <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                            <th class="darkbackcolour">Dosing <br>frequency</th>
                            <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 14 days</td>
                            <td>15 mg/kg</td>
                            <td>18-hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>14 days or older</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                                &#40;NB1&#41;</td>
                            <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">12-hourly</td>
                            <td class="bluebackcolour">Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">8-hourly</td>
                            <td class="bluebackcolour">Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 7 days</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>7 days or older</td>
                            <td>15 mg/kg</td>
                            <td>8-hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                            <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                            <td class="bluebackcolour">6-hourly</td>
                            <td class="bluebackcolour">Before the fifth dose</td>
                        </tr>
                    </table>
                    <ul class="line30">
                        <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                            period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                        <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                            however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                    </ul>
                </div>
                <hr />
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br />48 hly</td>
                            <td>750 mg<br />24 hly</td>
                            <td>750 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />15 min</td>
                        </tr>
                        <tr>
                            <td>50-64</td>
                            <td>1000 mg<br />48 hly</td>
                            <td>1000 mg<br />24 hly</td>
                            <td>1000 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br />48 hly</td>
                            <td>1250 mg<br />24 hly</td>
                            <td>1250 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />5 min</td>
                        </tr>
                        <tr>
                            <td>80-94</td>
                            <td>1500 mg<br />48 hly</td>
                            <td>1500 mg<br />24 hly</td>
                            <td>1500 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br />48 hly</td>
                            <td>1750 mg<br />24 hly</td>
                            <td>1750 mg<br />12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                            class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                        considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                        the next dose is given before the trough concentration is available or withheld until the result is
                        known</li>
                </ol>
                <hr />
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                        baseline creatinine will almost always result in an increase in vancomycin concentration as
                        vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                        an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                        available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                        interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c1a -->

    <!-- Start of post traumatic wound infection page: OK PEN, DEEP/SYSTEMIC, YES MRSA, NO FOOTWEAR BUT CONTAMINATION  -->
    <div data-role="page" id="trauma1c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient with heavily contaminated injuries or severe tissue maceration at risk of MRSA infection or with severe penicillin allergy give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin as per nomograms below or use the <a
                                href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly.</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>tra</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>Collect samples for Gram stain and culture before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>Switch to oral therapy as soon as possible (eg 48 hours after surgery); if P. aeruginosa infection is confirmed, seek expert advice for oral continuation therapy.</li>
                    <li>Total duration of treatment (intravenous + oral) is 5 to 7 days, depending on clinical response; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons). For the suggested duration of intravenous and oral therapy, contact infectious diseases and see the Therapeutic Guidelines for infection involving bone, and for infection involving a joint.</li>
                    <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered">
                        <tr>
                            <th class="darkbackcolour" colspan="2">Age</th>
                            <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                            <th class="darkbackcolour">Dosing <br>frequency</th>
                            <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 14 days</td>
                            <td>15 mg/kg</td>
                            <td>18-hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>14 days or older</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                                &#40;NB1&#41;</td>
                            <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">12-hourly</td>
                            <td class="bluebackcolour">Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">8-hourly</td>
                            <td class="bluebackcolour">Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 7 days</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>7 days or older</td>
                            <td>15 mg/kg</td>
                            <td>8-hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                            <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                            <td class="bluebackcolour">6-hourly</td>
                            <td class="bluebackcolour">Before the fifth dose</td>
                        </tr>
                    </table>
                    <ul class="line30">
                        <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                            period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                        <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                            however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                    </ul>
                </div>
                <hr />
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br />48 hly</td>
                            <td>750 mg<br />24 hly</td>
                            <td>750 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />15 min</td>
                        </tr>
                        <tr>
                            <td>50-64</td>
                            <td>1000 mg<br />48 hly</td>
                            <td>1000 mg<br />24 hly</td>
                            <td>1000 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br />48 hly</td>
                            <td>1250 mg<br />24 hly</td>
                            <td>1250 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />5 min</td>
                        </tr>
                        <tr>
                            <td>80-94</td>
                            <td>1500 mg<br />48 hly</td>
                            <td>1500 mg<br />24 hly</td>
                            <td>1500 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br />48 hly</td>
                            <td>1750 mg<br />24 hly</td>
                            <td>1750 mg<br />12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                            class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                        considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                        the next dose is given before the trough concentration is available or withheld until the result is
                        known</li>
                </ol>
                <hr />
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                        baseline creatinine will almost always result in an increase in vancomycin concentration as
                        vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                        an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                        available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                        interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c1b -->

    <!-- Start of post traumatic wound infection page: OK PEN, DEEP/SYSTEMIC, YES MRSA, FOOTWEAR -->
    <div data-role="page" id="trauma1c1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For a patient at risk of MRSA infection or with severe penicillin allergy with a penetrating injury through footware give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin as per nomograms below or use the <a
                                href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly.</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin and ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>tra</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>Ciprofloxacin is not licensed for use in children on the basis of animal studies that showed an adverse effect on cartilage development with quinolone use; however, there are few data from human trials to support this finding. Ciprofloxacin can be used in children when it is the drug of choice.</li>
                    <li>Collect samples for Gram stain and culture before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>Switch to oral therapy as soon as possible (eg 48 hours after surgery); if P. aeruginosa infection is confirmed, seek expert advice for oral continuation therapy.</li>
                    <li>Total duration of treatment (intravenous + oral) is 5 to 7 days, depending on clinical response; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons). For the suggested duration of intravenous and oral therapy, contact infectious diseases and see the Therapeutic Guidelines for infection involving bone, and for infection involving a joint.</li>
                    <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                    <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                    <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                    <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                    <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered">
                        <tr>
                            <th class="darkbackcolour" colspan="2">Age</th>
                            <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                            <th class="darkbackcolour">Dosing <br>frequency</th>
                            <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 14 days</td>
                            <td>15 mg/kg</td>
                            <td>18-hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>14 days or older</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                                &#40;NB1&#41;</td>
                            <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">12-hourly</td>
                            <td class="bluebackcolour">Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">8-hourly</td>
                            <td class="bluebackcolour">Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 7 days</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>7 days or older</td>
                            <td>15 mg/kg</td>
                            <td>8-hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                            <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                            <td class="bluebackcolour">6-hourly</td>
                            <td class="bluebackcolour">Before the fifth dose</td>
                        </tr>
                    </table>
                    <ul class="line30">
                        <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                            period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                        <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                            however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                    </ul>
                </div>
                <hr />
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br />48 hly</td>
                            <td>750 mg<br />24 hly</td>
                            <td>750 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />15 min</td>
                        </tr>
                        <tr>
                            <td>50-64</td>
                            <td>1000 mg<br />48 hly</td>
                            <td>1000 mg<br />24 hly</td>
                            <td>1000 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br />48 hly</td>
                            <td>1250 mg<br />24 hly</td>
                            <td>1250 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />5 min</td>
                        </tr>
                        <tr>
                            <td>80-94</td>
                            <td>1500 mg<br />48 hly</td>
                            <td>1500 mg<br />24 hly</td>
                            <td>1500 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br />48 hly</td>
                            <td>1750 mg<br />24 hly</td>
                            <td>1750 mg<br />12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                            class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                        considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                        the next dose is given before the trough concentration is available or withheld until the result is
                        known</li>
                </ol>
                <hr />
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                        baseline creatinine will almost always result in an increase in vancomycin concentration as
                        vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                        an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                        available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                        interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c1c -->

    <!-- Start of post traumatic wound infection page: OK PEN, DEEP/SYSTEMIC, NO MRSA, NO FOOTWEAR NO CONTAMINATION  -->
    <div data-role="page" id="trauma1c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient without significant wound contamination, maceration or footware involvement not at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly.</span>
                </h4>
            </div>
            <hr>
            <ul type=circle>
                <li>Collect samples for Gram stain and culture before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                <li>Switch to oral therapy as soon as possible (eg 48 hours after surgery); if P. aeruginosa infection is confirmed, seek expert advice for oral continuation therapy.</li>
                <li>Total duration of treatment (intravenous + oral) is 5 to 7 days, depending on clinical response; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons). For the suggested duration of intravenous and oral therapy, contact infectious diseases and see the Therapeutic Guidelines for infection involving bone, and for infection involving a joint.</li>
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c2a -->

    <!-- Start of post traumatic wound infection page: OK PEN, DEEP/SYSTEMIC, NO MRSA, CONTAMINATION  -->
    <div data-role="page" id="trauma1c2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with significant wound contamination or maceration not at risk of MRSA infection with no penicillin allergy give:</h3>
            <div id="backcolour">
                <p class="mrgn20b"><b>As a single agent:</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin + clavulanate intravenously for 3 days</span>
                    <br><br>
                        <div class="table-responsive">
                            <table class="table-blank">
                                <tr>
                                    <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                    <td><span class="color-purple">1 + 0.2 g 8-hourly, If the <u>bone is infected</u>, use a dose of 1+0.2 g 6-hourly</span></td>
                                </tr>
                                <tr>
                                    <td><span class="font17">child younger than 3 months and less than 4kg:  &nbsp;</span></td>
                                    <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                                </tr>
                                <tr>
                                    <td><span class="font17">child younger than 3 months and 4 kg or more:  &nbsp;</span></td>
                                    <td><span class="color-purple"> 25+5 mg/kg 8-hourly,</span></td>
                                </tr>
                                <tr>
                                    <td><span class="font17">child 3 months or older::  &nbsp;</span></td>
                                    <td><span class="color-purple"> 25+5 mg/kg up to 1+0.2 g 8-hourly. If the <u>bone is infected</u>, use a dose of 25+5 mg/kg up to 1+0.2 g 6-hourly</span></td>
                                </tr>
                            </table>
                        </div>
                    </h4>
                <p class="mrgn20b"><b>OR</b> (as a two-drug regimen)</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly.</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV Amoxicillin+Clavulanate is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>tra</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul type=circle>
                <li>Collect samples for Gram stain and culture before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                <li>Switch to oral therapy as soon as possible (eg 48 hours after surgery); if P. aeruginosa infection is confirmed, seek expert advice for oral continuation therapy.</li>
                <li>Total duration of treatment (intravenous + oral) is 5 to 7 days, depending on clinical response; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons). For the suggested duration of intravenous and oral therapy, contact infectious diseases and see the Therapeutic Guidelines for infection involving bone, and for infection involving a joint.</li>
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c2b -->

    <!-- Start of post traumatic wound infection page: OK PEN, DEEP/SYSTEMIC, NO MRSA, FOOTWEAR CONTAMINATION  -->
    <div data-role="page" id="trauma1c2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with a footware associated wound, not at risk of MRSA infection, with no penicillin allergy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g (child: 100+12.5 mg/kg up to 4+0.5 g) intravenously, 6-hourly.</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>tra</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul type=circle>
                <li>Collect samples for Gram stain and culture before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                <li>Switch to oral therapy as soon as possible (eg 48 hours after surgery); if P. aeruginosa infection is confirmed, seek expert advice for oral continuation therapy.</li>
                <li>Total duration of treatment (intravenous + oral) is 5 to 7 days, depending on clinical response; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons). For the suggested duration of intravenous and oral therapy, contact infectious diseases and see the Therapeutic Guidelines for infection involving bone, and for infection involving a joint.</li>
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma1c2c -->

    <!-- Start of post traumatic wound infection page: MILD PEN, DEEP/SYSTEMIC, NO MRSA, CONTAMINATION  -->
    <div data-role="page" id="trauma2c2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with significant wound contamination or maceration not at risk of MRSA infection with non-severe penicillin allergy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly.</span>
                </h4>
            </div>
            <hr>
            <ul type=circle>
                <li>Collect samples for Gram stain and culture before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                <li>Switch to oral therapy as soon as possible (eg 48 hours after surgery); if P. aeruginosa infection is confirmed, seek expert advice for oral continuation therapy.</li>
                <li>Total duration of treatment (intravenous + oral) is 5 to 7 days, depending on clinical response; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons). For the suggested duration of intravenous and oral therapy, contact infectious diseases and see the Therapeutic Guidelines for infection involving bone, and for infection involving a joint.</li>
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2c2b -->

    <!-- Start of post traumatic wound infection page: MILD PEN, DEEP/SYSTEMIC, NO MRSA, FOOT CONTAMINATION  -->
    <div data-role="page" id="trauma2c2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with footware associated wound infection and a penicillin allergy not at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV Ciprofloxacin and Clindamycin is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>tra</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul type=circle>
                <li>Ciprofloxacin is not licensed for use in children on the basis of animal studies that showed an adverse effect on cartilage development with quinolone use; however, there are few data from human trials to support this finding. Ciprofloxacin can be used in children when it is the drug of choice.</li>
                <li>Collect samples for Gram stain and culture before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                <li>Switch to oral therapy as soon as possible (eg 48 hours after surgery); if P. aeruginosa infection is confirmed, seek expert advice for oral continuation therapy.</li>
                <li>Total duration of treatment (intravenous + oral) is 5 to 7 days, depending on clinical response; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons). For the suggested duration of intravenous and oral therapy, contact infectious diseases and see the Therapeutic Guidelines for infection involving bone, and for infection involving a joint.</li>
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma2c2c -->

    <!-- Start of post traumatic wound infection page: BAD PEN, DEEP/SYSTEMIC, NO MRSA, NO CONTAMINATION  -->
    <div data-role="page" id="trauma3c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
        <div data-role="header" class="secondpage">
            <h1>Post traumatic wound prophylaxis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="color-primary mrgn15b">For a patient with severe penicillin allergy not at risk of MRSA infection give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr/>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for IV Clindamycin is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>tra</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul type=circle>
                <li>Collect samples for Gram stain and culture before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                <li>Switch to oral therapy as soon as possible (eg 48 hours after surgery); if P. aeruginosa infection is confirmed, seek expert advice for oral continuation therapy.</li>
                <li>Total duration of treatment (intravenous + oral) is 5 to 7 days, depending on clinical response; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons). For the suggested duration of intravenous and oral therapy, contact infectious diseases and see the Therapeutic Guidelines for infection involving bone, and for infection involving a joint.</li>
                <li>It is safe to use cefalexin in patients who had a delayed nonsevere reaction to a penicillin in the distant past. It is also safe to use cefalexin in patients who have had a delayed nonsevere reaction recently, unless the reaction involved amoxicillin or ampicillin, because cross-reactivity between these drugs is possible. For patients who have had a recent delayed nonsevere reaction to amoxicillin or ampicillin, use the drug recommended for patients with immediate (nonsevere or severe) or delayed severe hypersensitivity</li>
                <li>For patients with traumatic wounds, ensure that tetanus immunisation is up-to-date. See the Therapeutic Guidelines Antibiotic for details on when tetanus vaccine is required</li>
                <li>Careful cleaning and debridement of traumatic wounds is important to prevent infection; immobilisation and elevation are also beneficial</li>
                <li>If antibiotic therapy is indicated for a traumatic wound that has been immersed in water, see <a href="#watwo">Water-immersed wound infections</a> for antibiotic choice.</li>
                <li>Likely pathogens in post-traumatic wound infection include <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> (group A streptococcus). Anaerobic post-traumatic wound infection (eg <i>Clostridium perfringens</i> infection) is rare but may follow severe injuries if the wound is heavily contaminated. A broader range of pathogens are seen in infections of traumatic wounds that have been immersed in water, including soil- or sewage-contaminated water (eg injuries sustained in a natural disaster, marine injuries).</li>
            </ul>
            <hr/>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on post traumatic wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /trauma3c2a -->

    <!-- POST TRAUMATIC WOUND INFECTION MAZE ENDS!! -->


    <!-- Skin ulcer (Non-diabetic) Maze Begins -->

    <!-- Start of uSkin ulcer (Non-diabetic) page, check if needed: #ulcer -->
    <div data-role="page" id="ulcer" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic)</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient require antibiotic treatment? &#40;see below&#41;</span>
            </h3>
            <hr/>
        <ul class="line30">
            <li>Non-diabetic related ulcers may be caused by a myriad of reasons including chronic pressure injuries, pyoderma gangrenosum or vascular insufficiency</li>
            <li>A chronic ulcer WITHOUT signs of infection &#40;ie surrounding cellulitis, osteomyelitis&#41; does NOT need antibiotics</li>
            <li><i>Pseudomonas aeruginosa</i> and other gram negative organisms may not be causative in infection. They may be colonisers and their presence should not always require coverage in empiric antibiotic regimens</li>
            <li>Taking microbiological samples before the administration of antibiotics is important</li>
        </ul> 
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#ulcer1">Yes, antibiotic treatment is required</a></li>
                <li><a href="index.html">No, get me out of here</a></li>            
            </ul>

        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ulcer -->



    <!-- Start of Skin ulcer (Non-diabetic) page After preamble: #ulcer1 -->
    <div data-role="page" id="ulcer1" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Skin ulcer (Non-diabetic)</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">   
        <h3 class="mrgn20b">
            <span class="color-primary">Does the patient have a penicillin allergy?</span>
            <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
        </h3>
        <ul data-role="listview"  data-inset="true" class="listview"> 
            <li><a href="#ulcer1a">No penicillin allergy</a></li>
            <li><a href="#ulcer1b">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
            <li><a href="#ulcer1c">Severe immediate or delayed penicillin hypersensitivity</a></li>    
        </ul>
        <hr/>
        <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
        <p class ="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use strategies for symptom control such as metoclopramide</li>
            </ul>
        <p class ="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin</li>
            </ul>        
        <p class ="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
        <p class ="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
        <div id="allergycolour">
            <div class="row">
                <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours) involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing, swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                <div class="col-sm-9">
                    <ul class="line30">
                        <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                        <b>OR</b>
                        <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                    </ul>
                </div>
            </div>
        </div>
        <p class ="bold">OR </p>
        <div id="allergycolour">
            <div class="row">
                <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:</div>
                <div class="col-sm-9">
                    <ul class="line30">
                        <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen lips-tongue-uvula&#41;.</li>
                        <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak expiratory flow, hypoxemia&#41;.</li>
                        <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope, incontinence&#41;.</li>
                        <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain, vomiting&#41;.</li>
                    </ul>
                </div>
            </div>
        </div>
        <p class ="bold">OR </p>
        <div id="allergycolour">
            <div class="row">
                <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient with known penicillin allergy &#40;within minutes to several hours&#41;
                </div>
                <div class="col-sm-9">
                    <ul class="line30">
                        <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30 percent decrease from that person's baseline</li>
                        <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41; or greater than 30 percent decrease in systolic BP</li>
                        <ul class="circle">
                            <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                            <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                            <li>Less than 90 mmHg from 11 to 17 years</li>
                        </ul>
                    </ul>
                </div>
            </div>
        </div>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
    </div>
    <!-- /ulcer -->

    <!-- Start of uSkin ulcer (Non-diabetic) page, treatment needed, no penicillin allergy: #ulcer1a -->
    <div data-role="page" id="ulcer1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic)</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the infection?</span>
            </h3>
            <hr/>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#ulcer1a1">Mild &#40;some surrounding cellulitis&#41;</a></li>
                <li><a href="#ulcer1a2">Moderate &#40;definitive surrounding cellulitis&#41;</a></li>
                <li><a href="#ulcer1a3">Severe &#40;life threatening infection or osteomyelitis&#41;</a></li>            
            </ul>
            <hr/>
            <ul class="line30">
                <li>Select severe if osteomyelitis is either suspected or proven</li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ulcer1a -->


    <!-- Start of uSkin ulcer (Non-diabetic) page, treatment needed, MILD penicillin allergy: #ulcer1b -->
    <div data-role="page" id="ulcer1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic)</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the infection?</span>
            </h3>
            <hr/>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#ulcer1b1">Mild &#40;some surrounding cellulitis&#41;</a></li>
                <li><a href="#ulcer1a2">Moderate &#40;definitive surrounding cellulitis&#41;</a></li>
                <li><a href="#ulcer1b3">Severe &#40;life threatening infection or osteomyelitis&#41;</a></li>            
            </ul>
            <hr/>
            <ul class="line30">
                <li>Select severe if osteomyelitis is either suspected or proven</li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ulcer1a -->

    <!-- Start of uSkin ulcer (Non-diabetic) page, treatment needed, BAD penicillin allergy: #ulcer1c -->
    <div data-role="page" id="ulcer1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic)</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How severe is the infection?</span>
            </h3>
            <hr/>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#ulcer1c1">Mild &#40;some surrounding cellulitis&#41;</a></li>
                <li><a href="#ulcer1c2">Moderate &#40;definitive surrounding cellulitis&#41;</a></li>
                <li><a href="#ulcer1b3">Severe &#40;life threatening infection or osteomyelitis&#41;</a></li>            
            </ul>
            <hr/>
            <ul class="line30">
                <li>Select severe if osteomyelitis is either suspected or proven</li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ulcer1c -->


    <!-- Start of ulcer, no pen allergy, mild: #ulcer1a1  -->
    <div data-role="page" id="ulcer1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic) treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has no penicillin allergy and mild infection use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Flucloxacillin 500 mg &#40;child flucloxacillin 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 5 to 10 days.</span>
                </h4>
            </div>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation. If MRSA is suspected please contact infectious diseases</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                    <li>Non-diabetic related ulcers may be caused by a myriad of reasons including chronic pressure injuries, pyoderma gangrenosum or vascular insufficiency</li>
                    <li>A chronic ulcer WITHOUT signs of infection &#40;ie surrounding cellulitis, osteomyelitis&#41; does NOT need antibiotics</li>
                    <li><i>Pseudomonas aeruginosa</i> and other gram negative organisms may not be causative in infection. They may be colonisers and their presence should not always require coverage in empiric antibiotic regimens</li>
                    <li>Taking microbiological samples before the administration of antibiotics is important</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ulcer1a1 -->

    <!-- Start of ulcer, no pen allergy, moderate: #ulcer1a2  -->
    <div data-role="page" id="ulcer1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic) treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has moderate infection use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 8-hourly</span>
                </h4>
            </div>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation. If MRSA is suspected please contact infectious diseases</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                    <li>Non-diabetic related ulcers may be caused by a myriad of reasons including chronic pressure injuries, pyoderma gangrenosum or vascular insufficiency</li>
                    <li>A chronic ulcer WITHOUT signs of infection &#40;ie surrounding cellulitis, osteomyelitis&#41; does NOT need antibiotics</li>
                    <li><i>Pseudomonas aeruginosa</i> and other gram negative organisms may not be causative in infection. They may be colonisers and their presence should not always require coverage in empiric antibiotic regimens</li>
                    <li>Taking microbiological samples before the administration of antibiotics is important</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ulcer1a2 -->


    <!-- Start of ulcer, no pen allergy, BAD: #ulcer1a3  -->
    <div data-role="page" id="ulcer1a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic) treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has severe infection use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                <span class="color-purple">Amoxicillin + clavulanate intravenously for 3 days</span>
                <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, </span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg:  &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or older:  &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>OR</b> if <i>pseudomonas</i> has been confirmed on microscopy or culture</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin 4 g and tazobactam 0.5 g &#40;child: 100+12.5mg/kg up to 4+0.5 g&#41; IV, 8-hourly until patient meets switch to oral criteria</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Amoxicillin IV & clavulanate or piperacillin/tazobactam is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>ulc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation. If MRSA is suspected please contact infectious diseases</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                    <li>Non-diabetic related ulcers may be caused by a myriad of reasons including chronic pressure injuries, pyoderma gangrenosum or vascular insufficiency</li>
                    <li>A chronic ulcer WITHOUT signs of infection &#40;ie surrounding cellulitis, osteomyelitis&#41; does NOT need antibiotics</li>
                    <li><i>Pseudomonas aeruginosa</i> and other gram negative organisms may not be causative in infection. They may be colonisers and their presence should not always require coverage in empiric antibiotic regimens</li>
                    <li>Taking microbiological samples before the administration of antibiotics is important</li>
                </ul>
                <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ulcer1a3 -->


    <!-- Start of ulcer, MILD pen allergy, MILD infection: #ulcer1b1   -->
    <div data-role="page" id="ulcer1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic) treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has mild infection use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefalexin 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; orally, 6-hourly for 5 to 10 days</span>
                </h4>
            </div>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation. If MRSA is suspected please contact infectious diseases</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                    <li>Non-diabetic related ulcers may be caused by a myriad of reasons including chronic pressure injuries, pyoderma gangrenosum or vascular insufficiency</li>
                    <li>A chronic ulcer WITHOUT signs of infection &#40;ie surrounding cellulitis, osteomyelitis&#41; does NOT need antibiotics</li>
                    <li><i>Pseudomonas aeruginosa</i> and other gram negative organisms may not be causative in infection. They may be colonisers and their presence should not always require coverage in empiric antibiotic regimens</li>
                    <li>Taking microbiological samples before the administration of antibiotics is important</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ulcer1b1 -->

    <!-- Start of ulcer, no pen allergy, BAD: #ulcer1b3  -->
    <div data-role="page" id="ulcer1b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic) treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has severe infection use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV, 8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; IV, 12-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin IV and clindamycin is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>ulc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation. If MRSA is suspected please contact infectious diseases</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                    <li>Non-diabetic related ulcers may be caused by a myriad of reasons including chronic pressure injuries, pyoderma gangrenosum or vascular insufficiency</li>
                    <li>A chronic ulcer WITHOUT signs of infection &#40;ie surrounding cellulitis, osteomyelitis&#41; does NOT need antibiotics</li>
                    <li><i>Pseudomonas aeruginosa</i> and other gram negative organisms may not be causative in infection. They may be colonisers and their presence should not always require coverage in empiric antibiotic regimens</li>
                    <li>Taking microbiological samples before the administration of antibiotics is important</li>
                </ul>
                <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ulcer1b3 -->

    <!-- Start of ulcer, no pen allergy, MILD INFECTION: #ulcer1c1  -->
    <div data-role="page" id="ulcer1c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic) treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has immediate penicillin hypersensitivity use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 450 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin orally is:</span>
                <span class="font15 bold"> 7<script> document.write(getCode())</script>ulc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>SEVEN</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 7 days. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation. Although clindamycin has cover for most non-multidrug resistant MRSA, if MRSA is suspected please contact infectious diseases</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                    <li>Non-diabetic related ulcers may be caused by a myriad of reasons including chronic pressure injuries, pyoderma gangrenosum or vascular insufficiency</li>
                    <li>A chronic ulcer WITHOUT signs of infection &#40;ie surrounding cellulitis, osteomyelitis&#41; does NOT need antibiotics</li>
                    <li><i>Pseudomonas aeruginosa</i> and other gram negative organisms may not be causative in infection. They may be colonisers and their presence should not always require coverage in empiric antibiotic regimens</li>
                    <li>Taking microbiological samples before the administration of antibiotics is important</li>
                </ul>
                <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ulcer1c1 -->


    <!-- Start of ulcer, no pen allergy, MEDIUM INFECTION: #ulcer1c2  -->
    <div data-role="page" id="ulcer1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Skin ulcer (Non-diabetic) treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
            <h3 class="mrgn20b">
                <span class="color-primary">If patient has immediate penicillin hypersensitivity use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin IV is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>ulc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to continue past 72 hours. Please annotate this code on the medication chart and document when infectious diseases are to be contacted in the patient notes.</div>
            </h4>
                <hr/>
                <ul class="line30">
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation. Although clindamycin has cover for most non-multidrug resistant MRSA, if MRSA is suspected please contact infectious diseases</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                    <li>Non-diabetic related ulcers may be caused by a myriad of reasons including chronic pressure injuries, pyoderma gangrenosum or vascular insufficiency</li>
                    <li>A chronic ulcer WITHOUT signs of infection &#40;ie surrounding cellulitis, osteomyelitis&#41; does NOT need antibiotics</li>
                    <li><i>Pseudomonas aeruginosa</i> and other gram negative organisms may not be causative in infection. They may be colonisers and their presence should not always require coverage in empiric antibiotic regimens</li>
                    <li>Taking microbiological samples before the administration of antibiotics is important</li>
                </ul>
                <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on carbuncles</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /ulcer1c2 -->


        <!--- NON DIABETIC ULCER MAZE ENDS -->


        <!-- WATER EXPOSED WOUNDS MAZE BEGINS -->

        <!-- Start of WATER EXPOSED WOUNDS ?RISK PATIENT  -->
        <div data-role="page" id="watwo" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Water Exposed Wounds</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">Does the patient have any clinical risk factors that could lead to severe infection?</h3>
                <ul type=circle>
                    <li>Risk factors for severe water-immersed wound infection include:</li>
                    <ul>
                        <li>liver disease</li>
                        <li>iron overload</li>
                        <li>immunocompromise (including treatment with immunosuppressive medications such as diabetes medications or immunosuppressants)</li>
                    </ul>    
                </ul>
                <br/>
                <ul data-role="listview"  data-inset="true" class="listview"> 
                    <li><a href="#watwo1">Yes</a></li>
                    <li><a href="#watwo2">No</a></li>
                </ul> 
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /watwo -->

        <!-- Start of WATER EXPOSED WOUNDS - Non risk patient ?Deep wound or systemic  -->
        <div data-role="page" id="watwo2" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Water Exposed Wounds</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">Is the patient displaying systemic features of infection, or does the wound involve deep tissues (see below)</h3>
                <ul data-role="listview"  data-inset="true" class="listview"> 
                    <li><a href="#watwo1">Yes</a></li>
                    <li><a href="#watwo2b">No</a></li>
                </ul> 
                <hr>
                    <ul type=circle>
                        <li>Deep tissue injuries include any wounds with bone, joint or tendon involvement</li>
                    </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /watwo2 -->

            <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, non deep wound ?local infection or prophylaxis  -->
            <div data-role="page" id="watwo2b" data-theme="a">
                <div data-role="header" class="frontpage">
                    <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
                </div>
                <!-- /header -->
                <div data-role="header" class="secondpage">
                    <h1>Water Exposed Wounds</h1>
                </div>
                <!-- /header -->
                <div data-role="content" class="container-fluid">
                    <h3 class="color-primary mrgn15b">Is the wound showing localised signs of infection, or at an increased risk of infection?</h3>
                    <span class="color-danger mrgn15b">Antibiotic prophylaxis is only required for wounds with
                        established infection or a high risk of infection such as:</span>
                    <ul type=circle>
                        <li>Wounds with delayed presentation for washout &#40;8 hours or more&#41;</li>
                        <li>Puncture wounds which can not be debrided adequately</li>
                        <li>Any wounds on the hands feet or face</li>
                        <li>Wounds involving deeper tissues &#40;eg. bones, joints, tendons&#41;</li>
                        <li>Wounds in immunocompromised patients</li>
                        <li>Wounds which also involve an open fracture &#40;see open fracture section&#41;</li>
                    </ul>
                    <ul data-role="listview"  data-inset="true" class="listview"> 
                        <li><a href="#watwo2b1">Yes</a></li>
                        <li><a href="#watwo2b2">No</a></li>
                    </ul> 
                </div>
                <!-- /content -->
                <div class="footer">
                    <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                </div>
                <!-- /footer -->
            </div>
            <!-- /watwo2b -->

    <!-- Start of watwo page: WATER EXPOSED WOUNDS - Non risk patient, non deep wound, no signs of infection or wound in bad place -->
    <div data-role="page" id="watwo2b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">Prophylaxis is not required:</h3>
                <div id = "backcolour">
                        <span class="color-danger bold">Antibiotic prophylaxis is not required for non-severe wounds at low risk of infection</span>
                </div>
                <hr>
                <ul type=circle>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo2b2 -->

        <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed  -->
        <div data-role="page" id="watwo2b1" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Water Exposed Wounds</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection?</h3>
                <ul data-role="listview"  data-inset="true" class="listview"> 
                    <li><a href="#watwo2b1a">Yes</a></li>
                    <li><a href="#watwo2b1b">No</a></li>
                </ul> 
                <hr>
                <ul type=circle>
                    <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                    <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
                </ul>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /watwo2b1 -->

            <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed  -->
            <div data-role="page" id="watwo2b1a" data-theme="a">
                <div data-role="header" class="frontpage">
                    <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
                </div>
                <!-- /header -->
                <div data-role="header" class="secondpage">
                    <h1>Water Exposed Wounds</h1>
                </div>
                <!-- /header -->
                <div data-role="content" class="container-fluid">
                    <h3 class="color-primary mrgn15b">What type of water has the wound been exposed to?</h3>
                    <ul data-role="listview"  data-inset="true" class="listview"> 
                        <li><a href="#watwo2b1a1">Sea Water</a></li>
                        <li><a href="#watwo2b1a1">Fresh/brackish or aquarium water (without soil or sewage contamination)</a></li>
                        <li><a href="#watwo2b1a2">Soil or sewage contaminated water</a></li>
                    </ul>
                </div>
                <!-- /content -->
                <div class="footer">
                    <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                </div>
                <!-- /footer -->
            </div>
            <!-- /watwo2b1 -->

            <!-- Start of watwo page: Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, MRSA risk, sea or fresh water  -->
    <div data-role="page" id="watwo2b1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For treatment or prophylaxis of a fresh or salt water wound in a patient at risk of MRSA infection or a patient with severe penicillin allergy:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Trimethoprim+sulfamethoxazole 320+1600 mg &#40;child 1 month or over: 8+40 mg/kg up to 320+1600 mg&#41; orally, 12-hourly</span>
                    </h4>
                </div>
                <hr>
                <ul type=circle>
                    <li>If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo2b1a1 -->

            <!-- Start of watwo page: Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, MRSA risk, dirty water  -->
            <div data-role="page" id="watwo2b1a2" data-theme="a">
                <div data-role="header" class="frontpage">
                    <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
                </div>
            <!-- header -->
            <div data-role="header" class="secondpage">
                <h1>Water Exposed Wounds</h1>
                </div>
                <!-- /header -->
                <div data-role="content" class="container-fluid">   
                        <h3 class="color-primary mrgn15b">For treatment or prophylaxis of a sewage or soil contaminated water wound in a patient at risk of MRSA infection or with severe penicillin allergy:</h3>
                        <div id="backcolour">
                            <h4 class="medicine mrgn20b">
                                <span class="color-purple">Trimethoprim+sulfamethoxazole 320+1600 mg &#40;child 1 month or over: 8+40 mg/kg up to 320+1600 mg&#41; orally, 12-hourly</span>
                            </h4>
                            <p class="mrgn20b"><b>AND</b></p>
                            <h4 class="medicine mrgn20b">
                                <span class="color-purple">Metronidazole 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; orally, 12-hourly</span>
                            </h4>
                        </div>
                        <hr>
                        <ul type=circle>
                            <li>If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate</li>
                            <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                            <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                            <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                            <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                            <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                        </ul>
                        <hr>
                        <h4 class="mrgn20b references">
                            <span class="color-purple"><b>References: </b></span><br><br>
                            <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                        </h4>
                </div>
                <!-- /content -->
                <div class="footer">
                    <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                </div>
                <!-- /footer -->
            </div>
            <!-- /watwo2b1a2 -->


            <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA  -->
            <div data-role="page" id="watwo2b1b" data-theme="a">
                <div data-role="header" class="frontpage">
                    <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
                </div>
                <!-- /header -->
                <div data-role="header" class="secondpage">
                    <h1>Water Exposed Wounds</h1>
                </div>
                <!-- /header -->
                <div data-role="content" class="container-fluid">
                    <h3 class="color-primary mrgn15b">What type of water has the wound been exposed to?</h3>
                    <ul data-role="listview"  data-inset="true" class="listview"> 
                        <li><a href="#watwo2b1b1">Sea Water</a></li>
                        <li><a href="#watwo2b1b2">Fresh/brackish or aquarium water (without soil or sewage contamination)</a></li>
                        <li><a href="#watwo2b1b3">Soil or sewage contaminated water</a></li>
                    </ul>
                </div>
                <!-- /content -->
                <div class="footer">
                    <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                </div>
                <!-- /footer -->
            </div>
            <!-- /watwo2b1b -->

    <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, SEA WATER, ?Pen all -->
    <div data-role="page" id="watwo2b1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#watwo2b1b1a">No penicillin allergy</a></li>
                <li><a href="#watwo2b1b1b">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#watwo2b1a1">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo2b1b1 -->

            <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, SEA WATER, No Pen all  -->
            <div data-role="page" id="watwo2b1b1a" data-theme="a">
                <div data-role="header" class="frontpage">
                    <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
                </div>
            <!-- header -->
            <div data-role="header" class="secondpage">
                <h1>Water Exposed Wounds</h1>
                </div>
                <!-- /header -->
                <div data-role="content" class="container-fluid">   
                        <h3 class="color-primary mrgn15b">For treatment or prophylaxis of a sea water wound in a patient not at risk of MRSA infection with no penicillin allergy:</h3>
                        <div id="backcolour">
                            <h4 class="medicine mrgn20b">
                                <span class="color-purple"> Doxycycline orally, 12-hourly</span>
                                <br><br>
                                <div class="table-responsive">
                                    <table class="table-blank">
                                        <tr>
                                            <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                            <td><span class="color-purple">100 mg </span></td>
                                        </tr>
                                        <tr>
                                            <td><span class="font17">child 8 years or older and less than 26 kg: &nbsp;</span>
                                            </td>
                                            <td><span class="color-purple"> 50 mg </span></td>
                                        </tr>
                                        <tr>
                                            <td><span class="font17">child 8 years or older and 26 to 35 kg: &nbsp;</span></td>
                                            <td><span class="color-purple"> 75 mg</span></td>
                                        </tr>
                                        <tr>
                                            <td><span class="font17">child 8 years or older and more than 35 kg: &nbsp;</span></td>
                                            <td><span class="color-purple"> 100 mg</span></td>
                                        </tr>
                                    </table>
                                </div>
                            </h4>
                            <p class="mrgn20b"><b>AND</b></p>
                            <h4 class="medicine mrgn20b">
                                <span class="color-purple">Flucloxacillin 500 mg orally, 6-hourly. &#40;Give cefalexin 12.5mg/kg up to 500mg orally 6-hourly if treating a child&#41;</span>
                            </h4>
                        </div>
                        <br/>
                        <div id="backcolour">
                            <p class="mrgn20b"><b>OR</b> if treating a child less than 8 years of age, replace doxycycline above with:</p>
                            <h4 class="medicine mrgn20b">
                                <span class="color-purple">Ciprofloxacin &#40;child younger than 8 years&#41; 12.5 mg/kg up to 500 mg orally, 12-hourly</span>
                            </h4>
                        </div>
                        <hr/>
                        <h4 class="mrgn20b text-center codefor">
                            <span class="color-success">Code for oral ciprofloxacin is:</span>
                            <span class="font15 bold"> 5<script> document.write(getCode())</script>wat</span>
                            <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                                first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                                continue past 5 days. Please annotate this code on the medication chart and document when
                                infectious diseases are to be contacted in the patient notes.</div>
                        </h4>
                        <hr>
                        <ul type=circle>
                            <li>Doxycycline has not been associated with tooth discolouration, enamel hypoplasia or bone deposition, even in children younger than 8 years, so is increasingly used in this age group. However, use is limited by the lack of a suitable formulation.</li>
                            <li>If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate</li>
                            <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                            <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                            <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                            <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                            <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                        </ul>
                        <hr>
                        <h4 class="mrgn20b references">
                            <span class="color-purple"><b>References: </b></span><br><br>
                            <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                        </h4>
                </div>
                <!-- /content -->
                <div class="footer">
                    <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                </div>
                <!-- /footer -->
            </div>
            <!-- /watwo2b1a2 -->


                    <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, SEA WATER, No Pen all  -->
            <div data-role="page" id="watwo2b1b1a" data-theme="a">
                <div data-role="header" class="frontpage">
                    <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
                </div>
            <!-- header -->
            <div data-role="header" class="secondpage">
                <h1>Water Exposed Wounds</h1>
                </div>
                <!-- /header -->
                <div data-role="content" class="container-fluid">   
                        <h3 class="color-primary mrgn15b">For treatment or prophylaxis of a sea water wound in a patient not at risk of MRSA infection with no penicillin allergy:</h3>
                        <div id="backcolour">
                            <h4 class="medicine mrgn20b">
                                <span class="color-purple"> Doxycycline orally, 12-hourly</span>
                                <br><br>
                                <div class="table-responsive">
                                    <table class="table-blank">
                                        <tr>
                                            <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                            <td><span class="color-purple">100 mg </span></td>
                                        </tr>
                                        <tr>
                                            <td><span class="font17">child 8 years or older and less than 26 kg: &nbsp;</span>
                                            </td>
                                            <td><span class="color-purple"> 50 mg </span></td>
                                        </tr>
                                        <tr>
                                            <td><span class="font17">child 8 years or older and 26 to 35 kg: &nbsp;</span></td>
                                            <td><span class="color-purple"> 75 mg</span></td>
                                        </tr>
                                        <tr>
                                            <td><span class="font17">child 8 years or older and more than 35 kg: &nbsp;</span></td>
                                            <td><span class="color-purple"> 100 mg</span></td>
                                        </tr>
                                    </table>
                                </div>
                            </h4>
                            <p class="mrgn20b"><b>AND</b></p>
                            <h4 class="medicine mrgn20b">
                                <span class="color-purple">Flucloxacillin 500 mg orally, 6-hourly. &#40;Give cefalexin 12.5mg/kg up to 500mg orally 6-hourly if treating a child&#41;</span>
                            </h4>
                        </div>
                        <br/>
                        <div id="backcolour">
                            <p class="mrgn20b"><b>OR</b> if treating a child less than 8 years of age, replace doxycycline above with:</p>
                            <h4 class="medicine mrgn20b">
                                <span class="color-purple">Ciprofloxacin &#40;child younger than 8 years&#41; 12.5 mg/kg up to 500 mg orally, 12-hourly</span>
                            </h4>
                        </div>
                        <hr/>
                        <h4 class="mrgn20b text-center codefor">
                            <span class="color-success">Code for oral ciprofloxacin is:</span>
                            <span class="font15 bold"> 5<script> document.write(getCode())</script>wat</span>
                            <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                                first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                                continue past 5 days. Please annotate this code on the medication chart and document when
                                infectious diseases are to be contacted in the patient notes.</div>
                        </h4>
                        <hr>
                        <ul type=circle>
                            <li>Doxycycline has not been associated with tooth discolouration, enamel hypoplasia or bone deposition, even in children younger than 8 years, so is increasingly used in this age group. However, use is limited by the lack of a suitable formulation.</li>
                            <li>If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate</li>
                            <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                            <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                            <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                            <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                            <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                        </ul>
                        <hr>
                        <h4 class="mrgn20b references">
                            <span class="color-purple"><b>References: </b></span><br><br>
                            <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                        </h4>
                </div>
                <!-- /content -->
                <div class="footer">
                    <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                </div>
                <!-- /footer -->
            </div>
            <!-- /watwo2b1b1a -->

                    <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, SEA WATER, Mild Pen all  -->
                    <div data-role="page" id="watwo2b1b1b" data-theme="a">
                        <div data-role="header" class="frontpage">
                            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
                        </div>
                    <!-- header -->
                    <div data-role="header" class="secondpage">
                        <h1>Water Exposed Wounds</h1>
                        </div>
                        <!-- /header -->
                        <div data-role="content" class="container-fluid">   
                                <h3 class="color-primary mrgn15b">For treatment or prophylaxis of a sea water wound in a patient not at risk of MRSA infection with no penicillin allergy:</h3>
                                <div id="backcolour">
                                    <h4 class="medicine mrgn20b">
                                        <span class="color-purple"> Doxycycline orally, 12-hourly</span>
                                        <br><br>
                                        <div class="table-responsive">
                                            <table class="table-blank">
                                                <tr>
                                                    <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                                    <td><span class="color-purple">100 mg </span></td>
                                                </tr>
                                                <tr>
                                                    <td><span class="font17">child 8 years or older and less than 26 kg: &nbsp;</span>
                                                    </td>
                                                    <td><span class="color-purple"> 50 mg </span></td>
                                                </tr>
                                                <tr>
                                                    <td><span class="font17">child 8 years or older and 26 to 35 kg: &nbsp;</span></td>
                                                    <td><span class="color-purple"> 75 mg</span></td>
                                                </tr>
                                                <tr>
                                                    <td><span class="font17">child 8 years or older and more than 35 kg: &nbsp;</span></td>
                                                    <td><span class="color-purple"> 100 mg</span></td>
                                                </tr>
                                            </table>
                                        </div>
                                    </h4>
                                    <p class="mrgn20b"><b>AND</b></p>
                                    <h4 class="medicine mrgn20b">
                                        <span class="color-purple">Cefalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly</span>
                                    </h4>
                                </div>
                                <br/>
                                <div id="backcolour">
                                    <p class="mrgn20b"><b>OR</b> if treating a child less than 8 years of age, replace doxycycline above with:</p>
                                    <h4 class="medicine mrgn20b">
                                        <span class="color-purple">Ciprofloxacin &#40;child younger than 8 years&#41; 12.5 mg/kg up to 500 mg orally, 12-hourly</span>
                                    </h4>
                                </div>
                                <hr/>
                                <h4 class="mrgn20b text-center codefor">
                                    <span class="color-success">Code for oral ciprofloxacin is:</span>
                                    <span class="font15 bold"> 5<script> document.write(getCode())</script>wat</span>
                                    <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                                        continue past 5 days. Please annotate this code on the medication chart and document when
                                        infectious diseases are to be contacted in the patient notes.</div>
                                </h4>
                                <hr>
                                <ul type=circle>
                                    <li>Doxycycline has not been associated with tooth discolouration, enamel hypoplasia or bone deposition, even in children younger than 8 years, so is increasingly used in this age group. However, use is limited by the lack of a suitable formulation.</li>
                                    <li>If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate</li>
                                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                                </ul>
                                <hr>
                                <h4 class="mrgn20b references">
                                    <span class="color-purple"><b>References: </b></span><br><br>
                                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                                </h4>
                        </div>
                        <!-- /content -->
                        <div class="footer">
                            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
                        </div>
                        <!-- /footer -->
                    </div>
                    <!-- /watwo2b1b1b -->


    <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, FRESH/BRACKISH WATER, ?Pen all -->
    <div data-role="page" id="watwo2b1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#watwo2b1b2a">No penicillin allergy</a></li>
                <li><a href="#watwo2b1b2b">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#watwo2b1a1">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo2b1b2 -->


        <!--Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, FRESH/BRACKISH WATER, NO Pen all -->
        <div data-role="page" id="watwo2b1b2a" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
           <!-- header -->
           <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">   
                    <h3 class="color-primary mrgn15b">For treatment or prophylaxis of a fresh or brackish water contaminated wound in a patient not at risk of MRSA infection with no penicillin allergy give either:</h3>
                    <div id="backcolour">
                        <h4 class="medicine mrgn20b">
                            <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 320+1600 mg &#40;child 1 month or over: 8+40 mg/kg up to 320+1600 mg&#41; orally, 12-hourly</span>
                        </h4>
                        <p class="mrgn20b"><b>OR</b> as a two drug regimen:</p>
                        <h4 class="medicine mrgn20b">
                            <span class="font17">&#9313;</span><span class="color-purple"> Ciprofloxacin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 12-hourly</span>
                        </h4>
                        <p class="mrgn20b"><b>AND</b>:</p>
                        <h4 class="medicine mrgn20b">
                            <span class="font17">&#9313;</span><span class="color-purple"> Flucloxacillin 500 mg orally, 6-hourly (child: replace flucloxacillin with cefalexin 12.5 mg/kg up to 500 mg)</span>
                        </h4>
                    </div>
                    <hr/>
                            <h4 class="mrgn20b text-center codefor">
                                <span class="color-success">Code for oral ciprofloxacin is:</span>
                                <span class="font15 bold"> 5<script> document.write(getCode())</script>wat</span>
                                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                                    continue past 5 days. Please annotate this code on the medication chart and document when
                                    infectious diseases are to be contacted in the patient notes.</div>
                            </h4>
                    <hr>
                    <ul type=circle>
                        <li>If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate</li>
                        <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                        <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                        <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                        <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                        <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                    </ul>
                    <hr>
                    <h4 class="mrgn20b references">
                        <span class="color-purple"><b>References: </b></span><br><br>
                        <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                    </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /watwo2b1b2a -->


        <!--Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, FRESH/BRACKISH WATER, Mild Pen all -->
        <div data-role="page" id="watwo2b1b2b" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
            </div>
            <!-- header -->
            <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">   
                    <h3 class="color-primary mrgn15b">For treatment or prophylaxis of a fresh or brackish water contaminated wound in a patient not at risk of MRSA infection with non-severe hypersensitivity to penicillin give either:</h3>
                    <div id="backcolour">
                        <h4 class="medicine mrgn20b">
                            <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 320+1600 mg &#40;child 1 month or over: 8+40 mg/kg up to 320+1600 mg&#41; orally, 12-hourly</span>
                        </h4>
                        <p class="mrgn20b"><b>OR</b> as a two drug regimen:</p>
                        <h4 class="medicine mrgn20b">
                            <span class="font17">&#9313;</span><span class="color-purple"> Ciprofloxacin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 12-hourly</span>
                        </h4>
                        <p class="mrgn20b"><b>AND</b>:</p>
                        <h4 class="medicine mrgn20b">
                            <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly </span>
                        </h4>
                    </div>
                    <hr>
                    <hr/>
                    <h4 class="mrgn20b text-center codefor">
                        <span class="color-success">Code for oral ciprofloxacin is:</span>
                        <span class="font15 bold"> 5<script> document.write(getCode())</script>wat</span>
                        <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                            first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                            continue past 5 days. Please annotate this code on the medication chart and document when
                            infectious diseases are to be contacted in the patient notes.</div>
                    </h4>
                    <ul type=circle>
                        <li>If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate</li>
                        <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                        <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                        <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                        <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                        <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                    </ul>
                    <hr>
                    <h4 class="mrgn20b references">
                        <span class="color-purple"><b>References: </b></span><br><br>
                        <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                    </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /watwo2b1b2b -->

    <!-- Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, GROSS WATER, ?Pen all -->
    <div data-role="page" id="watwo2b1b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#watwo2b1b3a">No penicillin allergy</a></li>
                <li><a href="#watwo2b1b3b">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#watwo2b1a2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo2b1b3 -->


    <!--Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, FRESH/BRACKISH WATER, NO Pen all -->
    <div data-role="page" id="watwo2b1b3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- header -->
        <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For treatment or prophylaxis of a fresh or brackish water contaminated wound in a patient not at risk of MRSA infection with no penicillin allergy give either:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 320+1600 mg &#40;child 1 month or over: 8+40 mg/kg up to 320+1600 mg&#41; orally, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>OR</b> as a three drug regimen replace the trimethoprim+sulfamethoxazole above with both:</p>
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9313;</span><span class="color-purple"> Ciprofloxacin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9313;</span><span class="color-purple"> Flucloxacillin 500 mg orally, 6-hourly (child: replace flucloxacillin with cefalexin 12.5 mg/kg up to 500 mg)</span>
                    </h4>
                </div>
                <hr/>
                        <h4 class="mrgn20b text-center codefor">
                            <span class="color-success">Code for oral ciprofloxacin is:</span>
                            <span class="font15 bold"> 5<script> document.write(getCode())</script>wat</span>
                            <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                                first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                                continue past 5 days. Please annotate this code on the medication chart and document when
                                infectious diseases are to be contacted in the patient notes.</div>
                        </h4>
                <hr>
                <ul type=circle>
                    <li>If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo2b1b3a -->


    <!--Start of WATER EXPOSED WOUNDS - Non risk patient, NOT Deep wound or systemic, YES local infection or proph needed, NOT MRSA, FRESH/BRACKISH WATER, Mild Pen all -->
    <div data-role="page" id="watwo2b1b3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- header -->
        <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For treatment or prophylaxis of a fresh or brackish water contaminated wound in a patient not at risk of MRSA infection with non-severe hypersensitivity to penicillin give either:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9312;</span><span class="color-purple"> Trimethoprim+sulfamethoxazole 320+1600 mg &#40;child 1 month or over: 8+40 mg/kg up to 320+1600 mg&#41; orally, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>OR</b> as a three drug regimen replace the trimethoprim+sulfamethoxazole above with both:</p>
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9313;</span><span class="color-purple"> Ciprofloxacin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b>:</p>
                    <h4 class="medicine mrgn20b">
                        <span class="font17">&#9313;</span><span class="color-purple"> Cefalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly </span>
                    </h4>
                </div>
                <hr>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for oral ciprofloxacin is:</span>
                    <span class="font15 bold"> 5<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 5 days. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <ul type=circle>
                    <li>If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo2b1b3b -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, ?Severe or Sewage -->
    <div data-role="page" id="watwo1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the wound associated with significant trauma or has it been exposed to soil or sewage contaminated water?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#watwo1a">Yes</a></li>
                <li><a href="#watwo1b">No</a></li>
            </ul> 
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1 -->



    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, Severe or Sewage, ?MRSA -->
    <div data-role="page" id="watwo1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection? (see below)</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#watwo1a1">Yes</a></li>
                <li><a href="#watwo1a2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1a -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, NOT Severe or Sewage, ?MRSA -->
    <div data-role="page" id="watwo1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"/><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient at increased risk of MRSA infection? (see below)</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#watwo1b1">Yes</a></li>
                <li><a href="#watwo1b2">No</a></li>
            </ul> 
            <hr>
            <ul type=circle>
                <li>Risk factors for MRSA infection include: residence in a jail or detention centre, indigenous heritage, previous MRSA colonisation and line associated infection</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1b -->


    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, Severe or Sewage, MRSA YES -->
    <div data-role="page" id="watwo1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#watwo1a1a">No penicillin allergy</a></li>
                <li><a href="#watwo1a1a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#watwo1a1c">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1a1 -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, Severe or Sewage, MRSA NO -->
    <div data-role="page" id="watwo1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#watwo1a2a">No penicillin allergy</a></li>
                <li><a href="#watwo1a2a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#watwo1a2c">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1a2 -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, NO Severe or Sewage, MRSA YES -->
    <div data-role="page" id="watwo1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#watwo1b1a">No penicillin allergy</a></li>
                <li><a href="#watwo1b1b">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#watwo1b1c">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1b1 -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, NO Severe or Sewage, MRSA NO -->
    <div data-role="page" id="watwo1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#watwo1b2a">No penicillin allergy</a></li>
                <li><a href="#watwo1b2b">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#watwo1b2c">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1b2 -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, Severe or Sewage, MRSA YES, No Pen Allergy  -->
    <div data-role="page" id="watwo1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds associated with significant trauma or exposed to soil/sewage at risk of MRSA use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefepime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin as per nomograms below or use the <a
                                href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV vancomycin and cefepime is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered">
                        <tr>
                            <th class="darkbackcolour" colspan="2">Age</th>
                            <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                            <th class="darkbackcolour">Dosing <br>frequency</th>
                            <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 14 days</td>
                            <td>15 mg/kg</td>
                            <td>18-hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>14 days or older</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                                &#40;NB1&#41;</td>
                            <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">12-hourly</td>
                            <td class="bluebackcolour">Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">8-hourly</td>
                            <td class="bluebackcolour">Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 7 days</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>7 days or older</td>
                            <td>15 mg/kg</td>
                            <td>8-hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                            <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                            <td class="bluebackcolour">6-hourly</td>
                            <td class="bluebackcolour">Before the fifth dose</td>
                        </tr>
                    </table>
                    <ul class="line30">
                        <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                            period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                        <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                            however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                    </ul>
                </div>
                <hr />
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br />48 hly</td>
                            <td>750 mg<br />24 hly</td>
                            <td>750 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />15 min</td>
                        </tr>
                        <tr>
                            <td>50-64</td>
                            <td>1000 mg<br />48 hly</td>
                            <td>1000 mg<br />24 hly</td>
                            <td>1000 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br />48 hly</td>
                            <td>1250 mg<br />24 hly</td>
                            <td>1250 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />5 min</td>
                        </tr>
                        <tr>
                            <td>80-94</td>
                            <td>1500 mg<br />48 hly</td>
                            <td>1500 mg<br />24 hly</td>
                            <td>1500 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br />48 hly</td>
                            <td>1750 mg<br />24 hly</td>
                            <td>1750 mg<br />12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                            class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                        considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                        the next dose is given before the trough concentration is available or withheld until the result is
                        known</li>
                </ol>
                <hr />
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                        baseline creatinine will almost always result in an increase in vancomycin concentration as
                        vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                        an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                        available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                        interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1a1a -->


    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, Severe or Sewage, MRSA YES, BAD Pen Allergy  -->
    <div data-role="page" id="watwo1a1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds associated with significant trauma or exposed to soil/sewage at risk of MRSA with severe penicillin allergy use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin as per nomograms below or use the <a
                                href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV vancomycin and IV Ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered">
                        <tr>
                            <th class="darkbackcolour" colspan="2">Age</th>
                            <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                            <th class="darkbackcolour">Dosing <br>frequency</th>
                            <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 14 days</td>
                            <td>15 mg/kg</td>
                            <td>18-hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>14 days or older</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                                &#40;NB1&#41;</td>
                            <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">12-hourly</td>
                            <td class="bluebackcolour">Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">8-hourly</td>
                            <td class="bluebackcolour">Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 7 days</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>7 days or older</td>
                            <td>15 mg/kg</td>
                            <td>8-hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                            <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                            <td class="bluebackcolour">6-hourly</td>
                            <td class="bluebackcolour">Before the fifth dose</td>
                        </tr>
                    </table>
                    <ul class="line30">
                        <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                            period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                        <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                            however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                    </ul>
                </div>
                <hr />
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br />48 hly</td>
                            <td>750 mg<br />24 hly</td>
                            <td>750 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />15 min</td>
                        </tr>
                        <tr>
                            <td>50-64</td>
                            <td>1000 mg<br />48 hly</td>
                            <td>1000 mg<br />24 hly</td>
                            <td>1000 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br />48 hly</td>
                            <td>1250 mg<br />24 hly</td>
                            <td>1250 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />5 min</td>
                        </tr>
                        <tr>
                            <td>80-94</td>
                            <td>1500 mg<br />48 hly</td>
                            <td>1500 mg<br />24 hly</td>
                            <td>1500 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br />48 hly</td>
                            <td>1750 mg<br />24 hly</td>
                            <td>1750 mg<br />12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                            class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                        considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                        the next dose is given before the trough concentration is available or withheld until the result is
                        known</li>
                </ol>
                <hr />
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                        baseline creatinine will almost always result in an increase in vancomycin concentration as
                        vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                        an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                        available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                        interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1a1c -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, NOT Severe or Sewage, MRSA YES, No Pen Allergy  -->
    <div data-role="page" id="watwo1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds not associated with significant trauma or exposed to soil/sewage but at risk of MRSA in a patient with no penicillin allergy use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Flucloxacillin 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin as per nomograms below or use the <a
                                href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV vancomycin and ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered">
                        <tr>
                            <th class="darkbackcolour" colspan="2">Age</th>
                            <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                            <th class="darkbackcolour">Dosing <br>frequency</th>
                            <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 14 days</td>
                            <td>15 mg/kg</td>
                            <td>18-hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>14 days or older</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                                &#40;NB1&#41;</td>
                            <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">12-hourly</td>
                            <td class="bluebackcolour">Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">8-hourly</td>
                            <td class="bluebackcolour">Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 7 days</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>7 days or older</td>
                            <td>15 mg/kg</td>
                            <td>8-hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                            <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                            <td class="bluebackcolour">6-hourly</td>
                            <td class="bluebackcolour">Before the fifth dose</td>
                        </tr>
                    </table>
                    <ul class="line30">
                        <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                            period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                        <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                            however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                    </ul>
                </div>
                <hr />
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br />48 hly</td>
                            <td>750 mg<br />24 hly</td>
                            <td>750 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />15 min</td>
                        </tr>
                        <tr>
                            <td>50-64</td>
                            <td>1000 mg<br />48 hly</td>
                            <td>1000 mg<br />24 hly</td>
                            <td>1000 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br />48 hly</td>
                            <td>1250 mg<br />24 hly</td>
                            <td>1250 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />5 min</td>
                        </tr>
                        <tr>
                            <td>80-94</td>
                            <td>1500 mg<br />48 hly</td>
                            <td>1500 mg<br />24 hly</td>
                            <td>1500 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br />48 hly</td>
                            <td>1750 mg<br />24 hly</td>
                            <td>1750 mg<br />12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                            class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                        considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                        the next dose is given before the trough concentration is available or withheld until the result is
                        known</li>
                </ol>
                <hr />
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                        baseline creatinine will almost always result in an increase in vancomycin concentration as
                        vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                        an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                        available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                        interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1b1a -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, NOT Severe or Sewage, MRSA YES, MILD Pen Allergy  -->
    <div data-role="page" id="watwo1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds not associated with significant trauma or exposed to soil/sewage but at risk of MRSA in a patient with non-severe penicillin hypersensitivity use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefazolin 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin as per nomograms below or use the <a
                                href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV vancomycin and ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered">
                        <tr>
                            <th class="darkbackcolour" colspan="2">Age</th>
                            <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                            <th class="darkbackcolour">Dosing <br>frequency</th>
                            <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 14 days</td>
                            <td>15 mg/kg</td>
                            <td>18-hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>14 days or older</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                                &#40;NB1&#41;</td>
                            <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">12-hourly</td>
                            <td class="bluebackcolour">Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">8-hourly</td>
                            <td class="bluebackcolour">Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 7 days</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>7 days or older</td>
                            <td>15 mg/kg</td>
                            <td>8-hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                            <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                            <td class="bluebackcolour">6-hourly</td>
                            <td class="bluebackcolour">Before the fifth dose</td>
                        </tr>
                    </table>
                    <ul class="line30">
                        <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                            period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                        <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                            however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                    </ul>
                </div>
                <hr />
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br />48 hly</td>
                            <td>750 mg<br />24 hly</td>
                            <td>750 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />15 min</td>
                        </tr>
                        <tr>
                            <td>50-64</td>
                            <td>1000 mg<br />48 hly</td>
                            <td>1000 mg<br />24 hly</td>
                            <td>1000 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br />48 hly</td>
                            <td>1250 mg<br />24 hly</td>
                            <td>1250 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />5 min</td>
                        </tr>
                        <tr>
                            <td>80-94</td>
                            <td>1500 mg<br />48 hly</td>
                            <td>1500 mg<br />24 hly</td>
                            <td>1500 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br />48 hly</td>
                            <td>1750 mg<br />24 hly</td>
                            <td>1750 mg<br />12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                            class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                        considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                        the next dose is given before the trough concentration is available or withheld until the result is
                        known</li>
                </ol>
                <hr />
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                        baseline creatinine will almost always result in an increase in vancomycin concentration as
                        vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                        an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                        available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                        interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1b1b -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, NOT Severe or Sewage, MRSA YES, BAD Pen Allergy  -->
    <div data-role="page" id="watwo1b1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds not associated with significant trauma or exposed to soil/sewage but at risk of MRSA in a patient with non-severe penicillin hypersensitivity use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Vancomycin as per nomograms below or use the <a
                                href="dosecalcs.html#dose6">vancomycin empiric dose calculator for adults</a></span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV vancomycin and ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr/>
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Paediatrics</h4>
                <div class="table-responsive">
                    <table class="table table-bordered">
                        <tr>
                            <th class="darkbackcolour" colspan="2">Age</th>
                            <th class="darkbackcolour">Starting Dose <br>&#40;use actual body weight&#41;</th>
                            <th class="darkbackcolour">Dosing <br>frequency</th>
                            <th class="darkbackcolour">Timing of first <br>trough concentration</th>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates &lt; 30 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 14 days</td>
                            <td>15 mg/kg</td>
                            <td>18-hourly</td>
                            <td>Before the second dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>14 days or older</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" rowspan="2">Neonates 30 to 36 weeks<br> postmenstrual age
                                &#40;NB1&#41;</td>
                            <td class="bluebackcolour">postnatal age <br>0 to 14 days</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">12-hourly</td>
                            <td class="bluebackcolour">Before the third dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour">postnatal age <br>14 days or older</td>
                            <td class="bluebackcolour">15 mg/kg</td>
                            <td class="bluebackcolour">8-hourly</td>
                            <td class="bluebackcolour">Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td rowspan="2">Neonates 37 to 44 weeks<br> postmenstrual age &#40;NB1&#41;</td>
                            <td>postnatal age<br> 0 to 7 days</td>
                            <td>15 mg/kg</td>
                            <td>12-hourly</td>
                            <td>Before the third dose</td>
                        </tr>
                        <tr>
                            <td>postnatal age <br>7 days or older</td>
                            <td>15 mg/kg</td>
                            <td>8-hourly</td>
                            <td>Before the fourth dose</td>
                        </tr>
                        <tr>
                            <td class="bluebackcolour" colspan="2">Infants and children &#40;NB2&#41;</td>
                            <td class="bluebackcolour">15 mg/kg up to 750 mg</td>
                            <td class="bluebackcolour">6-hourly</td>
                            <td class="bluebackcolour">Before the fifth dose</td>
                        </tr>
                    </table>
                    <ul class="line30">
                        <li><b>NB1</b>- Postmenstrual age is the time elapsed between the first day of the last menstrual
                            period and birth (gestational age) plus the time elapsed after birth (postnatal age)</li>
                        <li><b>NB2</b>- The Therapeutic Guidelines gives an alternative 12-hourly dosing in this group;
                            however local NT data support using 6-hourly dosing in all children up to 12 years</li>
                    </ul>
                </div>
                <hr />
                <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
                <div class="table-responsive">
                    <table class="table table-bordered table-striped">
                        <tr>
                            <td>Actual body<br> weight &#40;kg&#41;</td>
                            <td>CrClr <br>&lt; 20 mL/min</td>
                            <td>CrClr <br>20-60 mL/min</td>
                            <td>CrClr <br>&gt; 60 mL/min</td>
                            <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                        </tr>
                        <tr>
                            <td>&lt; 40</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td>40-49</td>
                            <td>750 mg<br />48 hly</td>
                            <td>750 mg<br />24 hly</td>
                            <td>750 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />15 min</td>
                        </tr>
                        <tr>
                            <td>50-64</td>
                            <td>1000 mg<br />48 hly</td>
                            <td>1000 mg<br />24 hly</td>
                            <td>1000 mg<br />12 hly</td>
                            <td class="bg-success">1 hr<br />40 min</td>
                        </tr>
                        <tr>
                            <td>65-79</td>
                            <td>1250 mg<br />48 hly</td>
                            <td>1250 mg<br />24 hly</td>
                            <td>1250 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />5 min</td>
                        </tr>
                        <tr>
                            <td>80-94</td>
                            <td>1500 mg<br />48 hly</td>
                            <td>1500 mg<br />24 hly</td>
                            <td>1500 mg<br />12 hly</td>
                            <td class="bg-success">2 hrs<br />30 min</td>
                        </tr>
                        <tr>
                            <td>95-110</td>
                            <td>1750 mg<br />48 hly</td>
                            <td>1750 mg<br />24 hly</td>
                            <td>1750 mg<br />12 hly</td>
                            <td class="bg-success">3 hrs</td>
                        </tr>
                        <tr>
                            <td>&gt; 110</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td>Call infectious diseases</td>
                            <td class="bg-success">---</td>
                        </tr>
                        <tr>
                            <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                            <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                            <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                            <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                            <td class="bg-success">---</td>
                        </tr>
                    </table>
                </div>
                <ol type="1" class="line30">
                    <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                            class="color-danger bold">Red Person</span> Syndrome</li>
                    <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                        considered the first dose</li>
                    <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                        the next dose is given before the trough concentration is available or withheld until the result is
                        known</li>
                </ol>
                <hr />
                <ul type=circle class="line30">
                    <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
                    <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                        baseline creatinine will almost always result in an increase in vancomycin concentration as
                        vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                        an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                        available.</li>
                    <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                        interpretation of trough levels as vancomycin will not have reached steady state</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1b1c -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, NOT Severe or Sewage, MRSA NO, No Pen Allergy  -->
    <div data-role="page" id="watwo1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds not associated with significant trauma or exposed to soil/sewage not at risk of MRSA in a patient with no penicillin allergy use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Flucloxacillin 2 g (child: 50 mg/kg up to 2 g) intravenously, 6-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1b2a -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, NOT Severe or Sewage, MRSA NO, MILD Pen Allergy  -->
    <div data-role="page" id="watwo1b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds not associated with significant trauma or exposed to soil/sewage not at risk of MRSA in a patient with non-severe penicillin hypersensitivity use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefazolin 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV ciprofloxacin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1b2b -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, NOT Severe or Sewage, MRSA NO, BAD Pen Allergy  -->
    <div data-role="page" id="watwo1b2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds not associated with significant trauma or exposed to soil/sewage not at risk of MRSA in a patient with non-severe penicillin hypersensitivity use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV ciprofloxacin and IV Clindamycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1b2c -->

    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, Severe or Sewage, MRSA NO, No Pen Allergy  -->
    <div data-role="page" id="watwo1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds associated with significant trauma or exposed to soil/sewage not at risk of MRSA use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Cefepime 2 g (child: 50 mg/kg up to 2 g) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV cefepime is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1a2a -->


    <!-- Start of WATER EXPOSED WOUNDS - Risk of severe infection, or deep tissue wound or systemic features, Severe or Sewage, MRSA NO, BAD Pen Allergy  -->
    <div data-role="page" id="watwo1a2c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
    <!-- header -->
    <div data-role="header" class="secondpage">
        <h1>Water Exposed Wounds</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">   
                <h3 class="color-primary mrgn15b">For wounds associated with significant trauma or exposed to soil/sewage not at risk of MRSA with severe penicillin allergy use:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Ciprofloxacin 400 mg (child: 10 mg/kg up to 400 mg) intravenously, 8-hourly</span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously, 8-hourly</span>
                    </h4>
                </div>
                <hr/>
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for IV Ciprofloxacin and Clindamycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>wat</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                        continue past 72 hours. Please annotate this code on the medication chart and document when
                        infectious diseases are to be contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul type=circle>
                    <li>If the patient is showing signs of sepsis treat as for <a href="#necro">necrotising fasciitis</a> with water exposure</li>
                    <li>If a pathogen is not identified, the duration of empirical therapy is determined by clinical response. Switch to oral therapy (as for localised infection) as soon as possible. A total duration of therapy (intravenous + oral) of 5 to 7 days is likely to be appropriate; however, a longer duration of therapy is needed for wounds involving the deeper tissues (such as bones, joints or tendons)</li>
                    <li>Careful cleaning, and debridement if necessary, of wounds that have been immersed in water is important to prevent infection</li>
                    <li>For patients with traumatic water-immersed wounds, ensure that tetanus immunisation is up-to-date</li>
                    <li>Seek expert advice if infection is associated with systemic symptoms or involves deeper tissues (such as bones, joints or tendons), or if localised infection progresses</li>
                    <li>The appropriate antibiotic regimen for definitive therapy depends on the pathogen. Collect samples of infected tissue or wound exudate for Gram stain, culture and susceptibility testing before antibiotic therapy is started. Modify therapy based on the results of culture and susceptibility testing.</li>
                    <li>See 'management of penetrating venomous marine wounds' in the Therapeutic Guidelines if managing a venomous marine injury</li>
                </ul>
                <hr/>
                <h4 class="mrgn20b references">
                    <span class="color-purple"><b>References: </b></span><br><br>
                    <span class="font15"><a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true" target="_blank">See section on water immersed wound infections</a> - Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
                </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html#home" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /watwo1a2c -->

</body>
<script src="bootstrap/js/script.js"></script>
<script src="bootstrap/js/test.js"></script>
<script src="bootstrap/js/email.js"></script>

</html>